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Phosphorylation cascades governed by two-component signal transduction systems 
provide key signalling mechanisms in bacteria, simple eukaryotes and higher plants, 
allowing them to translate signals into adaptive responses. These regulatory pathways 
consist of a transmembrane sensor protein that responds to an environmental cue leading 
to autophosphorylation, followed by the transfer of the phosphate to a cytoplasmic 
response regulator. Here, I study AtsR, a membrane-bound hybrid sensor kinase of 
Burkholderia cenocepacia, that negatively regulates quorum sensing related virulence 
factors such as biofilm, type 6-secretion and protease secretion. B. cenocepacia is a 
Gram-negative opportunistic pathogen which causes severe, chronic respiratory infections 
in patients with cystic fibrosis and other immunocompromised conditions. This bacterium 
is also pathogenic in animal, plant, nematode, and insect infection models, and can 
survive within amoebae and macrophages. Presumably, the ability to survive in various 
niches requires adaptability to deal with changing environments. I hypothesize that AtsR 
is part of a multi-protein phosphorelay pathway which plays a critical role in regulation of 
niche adaptation and survival of B. cenocepacia in different hosts. In this thesis, I 
investigated AtsR function by characterizing the role of critical functional residues within 
the individual domains of AtsR and identified its cognate response regulator AtsT as a 
key component of the AtsR phosphorelay pathway. Furthermore, subsets of genes that are 
directly regulated by the AtsR cognate response regulator were identified by Chromatin 
immunoprecipitation followed by next generation sequencing (ChIP-Seq) analysis and its 
corresponding consensus DNA binding site was determined. I also investigated the role of 





infection model. Together, these studies identified a new regulatory network that 
highlights the importance of bacterial virulence and pathogenicity with careful 
consideration of the host. This work may provide an understanding at the molecular level 
of bacterial adaptation to ever changing niche environments. 
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1. 1 Overview of two-component regulatory systems  
Bacteria like other living organisms, must be able to sense their environment and change 
their behavior in a timely manner in response to several different cues. They need to sense 
internal and external stimuli to adequately tune their cellular life. This requires changes in 
gene expression. One of the common mechanisms for bacterial adaptive responses to their 
surrounding environment is the two-component regulatory system (TCS). In 1986, Nixon 
and co-workers introduced the term "two-component regulatory systems" to describe their 
discovery that nitrogen assimilation proteins NtrB and NtrC of Bradyrhizobium sp. share 
strong similarity with other proteins such as EnvZ and PhoR in Escherichia coli, as well 
as VirA in Agrobacterium tumefaciens (1). They suggested that pairs of regulatory 
proteins with similar amino acid sequences respond to environmental stimuli and control 
diverse cellular processes. This finding was complemented with another discovery, also 
in 1986, that the TCSs utilize protein phosphorylation (2). A few years later, the Nobel 
Prize was awarded jointly to Edmond Fischer and Edwin Krebs for their work on protein 
phosphorylation as a biological regulatory mechanism. Since then hundreds of two-
component signalling proteins have been identified in bacteria [(3) and 
http://www.ncbi.nlm.nih.gov/Complete_Genomes/RRcensus.html].  
TCSs respond to an enormous range of signals (e.g. pH, temperature, nutrient availability, 
oxygen levels, etc) and control the regulation of a wide variety of cellular functions, 
virulence factors, chemotaxis, adaptation and survival. This provides a means for bacteria 
to detect environmental signals and process information and respond appropriately in a 
constantly changing environment. Therefore, understanding the mechanism of function of 





between the number of two-component regulatory proteins and the genome size (4) and 
some investigators have taken it to the extreme to use it as a criteria to explain bacterial 
intelligence (5). 
1.2 Signal transduction mechanism 
Bacterial TCS convert extra or intracellular signals into modification of gene expression 
via reversible protein phosphotransfer from histidine to aspartate (3). A canonical 
signaling pathway consists of a sensor kinase protein and a response regulator protein. 
The sensor kinase protein detects a stimulus and the histidine kinase (HK) domain 
autophosphorylates using the ɣ-phosphate of ATP and undergoes a conformational 
change.  This way, the information as a stimulus is converted into a high energy 
phosphoryl group that is then transferred to a conserved aspartate in the response 
regulator (RR) protein, which modulates gene expression accordingly (Fig. 1.1A) (6). 
There are two proteins in a canonical pathway, one with sensor and kinase function and 
the other as the receiver and effector function. In many cases there is an extended 
multistep phosphorelay and instead of only two, there are various phosphotransfer 
reactions (His-Asp-His-Asp). It typically initiates with a hybrid sensor kinase, which has 
a HK domain and a C-terminal receiver domain (Fig. 1.1B&C). The other essential 
module is a histidine phosphotransferase (Hpt) domain which may exist as a separate 
protein or as an addition to the hybrid sensor kinase. In such cases the phosphoryl group 
is transferred from histidine to aspartate within the hybrid sensor kinase and 
subsequently, to the histidine residue of the intermediate Hpt protein and finally to an 
aspartate of a terminal response regulator (Fig. 1.1C) (7). In the Bacillus subtilis Kin/Spo 







Figure 1.1: Schematic diagram representing two-component signal transduction. A) 
Schematic of a basic two-component model consisting of a sensor histidine kinase and a 
response regulator. A conserved histidine autophosphorylates and the phosphoryl group is 
transferred to an aspartate in the receiver domain of a response regulator. B) Illustration 
of a phosphorelay system with a hybrid HK containing both receiver domain and Hpt 
domain. The hybrid HK phosphorylates and transfers its phosphoryl group 
intramolecularly to its receiver domain and then to the Hpt domain. The phosphate is then 
transferred to the aspartate of the response regulator. C) A phosphorelay system with a 
hybrid sensor kinase and a separate intermediate Hpt protein. Blue box: sensory domain, 
light green box: HK domain, orange box: catalytic domain, red box: receiver domain, 
gray box: effector domain. His: histidine, Asp: aspartate, p: phosphoryl group, arrows 





proteins (8), while the Bordetella spp. BvgAS regulatory system (9) and the Burkholderia 
cenocepacia cblS and cblT genes encode multidomain hybrid sensor kinases (10). Such 
multistep phosphorelay pathways provide multiple phosphorylation checkpoints which 
may imply a better fine-tuning mechanism than a typical TCS. 
In most cases, sensor kinases can have both kinase or phosphatase activity; thus, it is 
ultimately the ratio of kinase to phosphatase activity that determines the level of RR 
phosphorylation (3). For those that do not have phosphatase activity, regulation occurs 
only at the level of autophosphorylation (11). Either of these activities can be regulated 
directly or indirectly by stimuli. Phosphotransfer itself can also be regulated. The C-
terminal Asp-containing domain of the hybrid sensor kinase VirA in A. tumefaciens 
interacts with the autophosphorylation site and modulates the phosphotransfer ability of 
the kinase core (12). 
1.3 Sensor kinases 
A typical sensor kinase protein is an integral membrane protein with at least two 
hydrophobic transmembrane (TM) helices (13) and a periplasmic sensor domain that is 
surrounded by the two TM helices. It should be noted that not all sensor histidine kinases 
possess two transmembrane domains. For example the sensor kinases KdpD and UhpB of 
E. coli have 4 and 8 predicted transmembrane helices, respectively (14). The cytosolic 
part of the protein is composed of a phosphorylation site and a catalytic ATP-binding 
domain that together form the kinase core of the protein which is connected to the second 
TM. Most kinases have a linker domain between the second TM and the kinase domain. 





linker domain is variable ranging from 40 to more than 180 amino acids forming α-
helical, coiled coil-like motifs (3). Sensor histidine kinases can be divided into two 
functionally and structurally distinct regions: the extracellular portion that senses stimuli, 
and the cytoplasmic domain involved in autophosphorylation and phosphotransfer to the 
cognate response regulator (Fig. 1.2). 
HK sensing proteins typically act as homodimers with the kinase domain of one subunit 
catalysing the phosphorylation of a second subunit (15, 16). With these characteristic 
properties hundreds of HK proteins can be identified through genome sequences but some 
aspects such as the type of perceived signals and interactions with auxiliary proteins are 
still poorly understood.  
1.3.1 Kinase domain 
The kinase domains contain several signature motifs including the H box with conserved 
histidine, followed by the N, G1, F, and G2 boxes which make the binding cleft (Fig. 
1.2). These motifs may exhibit different spacing across the kinase domain but they are 
arranged in the same order. The H box contains the site of histidine phosphorylation 
which is usually located approximately 110 amino acids from the N-box (3). Although the 
region surrounding the conserved histidine residue might have an influence on the ratio of 
autophosphorylation and phosphatase activities, substitution of this conserved histidine 
residue results in lack of enzymatic activities (17).  Furthermore, the N box itself has a 
critical role for kinase activity and ATP binding, as the magnesium ion connects the 
phosphate groups via hydrogen binding and is associated with the asparagines within the 









Figure 1.2: Schematic diagrams representing common domain organizations of sensor 
histidine kinases. Two TM domains are shown but kinases can harbor 1 to 13 TM 
domains. The cytosolic part consists of linker and kinase domains. Signature motifs H, N, 
G1, F and G2 are shown with common linker domains PAS, HAMP, and GAF. 
Abbreviation: HAMP: histidine kinase adenyl cyclase methyl-accepting protein and 
phosphatase; GAF: cGMP-specific phosphodiesterase adenylyl cyclase and FhlA; PAS: 







lid to secure bound ATP. Together these signature motifs form an ATP-binding cavity 
(19).  
1.3.2 Periplasmic sensory domains 
Unlike HK and receiver domains, periplasmic sensor domains do not share sequence 
homology as they may sense various signals. However, most of the known structures of 
periplasmic sensor domains include distinct structures such as mixed αβ, all-helical, and 
β-sandwiches. Some well-known examples of periplasmic domains with all-helices are 
represented by NarX with its sensor domain having an antiparallel four-helix bundle (20) 
and TorS with two antiparallel helix bundles (21). Examples of mixed αβ fold structure 
which is the most common form of periplasmic sensor domains exist in PhoQ, DcuS and 
CitA proteins (22). This form of structure often consists of central antiparallel β-sheets, 
surrounded by α-helices on both sides (22, 23). Some other HK proteins have β-sandwich 
folding sensor domains with two or more antiparallel β-sheets stacking back-to-back such 
as in RetS from P. aeruginosa (24).  
1.3.3 Cytoplasmic and transmembrane sensory domains 
Several HK proteins have been identified that lack a periplasmic sensing domain, such as 
the chemotaxis kinase CheA and nitrogen-regulating NtrB (3, 25). Although the 
periplasmic sensory domain is the most common type associated with HKs (22, 26), other 
classes of sensor domains include cytoplasmic and transmembrane domains. 
Cytoplasmic-sensing HKs exist both as membrane-embedded as well as fully soluble 






Sensing domains that involve multiple membrane-spanning regions are thought to sense 
changes associated primarily with the membrane; however, some of them have also been 
implicated in forming protein-protein interactions or binding various natural ligands (22), 
as well as antibiotics (26, 27) via transmembrane helices. 
1.4 Response regulators 
Response regulators are cytoplasmic proteins that associate with a histidine kinase sensor 
protein. This protein family has a receiver domain which contains a conserved aspartic 
acid residue that accepts the phosphoryl group from the phosphorylated HK. Response 
regulators have also a DNA-binding effector domain that generates the outputs of the 
signaling events (28). Like the C-terminus of HKs, the conserved receiver domain of RRs 
exhibits amino acid sequence homology to other RRs. The transfer of a phosphate group 
to the receiver domain activates the transcriptional regulatory domain, which 
consequently results in activation or repression of a given set of genes (29). In contrast to 
the receiver domain, effector domains are very diverse reflecting the variable functions 
controlled by TCSs. The majority of RRs are transcription regulators with a winged helix-
turn-helix (wHTH) DNA-binding motif, a helix-turn-helix (HTH) motif or β-strands. 
However, the effector domain in some RRs works as an enzyme or binds RNA or proteins 
to regulate bacterial cellular processes at different levels (30).  
According to Stock and co-authors, phosphorylation of the regulatory domain often 
changes the effector domain from inactive conformational state to an active form 
although phosphorylation does not necessarily correspond to activation (3). Activation 





higher-order oligomerization (36, 37), or interactions with other proteins (38, 39). The 
half life of the phosphorylated RR may vary from only a few seconds to several hours, 
depending on the type of response output.  For example, processes occurring in a narrow 
time frame such as chemotaxis require rapid dephosphorylation of RR to fine tune the 
response. The CheY has a very short half life to allow E. coli to respond quickly to 
changes in chemotactic gradients (38). In contrast, signal transductions that lead to major 
changes in gene expression have a very long half life (40).  
1.5 Specificity in two-component signaling pathways  
It is straightforward to identify histidine kinases and response regulators in bacterial 
genomes based on their sequence homology. Some bacterial genomes encode as many as 
250 of these signaling proteins (41). The ability of discriminating a cognate RR from the 
pool of many others by a phosphorylated HK is extremely important to avoid 
mistranslation of a signal into an inappropriate outcome. It is believed that interfering 
crosstalk is rare due to mechanisms such as molecular recognition and substrate 
competition which play a key role in insulating signalling pathways. In a study by 
Skerker et al in 2005, a systematic phosphotransfer profiling was performed in 
Caulobacter crescentus genome demonstrating that HKs have a global kinetic preference 
for their cognate response regulator in vitro (42). They proposed that kinetic preference of 
histidine kinases for their cognate response regulators is fundamental to insulation of 
signaling pathways and lies in the existence of conserved molecular characteristics that 
determine protein–protein interaction specificity. By mutating the specificity residues of 





interaction with its cognate partner, OmpR but phosphorylated RstA, the cognate 
regulator of RstB (43, 44). 
The relative cellular concentration of HK and RR also determines the specificity (45). 
The higher abundance of the RR with respect to HKs observed in vivo provides a 
competitive environment in which a cognate regulator outcompetes non-cognate 
regulators. This may be an evolutionary strategy to minimise unwanted interactions. 
These mechanisms maintain specificity of TCS pathways at the level of phosphotransfer. 
However, there are reports of crosstalk between TCSs that normally activate separate 
pathways (46). It should be noted that phosphotransfer between non-cognate sensors and 
regulators has been found only in vitro, or in vivo in the presence of constitutively 
expressed non-cognate proteins or in the absence of the cognate histidine kinase (47, 48). 
Therefore, the biological relevance of such crosstalk is unclear because the efficiency of 
the interaction should be studied under physiological conditions when proteins are present 
at normal levels. 
Spatial or temporal separation of different systems also maintains interaction specificity 
as some TCS proteins are expressed at certain developmental stages (45). Scaffold 
proteins can also be involved in forming large protein complexes with hybrid HKs that 
may reduce the chances for crosstalk (49).  
1.6 Two-component systems and signal integration  
Signal integration is a combined information processing event that occurs between TCSs 
in branched phosphorylation mode. There are two generic modes of signal integration in 





protein (many-to-one), or one single HK phosphorylates multiple RRs (one-to-many) 
triggering multiple outputs (Figure1.3 A&B). This is an effective way to integrate signals 
and control multiple outputs at once. 
A physiologically meaningful example of “one-to-many” branched regulation is found in 
bacterial chemotaxis, where the CheA phosphorylates two response regulators CheY and 
CheB (50). A more complex version of “many-to-one” mode is seen in the signal 
transduction system controlling sporulation in B. subtilis where five distinct sensor kinase 
proteins, KinA, KinB, KinC, KinD, and KinE phosphorylate the receiver domain of 
Spo0F, and then the Hpt-containing Spo0B protein. Finally, the signal is transferred from 
Spo0B to the Spo0A response regulator (7). Each of the five sensor kinases is capable of 
phosphorylating Spo0F with various efficiencies (51). Another example is the activation 
of NarL by NarQ and NarX in E.coli (52). In B. subtilis, signal integration also occurs 
between the pathways controlling respiration (ResE/ResD) and phosphate utilization 
(PhoR/PhoP) in which phosphorylation of PhoP is required for expression of ResD and 
vice versa (53). This is an example of communication between distinct signalling 
pathways that work in parallel and provide physiological benefits to bacterial cells by 













Figure 1.3: Schematic representation of signal integration by two-component regulatory 
systems. A) One-to-many branched signalling pathway in which one histidine kinase 
phosphorylates multiple response regulators. B) Many-to-one branched pathway in which 
multiple histidine kinases perceive similar or different signals and transfer it to one 











1.7 Genomic organisation of two-component systems  
Genes encoding proteins of similar function are usually clustered together in bacterial 
genomes; this way they are more likely transcribed together and manifest a particular 
phenotype (54). Such co-localisation in an operon greatly facilitates identification of 
interacting pairs of TCSs. However, in many cases the signalling partner is not in the 
vicinity of a TCS protein. It might be due to gene duplication or lateral gene transfer 
within and between species (55). It has been proposed that when bacteria occupy a wide 
variety of environmental niches or utilise different metabolic sources then gene 
duplication occurs with domain shuffling and thus results in duplicated genes with 
sequence differentiation from the parental gene (55). When such event happens to one of 
the two genes encoding TCS proteins it would introduce an orphan protein with new 
domain arrangements and possibly new sensory or regulatory functions which may 
become involved in cross-regulation. This is a possible explanation for the presence of 
several orphan Kin histidine kinases in B. subtilis which can all phosphorylate the same 
RR, Spo0F to integrate multiple inputs for fine tuning of the adaptive responses (56). 
1.8 Autoregulation 
 
Many TCSs regulate their own expression. In fact, regulation of HK gene expression by 
its cognate RR and also endogenous regulation of RR itself in the form of positive or 
negative feedback is not uncommon in bacteria. This autoregulation depends on the 
amount of input signal such as the one observed for the PhoQ/PhoP system in E. coli that 
under sufficiently high stimulus conditions PhoB levels are transcriptionally auto-tuned to 





Similarly, depending on the intensity of the signal, autoregulation positively modulates 
the sensitivity of the BvgS/BvgA system in Bordetella bronchiseptica (58).  Another 
important factor is the RR functioning as a switch depending on the proportion of 
phosphorylation (3). As mentioned above, some TCSs have rapid conversion to the 
inactive state to enable highly sensitive responses. In addition, all TCSs seem to have 
intrinsic mechanisms regulating RR phosphorylation levels which ensure proper feedback 
mechanism, thus eliminating the effects of potential crosstalk (59, 60).  
Negative autoregulation, in which the response regulator represses its own expression, 
has been reported for the CovS/CovR system in Streptococcus pyogenes, where 
phosphorylated CovR represses transcription of its operon (61). There are also response 
regulators such as TorR (62) and LuxO (63) that repress their own expression regardless 
of phosphorylation status. This might be part of a complex regulatory network that 
accessory proteins are involved and interact with either histidine kinase or response 
regulator and thus, autoregulation may affect the entire system by controlling the 
availability of the interacting proteins (64). In other cases, autoregulation provides a 
threshold for gene activation and only when a signal persists sufficient levels of HK or 
RR proteins are produced (65). 
1.9 Two-component systems and bacterial virulence 
To establish a successful infection, bacteria should coordinate the expression of genes 
required for niche adaptation and virulence in response to signals from the host 
environment. Therefore, TCSs play a sophisticated role processing various signals to 





extensively examined in Streptococcus pneumoniae when systemic inactivation of 13 
TCSs led to a significant reduction in virulence in an in vivo mice model (66). Another 
well-studied example, AgrA/AgrC TCS in S. aureus responds to cell density and controls 
the transcription of the regulatory RNA III (67). Other examples include the BvgA-BvgS 
TCS in Bordetella pertussis (68), the RscC/B two-component system in enteric E. coli 
that regulates capsule formation (69) and many others that are listed in Table 1.1. The 
role of TCSs in virulence is not limited to bacteria. Several fungal pathogens such as 
Aspergillus fumigatus (70), Cryptococcus neoformans (13), Blastomyces dermatitidis, 
Histoplasma capsulatum (71) and Candida albicans (72) use phosphorelay signalling to 
regulate virulence.  
Besides the central role of TCS in virulence, some are essential for bacterial growth. In 
particular, the WalK/WalR TCS responsible for cell wall metabolism is indispensable for 
growth in several Gram-positive species, including B. subtilis, Staphylococcus aureus, 
Enterococcus faecalis, Listeria monocytogenes, Staphylococcus epidermidis, S. 
pneumoniae, Streptococcus mutans, and S. pyogenes (73). Also, Helicobacter pylori has 
response regulators that were found to be essential for cell growth (74, 75). Essential 









Table 1.1: List of selected TCS involved in virulence. Homologues of the described 
systems are present in other bacteria. The list represented in Table 1.1 is not exclusive. 
Organism TCS Function Ref. 
S. aureus AgrC/AgrA Adhesion, secreted invasive factor (76) 
 ArlS/ArlR Expression of α-toxin, β-haemolysin, Lipase, 
Coagulase and protein A 
(77) 
 SrrB/SrrA Regulator of virulence factors in response to 
environmental oxygen levels 
(78) 
 SaeS/SaeR Expression of α-toxin, β-haemolysin, Coagulase  (79) 
P. 
aeruginosa 
GacS/GacA Lipase, Elastase, Biofilm (80, 
81) 
 AlgR/FlmS Twitching motility (82) 
 SadR/SadS Biofilm (83) 
 RetS T3SS and its effector genes (83, 
84) 
 PprB/PrpA Cell motility, quorum sensing (85) 
 PirS/PirR Iron aquisition (86) 
 PilS/PilR Pilus production (87) 
Brucella 
abortus 





MisR/MisS Composition of LOS inner core (89) 
Clostridium 
perfringens 
VirR/VirS Toxin and adhesion genes (90) 
Salmonella 
enterica 






 PmrA/PmrB Lipid A modification (93) 
 RcsC-
YojN-RcsB 
Colonic acid capsule synthesis, chemotaxis, 
motility 
(94) 





Invasion genes (96) 
E. faecalis FsrC/FsrA Protease activity, Quorum sensing (97) 
 VanS/VanR Vancomycin resistance (98) 
Enterococcus  
gallinarum  
VanS/VanR Vancomycin resistance (99) 
Vibrio 
cholerae 
ToxS/ToxR Expression of toxins (100) 
 ArcA/ArcB Virulence regulator gene toxT (101) 
S. 
pneumoniae 
CiaH/CiaR Competence, resistance to cefotaxim (102) 
 PnpS/PnpR Competence, phosphate regulation (66) 





 MicA/MicB Virulence attenuation (104) 
S. pyogenes CovS/CovR Expression of capsule, pyrogenic exotoxin B, 














PhoP/PhoR Intracellular growth in macrophages (108) 
 PrrA/PrrB Survival in phagosome environment   (109) 
 MprA/Mpr
B 




VirR/ VirS Virulence attenuation (111) 
B. pertussis BvgS/BvgA Toxin and adhesion expression, biofilm 
formation 
(112) 
H. pylori FlgR/FlgS Flagellar motility (113) 
 ArsR-ArsS Urease and acid resistance genes (114) 
Campylobact
er jejuni 
DccR-DccS Colonization defect (115) 
S. 
typhimurium 




PmrB/PmrA Polymyxin B (117) 
Legionella 
pneumophila 
CpxR/CpxA icmR and icm-dot genes (118) 
Bacteroides 
fragilis 




PhoP Virulence attenuation, reduced survival in 
macrophages 
(120) 
EHEC QseC/QseB Quorum sensing regulation (121) 









Table 1.2: List of essential TCSs adapted from Gotoh et al 2010 (123). 
TCS Organism Function Ref 
WalK/WalR S. mutans Biofilm formation (124) 
 S. aureus Cell wall metabolism (125) 
 S. pyogenes Cell wall metabolism (126) 
 S. pneumoniae Cell wall metabolism (127) 
 S. epidermis Cell wall metabolism (128) 
 E. faecalis Unknown (129) 
 L. monocytogenes Unknown (130) 
YhcS/YhcR S. aureus Unknown (131) 
HP165/HP166 H. pylori Unknown (75) 













1.10 Two-component systems and antimicrobial resistance 
In addition to being involved directly in virulence, a number of bacterial TCSs have been 
identified to play a central role in antimicrobial resistance. Considering the number of 
genes regulated by TCSs, it is not surprising that some are involved in modulating several 
aspects of adaptive functions related to antibiotic sensitivity. Some of those are listed in 
Table 1.1 that regulate the resistance to antimicrobial agents. For example, the EvgA 
response regulator modulates multidrug transporter genes expression and subsequently 
controls drug efflux in E. coli (133). The VanS/R in enterococci provides resistance to 
vancomycin by controlling the expression of the genes for the synthesis of cell wall 
precursors that have much lower affinity for vancomycin (98, 134). Same TCS in S. 
pneumoniae triggers multiple cell death pathways in response to penicillin and similar 
antibiotics, like cephalosporins and glycopeptides (135). Similarly, the LytS/R two-
component system contributes to penicillin-induced killing of S. aureus (136). These 
features make TCSs ideal targets for therapy as it permits a drug to target multiple 
systems in the same bacterium. 
1.11 Two-component systems and quorum sensing 
To establish a successful infection, bacteria need to reach a critical cell density at the site 
of infection. Bacterial cell to cell communication via chemical signaling molecules and 
subsequent coordination of the expression of virulence factors in response to bacterial 
population density is known as quorum sensing (QS) (137). This allows a population of 
bacteria to coordinately control the gene expression of the entire community and behave 





aureus. This system is activated in response to a secreted auto-inducing peptide (AIP) in a 
cell density-dependent manner. At a certain concentration of AIP, the sensor kinase AgrC 
is autophosphorylated and transfers the phosphate to the AgrA response regulator. 
Activated AgrA activates the expression of genes encoding secreted virulence factors 
(76). Vancomycin-induced cell death is also modulated by the VncS/VncR two-
component system in S. pneumonia in a cell density-dependent manner (135). Another 
example is the fsrC and fsrA genes in E. faecalis, which encode a sensor kinase and 
response regulator pair that respond to a biosynthesis-activating pheromone in a cell 
density manner. The Lux system in Vibrio harveyi is a well-studied hybrid quorum 
sensing circuit. When acyl-homoserine lactone (AHL) inducers are accumulated as a 
function of cell density they are detected by LuxN, LuxP and LuxQ. LuxN and LuxQ are 
hybrid sensor kinase and response regulator pairs that transduce information to LuxU and 
then to the response regulator LuxO that controls the transcription of LuxR which is also 
required for expression of the luciferase structural operon (luxCDABE) (138). These are a 
few examples that indicate the important role of TCSs in bacterial communication within 
and between species that allows bacteria to compete with other species inhabiting unique 
niches. 
1.12 Two-component systems as therapeutic targets 
Several features of TCSs make them excellent candidates for the development of 
antimicrobial agents. First of all, the nature of histidine to aspartate phosphotransfer 
mechanism utilized by bacteria and fungi is distinct from the serine/threonine signaling 
pathways in eukaryotes. This feature alone makes TCS a good antimicrobial target as for 





host.  Second, sensor kinases and response regulators have sequence similarity and 
similar mode of action irrespective of bacterial species (139). This may be used to design 
broad spectrum inhibitors that target common structural or functional features. Third, 
TCSs modulate a wide variety of cellular functions and thus targeting TCSs is equal to 
addressing multiple targets. This feature alone has additional benefits such as minimizing 
the emergence of resistance in response to antibiotics simply because multiple TCS with 
different functions exist, and alteration mechanisms utilised by bacteria would no longer 
be effective. This is unlike available antibiotics that have a very specific mechanism of 
action against one target only or limited number of targets.  
1.13 Burkholderia cenocepacia 
Burkholderia cenocepacia is an opportunistic pathogen that belongs to the Burkholderia 
cepacia complex (Bcc), a group of Gram-negative non-spore forming bacilli that consists 
of at least 17 phenotypically similar but genetically distinct species (140). Due to their 
diverse genetics and metabolic capacity the Bcc strains can be found throughout the 
environment (141). Also, because of their opportunistic nature they are capable of causing 
infections in vulnerable individuals including immunocompromised and cystic fibrosis 
(CF) patients.  
Historically, B. cenocepacia ET-12 was the dominant Bcc pathogen in the CF 
community, responsible for the largest CF epidemic across Canada, United Kingdom and 
Italy prior to 2002 with 67% prevalence followed by B. multivorans as the next most 
dominant Bcc species (17%) (142). However, its prevalence has been reduced and B. 





North America and UK (143). B. cenocepacia is also associated with poor prognosis and 
increased risk of developing cepacia syndrome (144). Because of these complications 
lung transplantation for CF patients infected with B. cenocepacia has a poor outcome and 
patients have a high morbidity and mortality rate (145). 
1.13.1 B. cenocepacia in the environment 
B. cenocepacia has also been isolated from different environmental sources, ranging from 
urban (146) and agricultural (147) soils, to Mexican radish (148), and raw milk (149). B. 
cenocepacia engages in both beneficial and pathogenic interactions with plants. For 
example B. cenocepacia has been identified to establish an endophytic relationship in the 
rhizosphere of onion (150) and maize (151). B. cenocepacia has also been isolated from 
the stem and roots of sugar cane promoting the production of the growth hormone IAA 
and inhibiting hyphal growth of Fusarium moniliforme (152).  
B. cenocepacia is beneficial to a few plants but there are several examples indicating its 
role as a phytopathogen. B. cenocepacia has been isolated directly from the lesions of 
field-grown onion bulbs and is the causal agent of banana finger-tip rot (153). Strain K56-
2 could cause the plant tissue watersoaking (PTW) phenotype which is an accumulation 
of fluids in the intracellular spaces of plant tissues caused by a loss of cell membrane 
integrity (154).  
Further evidence that supports the direct environmental acquisition of B. cenocepacia in 
patients was found in a soil isolate that was genetically identical to strains isolated from 
patients during the 1980s B. cenocepacia CF epidemic (147). In a comprehensive genetic 





multivorans were not distinguishable from environmental isolates recovered from diverse 
environments such as river water, onion, radish, maize rhizosphere, pharmaceutical 
solutions, hospital equipment, shampoo and industrial settings (148). All together, these 
features make B. cenocepacia an ideal model for studying niche adaptation and 
opportunistic pathogenicity. 
1.13.2 Virulence factors in B. cenocepacia  
The genome of B. cenocepacia J2315 is divided into three circular chromosomes and a 
plasmid encoding 7261 putative coding sequences (CDS) in 8 Mbp of genetic material 
(155). The genes are designated with a prefix (Bcal, Bcam, Bcas, or pBca) and a number. 
The genome possesses a number of virulence factors including quorum sensing (QS) and 
secretion systems that are putatively involved in pathogenicity of B. cenocepacia 
[reviewed in (156)]. 
QS is a form of bacterial communication that detects a signaling molecule  relative to cell 
density to regulate gene expression (157). B. cenocepacia has AHL-dependent and 
independent QS modules: The CepIR and CciIR systems modulate gene expression via 
two AHL synthases, CepI and CciI, which produce N-octanoylhomoserine lactone (C8-
AHL) and N-hexanoylhomoserine lactone (C6-AHL), respectively, and activate their 
cognate transcriptional regulator CepR or CciR (158, 159). Another QS module in B. 
cenocepacia that produces cis-2-dodecenoic acid (BDSF) in a cell density-dependent 
manner is AHL-independent (160). These QS regulatory systems together allow B. 
cenocepacia to fine-tune the expression of its virulence factors including biofilm 





expression (163). Another critical feature utilized by B. cenocepacia is the specialized 
secretion systems to translocate effector molecules into the host cell. The pathogenic 
potential of types III, IV, and VI secretion systems in B. cenocepacia have been examined 
in several infection models (164, 165), (155, 166) and (167). In particular, the T6SS is the 
most recently discovered and has been shown to mediate actin rearrangement in 
macrophages infected by B. cenocepacia (168).  Mutation in the T6SS of B. cenocepacia 
results in susceptibility to predation by the amoeba Dictyostelium discoideum (168).  
Furthermore, it has been established that the ability of B. cenocepacia to cause chronic 
infection is associated with several virulence factors including the expression of T6SS, 
which is important for bacterial survival in the in vivo rat model of chronic lung infection 
(167). Our laboratory identified AtsR (Adherence and T6SS Regulator) protein as a 
global regulator of the expression of several virulence factors including biofilm and the 
T6SS in B. cenocepacia (168). In addition to affecting biofilm and T6SS activity, the 
deletion of atsR in B. cenocepacia leads to overproduction of other QS-regulated 
virulence determinants including proteases and swarming motility (169). Deletion of atsR 
upregulated the expression of the QS genes and increased AHL production, suggesting 
that AtsR plays a significant role in timing and fine-tuning of virulence gene expression 
by modulating QS signalling (169). Since the deletion of AtsR affects multiple virulence 
factors, it is likely that it initiates a signaling cascade with broad activity. 
1.14 Hypothesis and project objectives 
The work described in this thesis uses B. cenocepacia K56-2, isolated from the lungs of a 
Canadian CF patient. K56-2 belongs to the ET-12 lineage, and is assigned to the same 





K56-2 strain and is predicted to be a putative hybrid sensor kinase. Therefore, I 
hypothesize that AtsR is part of a multi-protein phosphorelay pathway which plays a 
critical role in regulation of virulence factors in B. cenocepacia K56-2 via a cognate 
cytosolic transcriptional regulator. 
The specific objectives of this project are: 
1) To characterize the AtsR phosphorelay pathway and identify its corresponding 
response regulator. 
2) To identify the regulon of AtsR/AtsT signaling pathway by whole genome 
mapping via microarray and chromatin immunoprecipitation followed by Next 
Generation Sequencing. 
3) To determine the topology of AtsR protein and find the functional residues in the 
periplasmic loop. 
4) To determine the pathogenicity of B. cenocepacia in a plant infection model and 
study the subsequent events of plant-B. cenocepacia interaction. 
In Chapter Two, I characterized the mechanism of AtsR signal transduction pathway by 
studying each specific domain and identifying conserved residues required for 
autophosphorylation within the kinase domain. Furthermore, I identified AtsT as the 
cognate response regulator that contribute to phosphotransfer and determined its position 
in the regulatory cascade. The biological significance of AtsR/AtsT phosphorylation was 
also studied in vivo. 
In Chapter Three, I studied the AtsR/AtsT regulon using a combination of transcriptome 





genes and determined a conserved binding motif for AtsT-DNA binding. 
In Chapter Four, the AtsR topology was experimentally determined and functional 
residues within the periplasmic sensing domain were identified.  
In Chapter Five, I took a different approach to study the concept of virulence and 
pathogenicity of B. cenocepacia as an opportunistic pathogen in the context of host and 
its innate susceptibility to infection. I used Arabidopsis as an infection model and 
hypothesized that modifications in key bacterial molecules such as LPS and flagellin 
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Phosphorylation cascades governed by two-component signal transduction systems 
provide key signalling mechanisms in bacteria, Archaea, simple eukaryotes and higher 
plants, allowing them to translate signals into adaptive responses (1). These regulatory 
pathways consist of a transmembrane protein that responds to an environmental cue 
leading to autophosphorylation, followed by the transfer of the phosphate to a 
cytoplasmic response regulator (RR). The sensor protein has a variable region, dedicated 
to sensing a signal, and a conserved histidine kinase (HK) domain. The RR typically 
consists of a conserved receiver domain (RD) and a variable effector domain that binds to 
DNA. Upon perceiving the signal, the HK becomes autophosphorylated on its conserved 
histidine (His) residue and the phosphate transferred to a conserved aspartic acid (Asp) 
residue on the RR. More complex phosphorelay systems require multiple phosphoryl 
transfer reactions involving a hybrid sensor kinase that contains an extra domain serving 
as an RD, a histidine-phosphotransfer protein, and response regulator proteins (1, 2). 
Since the mechanism of phosphotransfer is from His to Asp, histidine-phosphotransfer 
proteins shuttle phosphoryl groups between a hybrid sensor kinase and a RR, providing 
additional checkpoints of regulation in signaling pathways (3, 4). 
Burkholderia cenocepacia is a Gram-negative opportunistic pathogen belonging to the 
Burkholderia cepacia complex, which causes severe, chronic respiratory infections in 
patients with cystic fibrosis and other immunocompromised conditions (5, 6). 
Furthermore, B. cenocepacia can also be found in maize roots (7), present in sewage (8), 
and cause banana fingertip rot (9) and onion rot (10). This bacterium is also virulent in 





within amoebae and macrophages (13, 14). We have previously identified AtsR 
(Adhesion and Type six secretion system regulator), which negatively regulates the 
expression of the quorum sensing-regulated virulence factors in B. cenocepacia (15, 16). 
B. cenocepacia strains encode two N-acylhomoserine lactone-dependent quorum-sensing 
systems, CepIR and CciIR, which coordinate the expression of ZmpA and ZmpB zinc 
metalloproteases and other virulence factors during infection  (17-21). In the absence of 
atsR, expression of cepIR and cciIR is upregulated and mediates early and increased N-
acylhomoserine lactone production, suggesting that AtsR plays a role in controlling 
virulence gene expression by modulating the timing of quorum sensing signalling (16). 
AtsR also represses the expression of virulence genes by an N-acylhomoserine lactone-
independent mechanism (16). Consequently, inactivation of atsR in B. cenocepacia also 
leads to increased biofilm formation, adherence to polystyrene and lung epithelial cells, 
extracellular protease secretion and expression of a type 6 secretion system (T6SS). The 
latter is exemplified by actin cytoskeletal rearrangement with the formation of 
characteristic “pearls on a string-like structures” around infected macrophages (15, 16, 
22). 
AtsR is a predicted membrane protein with two transmembrane domains, and a sensor 
kinase region (containing the HK and ATPase domains) attached to an RD with 
conserved Asp residues. AtsR lacks a DNA binding motif found in canonical response 
regulator proteins, which suggests that AtsR does not bind directly to the promoter 
regions of target genes and is likely part of a multistep signal transduction pathway. Two 
genes near atsR encode two putative components of the AtsR phosphorelay pathway. One 
is Bcam0381 (herein designated atsT), a gene co-transcribed with atsR (15). AtsT is a 





domain related to domains found in repressors (23) and a receiver domain with a 
conserved Asp at the C-terminus. The other is Bcam0378, which locates immediately 
upstream of atsR and encodes a hypothetical protein containing His and Asp residues that 
form part of a conserved motif, UPF0047 (24). BCAM0378 might be functionally 
necessary as a histidine-phosphotransfer protein intermediate to transfer the phosphate 
from AtsR to the putative response regulator AtsT. 
In this work, I studied the mechanism of AtsR function by characterizing the role of 
critical functional residues within the individual domains of AtsR using phosphorylation 
assays. I identified the conserved residues His-245 and Asp-536 as phosphoacceptor sites 
in AtsR. Furthermore, I provided in vivo and in vitro evidence that AtsR is a hybrid 
sensor kinase that regulates downstream cellular activities through direct phosphorylation 
of AtsT.  
2.2 Materials and methods 
2.2.1 Bacterial strains, plasmids and growth conditions 
Bacterial strains and plasmids used in this study are listed in Table 2.1. Bacteria were 
grown in Luria broth (8) (Difco) at 37 °C unless indicated otherwise. E. coli cultures were 
supplemented, as required, with the following antibiotics (final concentrations): 
tetracycline 30 μg/ml, kanamycin 30 μg/ml and trimethoprim 50 μg/ml. B. cenocepacia 
cultures were supplemented, as required, with trimethoprim 100 μg/ml, tetracycline 150 








Table 2.1:  Strains and plasmids 
Strain or plasmid        Relevant characteristics
a
                   Source/reference 
Strains 
B. cenocepacia  
K56-2         ET12 clone related to J2315, CF clinical isolate             
b
BCRRC  
K56-2atsR            Deletion of atsR in K56-2                (25) 
K56-2cepI            Deletion of cepI in K56-2                (16) 
K56-2atsRcepI           Deletion of cepI in K56-2 atsR                (16) 
K56-2atsR atsR+ Chromosomal atsR integration in atsR                         This study 
K56-2atsRcepI atsR+ Chromosomal atsR integration in atsRcepI            This study 
K56-2atsRcepI atsRH245A
+
 Chromosomal atsRH245A integration in atsRcepI        This study 
K56-2atsRcepI atsRD536A
+
 Chromosomal atsRD536A integration in atsRcepI        This study 
K56-2atsRcepI atsRRD+ Chromosomal atsR∆RD integration in atsRcepI       This study 
K56-2atsR atsRH245A
+
 Chromosomal atsRH245A integration in atsR            This study 
K56-2atsR atsRD536A
+
 Chromosomal atsRD536A integration in atsR            This study 
K56-2atsR atsRRD+ Chromosomal atsRRD integration in atsR            This study 
K56-2atsRcepI +atsT atsRD536A     Deletion of atsT in atsRcepI atsRD536A
+
            This study 
K56-2atsRcepI +atsT atsRRD  Deletion of atsT in atsRcepI atsR∆RD+                    This study 
K56-2atsR atsT atsRD536A
+ 
          Deletion of atsT in atsR atsRD536A
+
            This study 
K56-2atsR atsT atsRRD+          Deletion of atsT in atsR atsRRD+                  This study 
K56-2cepI atsT            Deletion of atsT in cepI                   This study 
K56-2cepI atsT atsT +    Chromosomal atsT integration in cepI atsT             This study 
K56-2cepI atsT atsTD208A 
+
     Chromosomal atsTD208A integration in cepI atsT
          
This study 
K56-2atsRhcp           Deletion of hcp in atsR                 (25) 
E. coli 




) deoR          Laboratory stock 
 thi-1 nupG supE44 gyrA96 relA1 ∆(lacZYA-argF)U169, λ– 
BL21 F
- 




) gal λ(DE3)  Laboratory stock 
GT115               F
– 
mcrA ∆(mrr-hsdRMS-mcrBC) 80∆lacZ∆M15 ∆lacX74  
                          recA1 rpsL endA1∆dcm uidA(∆MluI)::pir-116 ∆sbcC-sbcD        Laboratory stock 
Plasmids 
pAtsRChr                 atsR cloned in pMH447 for chromosomal complementation           This study 





pAtsRD536AChr       atsRD536A cloned in pMH447 for chromosomal complementation     This study 
pAtsR∆RDChr      atsR∆RD cloned in pMH447 for chromosomal complementation      This study 
pAtsTChr      atsT cloned in pMH447 for chromosomal complementation            This study 
pAtsTD208AChr      atsTD208A cloned in pMH447 for chromosomal complementation       This study 




, expressing I-SceI, SacB                   (26) 
pET28a(+)        Cloning vector, IPTG inducible, N-terminal His, Kan
R               
Laboratory stock 
pDelatsT                    pGPI-SceI with fragments flanking atsT            This study  
pDelM0378                 pGPI-SceI with fragments flanking bcam0378            This study 
pMK1 pET28a(+) encoding B. cenocepacia bcam0378, 6X His: kan
R
            This study 
pMK2 pET28a(+) encoding B. cenocepacia atsT, 6X His: kan
R
             This study 
pMK4 pET28a(+) encoding B. cenocepacia atsR-RDD536A, 6X His: kan
R
          This study 
pMK5 pET28a(+) encoding B. cenocepacia atsRD536A, 6X His: kan
R
             This study 
pMZ24 pET28a(+) encoding B. cenocepacia atsR205-605, 6X His: kan
R 
          M. AlZayer 
pMZ25 pET28a(+) encoding B. cenocepacia atsR, 6X His: kan
R
          M. AlZayer 
pMZ33 pET28a(+) encoding B. cenocepacia atsR-HK, 6X His: kan
R
          M. AlZayer 
pMZ34 pET28a(+) encoding B. cenocepacia atsR-RD, 6X His: kan
R
           M. AlZayer 
pMZ36 pET28a(+) encoding B. cenocepacia atsR atsRH245A,6X His:kan
R              
M. AlZayer 
pMH447 pGPI-SceI derivative used for chromosomal complementation                      (27) 










, trimethoprim resistance, Kan
R
, kanamycin resistance, Tet
R
, tetracycline resistance. 
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2.2.2 General molecular techniques 
DNA manipulations were performed as described previously (29). T4 DNA ligase (Roche 
Diagnostics, Laval, Quebec, Canada) and Antarctic phosphatase (New England Biolabs, 
Pickering, Ontario, Canada) were used as recommended by the manufacturers. 
Transformation of E. coli DH5α and E. coli GT115 was done using the calcium chloride 
method (30). Mobilization of complementing plasmids and mutagenesis plasmids into B. 
cenocepacia K56-2 was performed by triparental mating using E. coli DH5α carrying the 
helper plasmid pRK2013 (28, 31). DNA amplification by PCR was performed using Bio-
Rad C1000
TM
 Thermal Cycler with Taq or HotStar HiFidelity DNA polymerases (Qiagen, 
Canada). DNA sequences of all primers used in this study are described in Table 2.2. 
DNA sequencing was performed at the DNA sequencing Facility of York University, 
Toronto, Canada. BLAST was used to analyse the sequenced genome of B. cenocepacia 
strain J2315.  
2.2.3 Plasmid construction and chromosomal complementation  
Unmarked and non-polar deletions were performed as described previously (16, 32). To 
delete atsT (Bcam0381) and Bcam0378, PCR amplifications of regions flanking these 
genes were performed individually using 2844-2836 and 2840-2839 primer pairs for atsT 
and 4009-4010 and 4011-4012 primer pairs for Bcam0378. The amplicons were digested 
with the restriction enzymes XbaI-XhoI and XhoI-EcoRI respectively, and cloned into the 
mutagenic plasmid pGPI-SceI digested with XbaI and EcoRI giving rise to pDelatsT and 
pDelM0378. To create His-tagged fusions of BCAM0378, AtsT, AtsR and its truncated 





(residues 488 to 606), AtsR∆TM (residues 205 to 606), and AtsR∆RD, sequences were 
amplified from B. cenocepacia K56-2 genomic DNA using primers 5798-5799; 5108-
5109; 4632-4633; 4799-4634; 4800-4736; 4634-4633; 4632-4799, respectively (Table 
2.2). Amplicons were digested with the appropriate restriction enzymes and ligated into 
similarly digested pET28a cloning vector. pET28a (Novagen) was used to engineer C-
terminally His-tagged proteins for expression in E. coli BL21. Site-directed mutagenesis 
was performed using the QuikChange Site-Directed Mutagenesis Kit from Stratagene 
(Santa Clara, California), as recommended by the supplier. Primers were designed with 
15-20 nucleotides flanking each side of the targeted mutation. Plasmid pMZ25 was used 
as a template to create H245A and D536A using 4880-4881 and 5959-5960 respectively. 
Plasmid pMK2 was used as a template to create D208A using 6997-6998. The resulting 
PCR products were digested with DpnI and introduced into E. coli DH5α. All constructs 
and replacement mutants were confirmed by sequencing. 
Chromosomal complementations of ∆atsR, ∆atsR∆cepI or ∆cepI∆atsT were performed 
using the pMH447 plasmid (26, 27). Primers 5866-4632 was used to PCR amplify atsR 
and its mutated versions. The amplicon was digested with NdeI-XbaI and cloned into the 
similarly digested pMH447, giving rise to pAtsRChr, pAtsRH245AChr, pAtsRD536AChr and 
pAtsR∆RDChr. Likewise, primers 7020-7021 was used to PCR amplify atsT and its 
mutated version. The amplicons were digested with NdeI and cloned into the similarly 







Table 2.2: Oligonucleotide primers 

















4009 TTTTTCTAGACACCGAGCAACGCTACAC XbaI 
4010 TTTTCTCGAGCGTGATGGCCTGTTGCAT XhoI 
4011 TTTTCTCGAGGATATCGTGCTGCATCT XhoI 
4012 TTTTGAATTCACCTCGTCGTGCTCGATCT EcoRI 
4632 AAAACATATGACGCGGCGGCGATGGAAGAA NdeI 
4633 AAAAGCGGCCGCGGCGAGCAGTGTCTCGACGA NotI 
4634 AAAACATATGCGCACGCGCGACGACCT NdeI 
4736 AAAAGCGGCCGCTCAGGCGAGCAGTGTCTCGACGA NotI 
4799 AAAAGCGGCCGCTCATTCGACCGGCAGCGTCAC NotI 







5108 AAAACATATGTCCACCACCGAGCAGGCCAA NdeI 
5109 AAAAGAATTCTCAGTTCGTCGCGGCCGCTG EcoRI 
5798 TTTTTTTCATATGCAACAGGCCATCACG NdeI 
5799 TTTTGCGGCCGCCTACTCGCCGAGCAGATG NotI 
5866 TTTTTCTAGAGCTTTGTTAGCAGCCGGATC XbaI 
5885 TTGATGGCGAGCGATTCTTC N/A 
5886 CCAGTTCTTCAGCGTGACGA N/A 
















   
*Restriction endonuclease sites incorporated in the oligonucleotide sequences are underlined. 









2.2.4 Protein expression and purification 
For over-expression and purification of recombinant proteins, a single colony was 
inoculated in LB broth supplemented with 30 μg/ml of kanamycin and grown at 37 ºC. 
Optical Density (OD600) was monitored until it reached 0.6. The culture was then shifted 
to 30 ºC and 0.2 mM isopropyl-beta-D-thiogalactopyranoside was added to induce the 
expression of proteins. Cultures were incubated for an additional 4 h. Samples were 
analyzed by SDS-PAGE and stained with Coomassie blue to check the induction of 
proteins. Cells were harvested by centrifugation at 8,000 xg for 10 min. Cell pellets were 
resuspended in lysis buffer containing [(50 mM Na phosphate pH 8, 0.3 M NaCl, 10 mM 
imidazole pH 8.0, 10% glycerol, 0.25% Tween 20, and 1X of EDTA-free protease 
inhibitor cocktail (Sigma))], and disrupted by One Shot cell disruptor (Thermo Scientific, 
Rockville, MD, USA). After centrifugation at 27,000 xg for 30 min at 4 ºC to remove the 
debris, the clarified cell lysate was loaded onto a Ni
+2
-binding sepharose beads, washed, 
and the His-tagged proteins were then eluted using increased gradient concentrations of 
imidazole (125-500 mM). Fractions were analyzed by SDS-PAGE and stained with 
Coomassie blue to determine the integrity of the purified protein. Fractions were pooled 
and buffer-exchanged against dialysis buffer (100 mM Tris-HCl pH 8, 50 mM KCl, 5 
mM MgCl2, 1 mM dithiothreitol (DTT), 10% glycerol) using Thermoscientific Slide-A-
Lyzer mini dialysis devices. Proteins were concentrated in Amicon ultrafiltration devices 
(10 kDa molecular weight cut off) and protein concentration was determined by standard 
Bradford assay (Bio-Rad, Hercules, CA). The purity of proteins was evaluated by SDS-






2.2.5 In vitro phosphorylation assay 
For autophosphorylation and phosphotransfer reactions 5 µmol of each protein was added 
to the phosphorylation buffer containing 50 mM Tris-HCl pH 8.0, 50 mM KCl, 5 mM 
MgCl2, 1 mM DTT and 5 µCi [γ-
33
P]-ATP (specific activity of 3000 Ci/mmol; 3.3 µM 
stock solution) (Perkin Elmer). The reactions were carried out at room temperature for the 
desired time and were terminated by adding 3X sample buffer (32). Experiments were 
conducted in presence or absence of the response regulator in a final volume of 10 µl. The 
reaction products were separated by electrophoresis on 14% SDS-PAGE gels. Gels were 
fixed, exposed to a high-resolution screen (Kodak), and analyzed using a Phosphorimager 
with ImageQuant software (Molecular Dynamics 5.0; Amersham Biosciences). For pulse-
chase experiments, an excess of nonradioactive ATP (20 mM) was added to the reaction 
mixture following a 10-min pre-incubation with (γ-33p) ATP. Aliquots were taken prior to 
the addition of unlabeled ATP (time zero) and at various time points after the addition of 
cold ATP.  
2.2.6 Analysis of chemical stability of H245-p and D536-P 
Phosphorylated AtsR and AtsRD536A proteins were prepared as described above and 
treated with 1 M HCl, 1 M NaOH or left untreated for 45 min at RT. The HCl reaction 
was neutralized with 0.25 vol. of 2 M Tris pH 8 and analyzed by 16% SDS-PAGE 
followed by Phosphorimager. 
2.2.7 Protease, swarming motility and biofilm formation assays 
Protease assays were performed as described previously (16). Briefly, 18 h cultures were 





brain heart infusion (D-BHI) agar plates containing 1.5% carnation milk. The plates were 
incubated at 37 °C and examined for zones of clearing around the bacterial spots at 48 h. 
The protease activity was recorded by measuring the radius of the surrounding halo (from 
the outside of the spot to the edge of the halo). Swarming motility assays were performed 
as described previously (16). Three μl of overnight culture, adjusted to an OD600 of 1, was 
spotted on a swarm plate (0.8% Nutrient Broth, 0.5% agar, 0.2% glucose). Plates were 
incubated at 37 °C for 20 h and the diameters of swarming zones were measured. Biofilm 
formation assays were performed as described previously (15). Assays were done in 
triplicate and repeated independently three times.  
2.2.8 Macrophage infections and T6SS activity 
Infections were performed as previously described (15) using the C57BL/6 murine bone 
marrow-derived macrophage cell line ANA-1. Bacteria were added to ANA-1 cells grown 
on glass cover slips at a MOI of 50. Cover slips were analysed by phase contrast 
microscopy after 4 h of incubation at 37 °C. T6SS activity was recorded as the ability of 
the bacteria to induce the formation of characteristic ectopic actin nucleation around the 
macrophages (15, 22).  
2.2.9 Western blot analysis 
For E. coli, overnight bacterial cultures in 5 mL of LB were diluted to an initial OD600 of 
0.2 and incubated at 37 °C until reaching an OD600 of 0.7. At this point, isopropyl-beta-D-
thiogalactopyranoside was added to a final concentration of 0.2 mM. Cells were 
incubated for 4 h at 30 °C and were then harvested by centrifugation at 8,000 xg for 10 





using a One-shot cell disrupter (Thermo Scientific, Rockville, MD, USA). Cell debris 
were removed by centrifugation (15,000 xg for 15 min at 4 °C), and the clear supernatant 
was centrifuged at 40,000 xg for 30 min at 4 °C. The pellet, containing total membranes, 
was suspended in lysis buffer. The protein concentration was determined by the Bradford 
assay (Bio-Rad, Hercules, CA). Staining was performed with Coomassie brilliant blue. 
SDS–PAGE, protein transfers to nitrocellulose membranes and immunoblots were 
performed as described (34). For detection of 6xHis-tagged proteins, membranes were 
incubated with a 1:10,000 dilution of anti-His IgG2a monoclonal antibodies (Amersham, 
Piscataway, NJ) and Alexa Fluor 680 anti-mouse IgG antibodies (molecular probes). For 
B. cenocepacia, overnight bacterial cultures in 5 ml of LB were diluted to an initial OD600 
of 0.2 and incubated at 37 °C for 8 h. His-tagged proteins were purified and detected by 
Western blot using an anti-His antibody as indicated above.  
2.3 Results and discussion 
2.3.1 Deletion of atsT causes the same phenotypes as ∆atsR mutants 
I reasoned that if AtsT (BCAM0381) was involved in the AtsR phosphorelay pathway, 
∆atsT and ∆atsR mutants should have similar phenotypes. Therefore, ∆atsT was tested in 
our macrophage infection model. Phase-contrast microscopy revealed that, in contrast to 
K56-2, ∆atsR and ∆atsT noticeably induce the formation of "pearls on a string-like 
structures" around infected macrophages (Fig. 2.1). These structures depend on T6SS-
mediated rearrangements of host actin, and are characteristic of an upregulated T6SS (15, 
16, 22). B. cenocepacia ∆atsR∆hcp, a T6SS defective mutant, was used as a negative 
control during the infections (25), and as expected it did not mediate the "pearls on a 





showed increased biofilm formation as evidenced by a robust ring of biofilm at the air-
liquid interface (Fig. 2.1B). Together, these results strongly suggest that AtsT and AtsR 
are in the same regulatory pathway, which is likely initiated by AtsR. 
2.3.2 Identification of phosphoacceptor residues within AtsR 
The region of AtsR corresponding to the HK domain (amino acids 233-457) was aligned 
with the HK domain of two well-characterized hybrid sensor kinase proteins, ArcB from 
Escherichia coli and RetS from P. aeruginosa (3, 35-37). The amino acid sequence of 
AtsR (606 amino acids) is 34% identical and 50% similar to that of ArcB, and 26% 
identical and 48% similar to that of RetS. The invariant His residue that is the site of 
autophosphorylation in these proteins corresponds to His-245 in AtsR. Also, the AtsR-RD 
(amino acids 488-601) showed 52% and 50% similarity at the amino acid level to ArcB 
and RetS, respectively. This region has an invariant Asp at position 536, which 
corresponds to the site of phosphorylation in ArcB and RetS. 
Truncated versions of AtsR spanning AtsR-HK and AtsR-RD were constructed and 
purified to analyze their biochemical properties. Residues 1-200, comprising the 
membrane spanning domains were removed to facilitate protein solubility and 
purification. Furthermore, to assess the contribution of conserved His and Asp residues to 
AtsR phosphorylation, His-245 and Asp-536 were individually replaced by alanine (Fig. 
2.2A). The truncated proteins along with the mutated polypeptides were assessed for their 
autophosphorylation activity in vitro using [γ-33P]-ATP. Only the polypeptides containing 
His-245 underwent autophosphorylation (Fig. 2.2B, lanes 1 and 3). Therefore, AtsR HK 







Figure 2.1 T6SS activity and biofilm formation of B. cenocepacia K56-2 wild-type and 
its mutant derivatives. A) Phase-contrast microscopy of infected ANA-1 murine 
macrophages to assess T6SS activity. Infections were performed at a multiplicity of 
infection of 50 for 4 h. The arrows indicate the presence of ectopic actin nucleation 
(“pearls on a string” phenotype; 15; 22) extending from infected macrophages, which 
denotes T6SS activity. B. cenocepacia K56-2 ∆atsR∆hcp, a T6SS defective mutant, was 
used as a negative control during the infections. Experiments consisted of three 
independent biological repeats where similar results were obtained. B) Biofilm formation 
by parental strains, ∆atsR and ∆atsT mutants. B. cenocepacia K56-2 wild-type and 
derivative mutants were tested for biofilm formation by crystal violet staining. Arrows 
indicate the ring corresponding to the biofilm formation characteristic in ∆atsR and ∆atsT 
mutants. The experiment was repeated three times in triplicates and pictures were taken 





pathway since the replacement of His with alanine at position 245 abolished 
autophosphorylation (Fig. 2.2B, lanes 2 and 6). Moreover, the AtsR-RD is unable to 
autophosphorylate in the absence of the HK domain (Fig. 2.2B, lane 4). The ability of 
AtsR-RD to accept the phosphoryl group from the AtsR-HK was tested in a 
phosphotransfer assay (Fig. 2.2B, lanes 5-7). Two bands were obtained after incubating 
AtsR-HK and AtsR-RD together in a reaction with [γ-33P]-ATP (Fig. 2.2B, lane 5). These 
bands corresponded to the phosphorylated form of these proteins, indicating the transfer 
of phosphoryl group from the HK domain to the RD domain of AtsR. To test whether 
Asp-536 within AtsR-RD is the residue accepting the phosphate from His-245, AtsR-
RDD536A was added to the reaction with AtsR-HK and [γ-
33
P]-ATP. No band 
corresponding to AtsR-RDD536A was detected (Fig. 2.2B, lane 7) clearly indicating that 
Asp-536 is necessary for phosphorylation. 
2.3.3 Chemical stability of phosphorylated proteins 
Phosphor amidates, such as histidine or lysine phosphate, are stable in alkali conditions 
but extremely labile to acid. Acyl phosphates such as aspartate and glutamate are, on the 
other hand, labile to either pH extremes (38). To compare wild-type AtsR and AtsRD536A 
chemical stability, phosphorylation reactions were performed for each, and the products 
were subjected to either no treatment or treatment with acid or alkali. If the wild-type 
AtsR protein is phosphorylated at both His-245 and Asp-536 and the AtsRD536A is 
phosphorylated at only His-245, the two proteins should behave distinctively upon 
treatment with base.  As shown in Fig. 2.2C (lanes 5-6), AtsR and AtsRD536A were both 
labile to acid and relatively stable to base (lanes 3-4), indicating that these two proteins 







Figure 2.2: Functional analysis of AtsR domains. A) Schematic domain organization of 
AtsR and its derivatives (domains are not drawn to scale). The predicted sites of 
phosphorylation are His-245 (H245) and Asp-536 (D536). TM: transmembrane domain, 





Alanine. B) In vitro phosphorylation assays. Purified proteins were added in a standard 
phosphorylation mixture [100 mM Tris-HCl pH 8, 50 mM KCl, 5 mM MgCl2, 1 mM DTT, 5 
µCi [γ-33P]-ATP] and incubated for 15 min at 25 °C. Samples were resolved on 16% SDS-
PAGE gel. The phosphorylated proteins were visualized using a phosphorimager (top). 
Phosphorylated and non-phosphorylated proteins were revealed by Coomassie Blue 
staining (bottom). The location of phosphorylated bands is denoted with arrows. C) 
Chemical stability of phosphorylated proteins. Phosphorylated AtsR (lanes 1, 3 and 5) 
and AtsRD536A (lanes 2, 4 and 6) were treated with 1 M NaOH or 1 M HCl or were left 
untreated for 45 min at RT. The reactions were neutralized with 2 M Tris pH 8 and 


















wild-type AtsR protein before and after alkali treatment in Fig. 2.2C, I concluded that at 
least a portion of the wild-type protein may be phosphorylated at the Asp-536. In 
quantitative analysis using densitometry, the wild-type AtsR retained 82 ± 6% of its label 
after alkali treatment compared with the untreated control, whereas the AtsRD536A mutant 
retained 91 ± 5% of its label. These results therefore suggest that the majority of 
phosphate present in both AtsR and AtsRD536A is in the form of amidyl phosphate. 
2.3.4 AtsR and AtsT form a cognate HK-RR pair 
I initially hypothesized that BCAM0378 could be a histidine-phosphotransfer protein 
component of the AtsR phosphorelay based on the proximity of Bcam0378 to atsR 
(Bcam0379) and bioinformatic data indicating the presence of highly conserved His and 
Asp residues within this family of proteins. To investigate the relationship between AtsR, 
BCAM0378 and AtsT we performed phosphotransfer assays employing combinations of 
these different proteins. The histidine-phosphotransfer candidate, BCAM0378 was not 
phosphorylated (Fig. 2.3, lanes 1, 2 and 3). To rule out the possibility of a rapid 
phosphotransfer from AtsR to BCAM0378, we repeated the experiment by reducing the 
incubation time from 10 min to either 1 or 5 min and increasing the temperature to 30 ˚C. 
A phosphorylated form of BCAM0378 was never detected in any condition tested (data 
not shown). However, AtsT was phosphorylated directly by AtsR and independently from 
BCAM0378 (Fig. 2.3, lane 4). To test whether AtsT autophosphorylates independently 
from AtsR, we incubated AtsT with AtsRH245A and BCAM0378 (Fig. 2.3, lane 3). No 
phosphorylated band was detected indicating that AtsT is unable to autophosphorylate, 
and it requires the HK domain of AtsR with the native His-245 to be phosphorylated. 






Figure 2.3: Phosphotransfer from AtsR and its derivatives to the AtsT response regulator. 
Five µmol of AtsR, AtsRH245A and AtsR-HK, was pre-incubated in individual standard 
phosphorylation mixtures for 15 min at 25 °C, followed by addition of 5 µmol of AtsT 
and /or BCAM0378. Reactions were terminated by adding 3x SDS-PAGE loading buffer 
after 15 min. Samples were resolved on 16% SDS-PAGE gel and stained with Coomassie 
Blue (Bottom). Phosphorylated proteins were visualized by a phosphorimager (Top). 
Phosphorylated bands corresponding to the expected mass of AtsR, AtsR-HK and AtsT 






transduction from a sensor kinase to a response regulator, and BCAM0378 is not involved 
in the transfer of the phosphate from AtsR to the AtsT under the conditions tested. This 
conclusion was supported by the lack of the "pearls on a string" phenotype in 
macrophages infected with a ∆Bcam0378 mutant (Fig. 2.1A), strongly suggesting that 
BCAM0378 is not part of the AtsR regulatory pathway. 
2.3.5 Kinetics of AtsR phosphorylation 
A pulse-chase experiment was performed to determine the stability of AtsR 
phosphorylation in the presence of AtsT and to determine whether phosphorylation of 
AtsT can take place independently from AtsR in excess of ATP. If AtsT is 
phosphorylated from the free nucleotide pool, then an excess of unlabeled ATP should 
compete with hot ATP for AtsT phosphorylation in a pulse-chase reaction. Conversely, if 
AtsR phosphorylates AtsT, then the label should be chased from AtsR to AtsT. AtsR was 
incubated with [γ-33P]-ATP for 10 min, and an excess of unlabeled ATP (20 mM) and 
AtsT were simultaneously added to the reaction. Labelling of AtsT coincided with 
immediate loss of signal from phosphorylated AtsR (Fig. 2.4A). A decrease of 
phosphorylation of nearly 50% was observed between time zero (pre-incubation) and 2 
min (Fig. 2.4C). Phosphorylated AtsR was highly stable, and the signal remained 
relatively strong at 60 min. We repeated this experiment and chased phosphorylated 
proteins for up to 80 min, and phosphorylated bands were still visible (data not shown). 
To control the quality of unlabeled ATP, AtsR was incubated simultaneously with both 
labeled and unlabeled ATP for 10 min, followed by the addition of AtsT (Fig. 2.4B). No 
labelling of AtsR or AtsT was detected in the control reaction indicating that 





Figure 2.4: Kinetics of phosphotransfer from AtsR to AtsT. A) Five µmol of AtsR was 
pre-incubated with 5 µCi [γ-33P]-ATP in a standard phosphorylation mixture for 15 min 
and then 5 µmol of AtsT and 20 mM ATP were simultaneously added to the reaction. The 
reaction was chased over time at 25 °C. Aliquots were removed before and after the chase 
at the times indicated. Reactions were terminated by adding SDS-PAGE loading buffer. 
Samples were run on 16% SDS-PAGE gel and stained with Coomassie Blue (bottom). 
Phosphorylated proteins were visualized by a phosphorimager (top). The images shown 
here are the representatives of two independent repeats. B) Five µmol of AtsR was 
incubated simultaneously with both labeled and unlabeled ATP for 10 min, followed by 
the addition of 5 µmol of AtsT and incubated for 15 min. Samples were run on 16% SDS-
PAGE gels and stained with Coomassie Blue (left) or visualized by a phosphorimager 
(right). C) The y-axis represents the percentage of normalized absorbance of densitometry 






with labeled ATP in the reaction. Thus, AtsR phosphorylation at His-245 is stable, and 
AtsT phosphorylation is resistant to competition from excess ATP, which confirms that 
AtsT acquires its phosphate directly from AtsR. 
2.3.6 The role of Asp-536 on AtsR-AtsT phosphorylation kinetics 
To determine the effect of Asp-536 on phosphotransfer, AtsR and AtsRD536A were 
incubated with [γ-33P]-ATP for 10 min in individual reactions to make a pool of 
phosphorylated proteins, followed by the addition of AtsT to each reaction. The rate of 
phosphate incorporation to the RR was followed as a function of time. The D536A 
replacement did not abolish the ability of AtsR to autophosphorylate, but the 
phosphotransfer capabilities of the parental and AtsRD536A proteins were quite different. 
The transfer of phosphate from AtsR to AtsT took place not only slower but also at a 
lower rate than from AtsRD536A to AtsT. Indeed, more than 90% of the phosphate was 
transferred from AtsRD536A to AtsT after 90 sec, and the amount of label gained by AtsT 
was almost equal to that lost by AtsRD536A (Fig. 2.5A and B). The increase in AtsT 
phosphorylation correlates with the disappearance of the AtsR and AtsRD536A 
phosphorylation signals. In contrast to native AtsR, where the phosphorylation signal was 
maintained from 2 min until the end of the experiment, phosphorylation of AtsT by 
AtsRD536A was rapidly detected 1 min after addition of RR to the reaction and the signal 
of AtsRD536A had already disappeared after 2 min under the conditions tested (Fig. 2.5B). 
Together, these results indicate that replacing Asp-536 with alanine increases and 
accelerates the phosphotransfer reaction to the RR. It also might be due to the fact that 





therefore, the persistence of the signal on wild-type protein is the result of Asp-536 
phosphorylation. 
2.3.7 In vivo reconstitution of the AtsR signalling pathway 
B. cenocepacia secretes two zinc metalloproteases ZmpA and ZmpB (17-21). Deletion of 
atsR upregulates the expression of several quorum sensing regulated virulence factors, 
including swarming motility and the secretion of zinc metalloproteases, both of which are 
also positively regulated by the CepI/CepR quorum sensing system (16). Moreover, 
whereas a ∆cepI mutant was protease deficient at 48 h when spotted on D-BHI milk agar 
plates, further deletion of atsR in ∆cepI resulted in increased proteolytic activity 
demonstrating that deletion of atsR upregulates protease activity independently of quorum 
sensing (16). We took advantage of the protease and swarming motility phenotypes to 
investigate whether AtsR phosphorylation is required for its function in vivo. The mutant 
strains ∆atsR and ∆atsR∆cepI were complemented at the chromosomal level with full-
length atsR or atsR variants encoding either AtsRH245A, AtsRD536A or AtsR lacking the RD 
(AtsR∆RD) eliminating the putative effect of other conserved Asp residues adjacent to 
Asp-536. The ability of AtsRH245A, AtsRD536A and AtsR∆RD to suppress the phenotypes 
of ∆atsR and ∆atsR∆cepI mutant backgrounds was first assessed using protease secretion 
assay (Fig. 2.6A). As expected, the radius of halo corresponding to casein degradation 
surrounding the ∆atsR spot was bigger compared to that of the wild-type within 48 h of 
incubation while no halo was present for ∆cepI (Fig. 2.6A and B). Proteolytic activity 
was also detectable for ∆atsR∆cepI to a lesser extent compared to WT and ∆atsR (Fig. 
2.6A, top row, and Fig. 2.6B). Successful complementation was achieved when a 







Figure 2.5: Kinetics of phosphotransfer from AtsR and AtsRD536A to AtsT. After 10 min 
of pre-incubation of 5 µmol AtsR (A) or AtsRD536A (B) in a standard phosphorylation 
mixture, AtsT was added to the reaction and aliquots were removed at the times indicated. 
The reaction was performed at 25 °C and terminated by adding SDS-PAGE loading 
buffer. Samples were run on 16% SDS-PAGE gel and stained with Coomassie Blue (top). 
Phosphorylated proteins were visualized with a phosphorimager (middle). The images 
shown here are the representatives of two independent repeats. The y-axis represents the 
percentage of normalized absorbance of densitometry readings from bands corresponding 








decreased protease activity to WT and ∆cepI levels, respectively (Fig. 2.6A, middle and 
bottom row, and Fig. 2.6B). 
 Since Asp-536 significantly increases the phosphotransfer from His-245 to AtsT in vitro, 
one could have expected that complementation of ∆atsR with AtsRD536A would have a 
stronger inhibitory effect than atsR in vivo. However, similar results were obtained when 
either atsR∆RD or atsRD536A was introduced to ∆atsR or ∆atsR∆cepI, respectively. This 
suggests that Asp-D536 does not have a strong modulatory effect on the AtsR-AtsT 
phosphotransfer in vivo under the conditions tested, or alternatively, that additional 
components not identified in this study may be involved in modulating the AtsR-AtsT 
phosphorelay pathway. 
In contrast, the phosphorylation status of AtsR is critical for its role in expression and/or 
secretion of proteases, as complementation failed when atsRH245A was introduced. These 
strains were also tested in a swarming motility assay. In agreement with previous results, 
only complementation of ∆atsR∆cepI strains with atsR or atsR∆RD, but not atsRH245A, 
could restore swarming motility to ∆cepI levels (Fig. 2.7). Protein expression was 
confirmed by Western blot analysis of bacterial membrane pellets prepared from K56-2 
∆atsR and ∆atsR∆cepI complemented with atsRH245A, atsRD536A, atsR∆RD and atsR and 
demonstrated that the encoded AtsR variants were similarly expressed (Fig. 2.6C). Thus, 
a lack of complementation by atsRH245A was not due to a defect in protein expression. 
Together, these data confirm the in vitro results and suggest that His-245 is essential for 








Figure 2.6: Proteolytic activity of B. cenocepacia K56-2 wild-type, ∆atsR, ∆atsR∆cepI 
and ∆cepI mutants and complemented mutants at the chromosomal level in different 
genetic backgrounds. A) Proteolysis was tested on D-BHI milk agar plates. The plates 
shown are representatives of three experiments performed in triplicate. Zones of clearing 
around the colonies were measured at 48 h of incubation at 37 °C. B) Values are average 
radius ± S.D. in millimeters of three experiments performed in triplicate. C) Anti-His 
Western blot analysis of His-tag purified AtsR, AtsR∆RD, AtsRD536A and AtsRH245A in B. 
cenocepacia. Arrows indicate the positions of full-length AtsR (AtsR, AtsRD536A and 










Figure 2.7: Swarming motility. B. cenocepacia K56-2 wild type and derivative mutants 
(A) and ∆atsR∆cepI mutant complemented by the integration of atsR, atsR-H245A, and 
atsR∆RD at the chromosomal level (B) were tested for swarming motility. The plates are 
representatives of at least three experiments performed in triplicate. The extent of the 













To confirm that AtsT is the cognate response regulator, which negatively controls the 
expression of protease activity, atsT was deleted in ∆atsR, ∆atsR∆cepI and ∆cepI strains 
which were then complemented with atsRD536A, atsR∆RD, atsT or atsTD208A. The resulting 
strains were spotted on D-BHI milk agar plates (Fig. 2.8A & B) and the proteolysis 
quantified by measuring the radius of clearing around the colonies (Fig. 2.8C). While 
complementation of ∆atsR and ∆atsR∆cepI strains with atsRD536A or atsR∆RD reduced the 
proteolytic activity to WT and ∆cepI levels (Fig. 2.6), further deletion of atsT bypassed 
the atsRD536A or atsR∆RD complementation and resulted in an increase of proteolytic 
activity. Furthermore, ∆cepI∆atsT has the same phenotype as ∆atsR∆cepI and as 
expected, by complementing ∆cepI∆atsT with atsT, proteolytic activity decreases to 
∆cepI levels whereas, atsTD208A is unable to complement. These results suggest that (i) 
AtsT indeed acts as a negative regulator, and (ii) is a direct target of AtsR contributing to 
the regulatory role of this protein on proteolytic activity and (iii) Asp-208 on AtsT is 
required for its function. 
2.4 Conclusion 
The predicted structural features of AtsR suggested this protein could not directly control 
gene expression because it lacks an effector domain. We demonstrate here three key 
properties of AtsR: (i) upon autophosphorylation AtsR transfers the phosphate to the 
response regulator AtsT without the participation of an intermediate histidine-
phosphotransfer protein; (ii) AtsR function in vitro and in vivo depends on 
autophosphorylation of the His-245 residue, which is absolutely essential for initiation of 
signal transduction; (iii) the AtsR-RD and more specifically the Asp-536 to some extent 






Figure 2.8: Proteolytic activity of B. cenocepacia ∆atsT, ∆atsR∆atsT atsR∆RD+, 
∆atsR∆cepI∆atsT atsR∆RD+, ∆atsR∆atsT atsRD536A+ and ∆atsR∆cepI∆atsT atsRD536A+.  
A) atsT was deleted from B. cenocepacia K56-2∆atsR atsR∆RD+, ∆atsR∆cepI 
atsR∆RD+, ∆atsR atsRD536A+ and ∆atsR∆cepI atsRD536A+ backgrounds. Mutants were 
tested on D-BHI milk agar plates. Zones of clearing around the colonies were measured at 
48 h of incubation at 37 °C. B) atsT was deleted from B. cenocepacia K56-2∆cepI 
background and the resulting strain was complemented with either atsT or atsTD208A at 
chromosomal level. Mutants were tested on D-BHI milk agar plates. C) Values are 
average radius in millimetres of three experiments performed in triplicates. The plates 





Other studies have shown that the sequential phosphotransfer between residues within the 
same hybrid sensor kinase modulates the phosphotransfer to the cytosolic response 
regulator and the overall response by determining the specificity for the cognate RR or by 
regulating the autokinase activity (2, 3, 39-42). The stability of the phosphorylated AtsR 
and AtsT determined by the pulse-chase kinetic experiments is remarkable as these 
proteins can maintain the response memory for at least 60 min, which agrees with their 
physiological function as negative regulators of gene expression. Comparative studies 
have suggested that the in vitro assay of HK autophosphorylation reflects, to a certain 
extent, the in vivo situation (43). For example, ArcB, NarQ, and NtrB with a high rate of 
phosphotransfer but a low level of autophosphorylation are able to respond quickly to 
changes in the environment thereby returning to the steady-state levels after transient 
activation or repression by external stresses, whereas, CheA and BaeS showed high levels 
of self-phosphorylation even though they had a slow signal transduction rate (43). In the 
case of AtsR, we find that the phosphate is transferred very quickly within 2 min from 
AtsR to AtsT, and both proteins are capable of prolonged phosphorylation. This may 
indicate that unlike some other systems (44, 45), AtsR might not have phosphatase 
activity although further experiments are needed to validate this notion. Based on the 
consistency of results obtained by in vitro and in vivo experimental approaches in this 
study, we propose a model (Fig. 2.9) in which AtsR autophosphorylates in vivo at His-
245. The phosphate is then transferred to AtsT and partly to the AtsR receiver domain on 
Asp-536, as stable phosphorylation of the AtsR receiver domain was detected in vitro. 
Our data strongly support the notion that AtsR phosphorylation has a significant 
biological relevance as a global virulence regulator modulating the expression of 











Figure 2.9: Diagram indicating the regulatory relationship between AtsR and 
corresponding response regulator and its effect on proteolytic activity.  OM, outer 
membrane; IM, inner membrane; His, histidine; Ala, alanine; Asp, aspartic acid; HTH, 
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Burkholderia cenocepacia is a prevalent member of the B. cepacia complex (Bcc), a 
group of closely related Burkholderia species that establish chronic lung infections in 
cystic fibrosis (CF) patients (1). Infection by B. cenocepacia can be transmitted from 
patient to patient and may lead to “cepacia syndrome”, a fatal form of necrotizing 
pneumonia (2). Experimentally, B. cenocepacia was shown to be virulent in several 
infection models including zebrafish (3), Arabidopsis (4), alfalfa, nematodes (5), and 
insect infection models (6), and can survive within amoebae and macrophages (7, 8). 
Survival in macrophages was also demonstrated in the lungs of infected patients 
undergoing transplant (9). This wide range of hosts and survival capabilities underscore 
the high adaptability of B. cenocepacia to establish infection in different niches, which 
may in part depend on regulatory networks allowing this bacterium to survive in different 
environments. Two-component system (TCS) regulators play a major role in regulation, 
as they allow coordinated expression of complex networks via changes in the expression 
of multiple genes in response to environmental cues (10).  
We have previously identified AtsR (Adhesion and Type 6 secretion system Regulator)  
as a global virulence regulator in B. cenocepacia that modulates quorum sensing (QS) 
signalling and consequently the expression of QS-regulated virulence factors including 
biofilm formation and expression of a Type 6 secretion system (T6SS) (11, 12). I recently 
showed AtsR is a hybrid sensor kinase that regulates downstream cellular activities 
through direct phosphorylation of AtsT. Autophosphorylation of a conserved histidine 
initiates a signal transduction phosphorelay into its cognate response regulator AtsT (13). 





domain related to domains found in transcriptional repressors (14) and a C-terminal 
receiver domain with a conserved aspartate at position 208 at the C-terminus (13). 
Deletion of either atsR or atsT in B. cenocepacia K56-2 or amino acid replacements 
blocking phosphotransfer from AtsR to AtsT lead to increased extracellular proteolytic 
activity, attributed to a significant increase in the expression of metalloproteases, and 
swarming motility, in addition to overexpression of the T6SS (13). This indicated AtsT is 
regulated directly by AtsR via phosphorylation and consequently, controls the expression 
of the downstream components in the AtsR/AtsT signalling pathway (13).  
In this work, I compare transcriptional responses of atsR mutant with AtsT genomic 
binding-location data to identify direct and indirect regulatory targets of the AtsR/AtsT 
signalling pathway, which is a key step to elucidating this regulatory network in B. 
cenocepacia. Expression profiles of B. cenocepacia lacking functional AtsR have been 
used to define AtsR-regulated genes. Since transcriptional analysis alone cannot 
distinguish between direct and indirect regulatory effects, we employed chromatin 
immunoprecipitation (ChIP) followed by sequence identification of the DNA fragments 
associated with the precipitated AtsT as the transcriptional regulator. This is a method of 
choice for mapping protein-DNA interactions on a genome scale in eukaryotes and has 
been recently utilized for mapping the genomic binding sites of bacterial transcriptional 
regulators (15, 16). 
To determine the binding locations of AtsT in B. cenocepacia, bioinformatic analyses of 
sequences corresponding to AtsT-enriched regions were used to predict individual 
binding sites and to search for a binding motif. The AtsT binding sites were then 





in the ∆atsR background. This combination of genome-wide approaches allowed us to 
identify additional operons under direct AtsT control, thereby providing a more complete 
understanding of the functional role of AtsR/AtsT signalling pathway in B. cenocepacia. 
3.2 Materials and methods 
3.2.1 Bacterial strains, plasmids and growth conditions 
Bacterial strains and plasmids used in this study are listed in Table 3.1. Bacteria were 
grown in LB at 37 °C unless indicated otherwise. Escherichia coli cultures were 
supplemented, as required, with the following antibiotics (final concentrations): 
tetracycline 30 μg/ml, kanamycin 30 μg/ml and trimethoprim 50 μg/ml. B. cenocepacia 
cultures were supplemented, as required, with trimethoprim 100 μg/ml, tetracycline 150 
μg/ml, ampicillin 200 μg/ml and polymyxin B 20 μg/ml. 
3.2.2 General molecular techniques 
DNA manipulations were performed as described previously (21). T4 DNA ligase (Roche 
Diagnostics, Laval, Quebec, Canada) and Antarctic phosphatase (New England Biolabs, 
Pickering, Ontario, Canada) were used as recommended by the manufacturers. 
Transformation of E. coli DH5α and E. coli GT115 was done by the calcium chloride 
method (22). Mobilization of complementing plasmids into B. cenocepacia K56-2 was 
performed by triparental mating using E. coli DH5α carrying the helper plasmid 
pRK2013 (23). DNA amplification by PCR was performed using Bio-Rad C1000
TM
 
Thermal Cycler with Taq or HotStar HiFidelity DNA polymerases (Qiagen, Canada). 
DNA sequences of all primers used in this study are described in Table 3.2. DNA 





Table 3.1: List of strains and plasmids 
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mcrA ∆(mrr-hsdRMS-mcrBC) 80∆lacZ∆M15 




Plasmids   
PGSVTP-lux Mobilizable suicide vector containing the lux operon, 
OriT; TpR 
(17) 
PDA154 pBcas0627::luxCDABE transcriptional fusion in 
pGSVTp-lux 
This study 






pMH447 pGPI-SceI derivative used for chromosomal 
complementation 
(18) 











, expressing I-SceI, SacB (20) 
pMK3 pET28a(+) expressing AtsT-His, kanR (13) 





K56-2 ET12 clone related to J2315, CF clinical isolate 
b
BCRRC 
K56-2atsR  Deletion of atsR in K56-2 (13) 
K56-2atsR::atsR Chromosomal atsR integration in K56-2 atsR (13) 
K56-2 atsRcepI Deletion of cepI in K56-2 atsR This study 
K56-2 
atsRcepI::atsR 
Chromosomal atsR integration in K56-2 atsRcepI This study 
K56-2 atsT   Deletion of atsR in K56-2 This study 





K56-2 atsTcepI  Deletion of cepI in K56-2 atsT This study 
K56-2 
atsTcepI::atsT   
Chromosomal atsT integration in K56-2 atsRcepI This study 
K56-2::PDA154 K56-2, pBcas0627::pGSVTp-luxCDABE; TpR This study 
PDA35::PDA154 K56-2atsR, pBcas0627::pGSVTp-luxCDABE This study 
DFA155 K56-2atsR::atsR, pBcas0627::pGSVTp-luxCDABE  This study 




MK111 K56-2atsT, pBcas0627::pGSVTp-luxCDABE This study 
MK112 K56-2atsT::atsT, pBcas0627::pGSVTp-luxCDABE This study 
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Table 3.2: List of primers 
Primer  
No. Primer Name Primer Sequence 
   5195 0627prom-For-Eco TTTTGAATTCGTCGCTTTGTCTACCACCAG 
5196 0627prom-Rev-Eco TTTTGAATTCGGGTATTTTCCTCACGTTTC 
2794 bcam0381-Rev-XbaI  TTTTTCTAGAGTTCGTCGCGGCCGCT 
5885 MH447-For TTGATGGCGAGCGATTCTTC 
5886 MH447-Rev CCAGTTCTTCAGCGTGACGA 
7128 Bcal3312 -For TATAGAATTCCGGAACCCGCGCCAATCTTA 
7129 Bcal3312-Rev TATACCATGGAGCGCGATCAGCCAGTGCAA 
7167 Bcas0627- For-IDY682 CGTGCCGTTTTCTGCCGTGTC 
7168 Bcam0192- For CGGAAAGAATATGAGAATGTCCG 
7169 Bcam0192-Rev GGGACTCTCCTAGTAATGTC 




7204 Bcam0382-For CTCGATGGGGTCTCCAGGGG 
7224 6-FAM-Bcas0627- For CGTGCCGTTTTCTGCCGTGTC 
7225 6-FAM-Bcam0382- For CTCGATGGGGTCTCCAGGGG 
7536 SigE-RT-For AGGAAACCAACCGTCAGATG 
7537 SigE-RT-Rev GCGACGGTATTCGAACTTGT 
7540 MtgA-RT-For GAAGAGCTACATCCGCAAGG 
7541 MtgA-RT-Rev TCGCGGGAATCTTGTAGTAA 
7546 DppA-RT-For ACTTCACCGACATGGGTCTC 
7547 DppA-RT-Rev GAATTCCATCGCCATGTTCT 
7548 FlhD-RT-For RACCAGCGAAATGCTCAGTG 
7549 FlhD-RT-Rev CATACCCATCGCCTTGTCTT 
7550 bcam0382-RT-For GGAGAAGTGGCTGTCGATC 
7551 bcam0382-RT-Rev CCGAGTACCAGTAGCCGTA 
7552 0338-RT-For ACCAACTACAGCGACGATCC 
7553 0338-RT-Rev ATCAGCTTGACCTGCGTCTT 
7554 ArgD-RT-For GTGATGGTGCCGGTATTTTC 
7555 ArgD-RT-Rev GTCCAGCACCTTCAGCAGTT 
7556 Bcal0849-RT-For CGACATCACCGAGAAGTTCA 
7557 Bcal0849-RT-Rev CCCTTCTGCTTCATCAGGTC 
7558 Bcal0511-RT-For GTTCGATGACGCGAAATTCT 
7559 Bcal0511-RT-Rev GTTGCAGTGGAAGAACACGA 
7595 FliC-RT-For GTTGCACAGCAGAACCTCAA 
7596 FliC-RT-Rev GGTTCAGACCGTTGATCTGG 





7598 Bcal0051-RT-Rev GCGATAGATGATGGTCGTGA 
7599 1293-RT-For CATCTCCGACTGCAAACCA 
7600 1293-RT-Rev AAGAATCGGTCCATGACAGC 
7601 Bcal0340-RT-For CGACTGCGGAAGTGTTCAA 
7602 Bcal0340-RT-Rev CGTAATGGTTTTGTGCGAACT 
7603 Bcas0080-RT-For ATTCTCGGGTTCACGATGG 
7604 Bcas0080-RT-Rev CGAACAGCAGGTTCAGTCCT 
7605 Bcas0034-RT-For AAGTGGCGTTCTGGGAGAAT 
7606 Bcas0034-RT-Rev CGATGATTTCGCCGTAGAGT 
7607 189-RT-For CGGGTTTTGGTATGACGACT 
7608 189-RT-Rev CTCGATCAGCACGTAATCTCC 
7609 Bcas0118-RT-For GCAGGAACTCGAAGCACAAC 
7610 Bcas0118-RT-Rev GCGAAATTCCCAAAAGCTC 
7611 0627-RT-For GCGACAAGGAATCGAAAAAG 
7612 0627-RT-Rev TACGGATAGCCCGAGTACCA 
7613 Bcas0110-RT-For CGTCACCGATACGAAGATCC 
7614 Bcas0110-RT-Rev TGTCCTTGAAGCTGTCGTTG 
7615 Bcal1296-RT-For GCCGCTCTCAAACATGAAAT 
7616 Bcal1296-RT-Rev CAGGTGTTGAAACCGTGTTG 
7617 Bcal1079-RT-For GGTGTACAGCGACAACCTCA 














Canada. BLAST was used to analyse the sequenced genome of B. cenocepacia strain 
J2315. 
3.2.3 Chromatin immunoprecipitation 
Despite several attempts for in vivo chromatin immunoprecipitation the assay failed 
(Appendix A) and we developed an in vitro assay that captures the AtsT protein bound to 
its corresponding DNA regions. DNA was isolated from K56-2 WT as described 
previously (11). Purified AtsT-His or BSA was added to the K56-2 DNA in a reaction 
buffer containing poly dI-dC, 10 mM Tris (pH 7.5), 120 mM KCl, 20% glycerol, 1 mM 
MgCl2 and 1 mM MnCl2 and incubated for 30 min at room temperature. Formaldehyde 
was added to the final concentration of 0.05% for 5 min followed by DNAse I digestion 
for 1 min. The reaction was incubated at 70 °C for 10 min and the AtsT-DNA complex 
was pulled down using sepharose beads coated with anti-His antibody. The reaction was 
incubated with beads for 1 h at 4 °C followed by washing with a buffer containing 100 
mM sodium phosphate, 600 mM NaCl and 10 mM imidazole. The AtsT-DNA complex 
then was eluted using increased gradient concentration of imidazole (120-400 mM). The 
eluates were incubated at 65 °C overnight to reverse crosslinks. Samples were incubated 
with 8μL of 10 mg/mL RNaseA for 2 h at 37 °C and then with 4 μL of 20 mg/mL 
proteinase K at 55 °C for 1h and were purified with Qiagen MinElute Reaction Cleanup 
Kit and confirmed with PCR using primers to amplify Bcas0627. Experiments were 
performed in triplicate. 
3.2.4 Next-Generation Sample Preparation and Sequencing  





submitted to the Sequencing Core Facility in the Robarts Research Institute, University of 
Western Ontario, Canada, and processed for library construction and Illumina MiSeq 
1x50 bp SE sequencing cartridges. Samples were processed by end repairing and the 
addition of a polyA tail as described by NEBNext ChIP-Seq sample preparation protocols 
from NewEngland Biolabs. The sequence reads were mapped to the B. cenocepacia 
J2315 genome using CLC genomic workbench software. A read track was created and 
unmapped reads were deleted. The detection of the enrichment was performed based on 
the comparison with the control sample to correct for sequencing biases such as genomic 
regions that are more accessible or repeated regions. Peak shape filter was applied to the 
experimental data to call peaks and a score was calculated at each genomic position. The 
score was obtained by extracting the genomic coverage profile of a window centered at 
the genomic position and then comparing this profile to the peak shape filter. The result 
of this comparison was defined as peak shape score. Once the peak shape score for the 
complete genome was calculated, the center of the peak was then identified as the 
genomic region with the highest peak shape score and the boundaries were determined by 
the genomic positions where the peak shape score becomes negative. The threshold for 
reporting peaks was set as Maximum P-value for peak calling 0.001, 0.0005 or 0.0001. 
Other parameters were set to the most stringent mode possible allowing maximum 
mismatch of 2, Insertion cost at 3, Deletion cost at 3, Length fraction at 0.5 and Similarity 
fraction at 0.8. We combined the peaks generated from all three samples and required that 
a peak be called in at least two of the three experiments to be considered an AtsT binding 
site. The average fragment length was 126 bp and a window size of 250 bp.  The peaks 
were then annotated with nearby genes including the name of the nearest 5' and 3' genes, 





3.2.5 Motif detection 
Sequences associated with peaks were extracted and used for motif analysis using 
MEME-ChIP (24) with motif occurrence set as ‘‘zero or one per sequence’’, minimum 
width as 6 and other parameters as default.  
3.2.6 RNA isolation and quantitative RT-PCR 
K56-2 ΔatsT and K56-2 WT cells were grown overnight and then diluted to OD600 of 
0.05 in 5 ml of LB. Cells were grown at 37 °C to the OD600 of 0.7 at 200 rpm then 
collected by centrifugation at 16000 ×g for 1.5 min. RNA was prepared using the 
Promega SV RNA isolation kit and treated with DNAse I (Qiagen Inc., Mississauga, ON, 
Canada) following the manufacturer’s protocol. cDNA was prepared from 1 µg of RNA 
using Qiagen cDNA synthesis kit. For ChIP-seq peak validation, relative-abundance 
quantitative RT-PCR (qRT-PCR) was performed with Wisent Fast SYBR green mix 
using Applied Biosystems StepOne Plus Real time PCR system. The thermal cycling 
conditions were 95 °C for 2 min, 40 cycles at 95 °C for 3 sec, 60 °C for 30 sec, and 72 °C 
for 15 sec. After the PCR a melt curve was obtained by increasing the temperature from 
72 °C to 95 °C in 1 °C increments. Each gene was normalized with RpoE (Bcam0918) as 
an endogenous control and fold changes were calculated using the 2
-∆∆CT
 Method (25). 
Data were calculated from 3 independent experiments in triplicate. 
3.2.7 Transcriptional fusions to luxCDABE and luminescence assays 
The promoter region from Bcas0627 was PCR amplified using primers 5195-5196. The 
PCR product was digested with EcoRI and cloned into the EcoRI digested and 





region of Bcas0627 fused to the luxCDABE reporter system. The plasmid was mobilized 
into K56-2 and the appropriate mutants by triparental mating. Transconjugants were 
selected on LB agar plates containing 100 μg/ml of trimethoprim (Tp), 200 μg/ml 
ampicillin and 20 μg/ml gentamicin. 
Luminescence assays were performed as described (12) to measure the expression of 
Bcas0627 in different mutant backgrounds including K56-2 WT, ∆atsR, ∆atsT, 
∆atsR::atsR (∆atsR complemented at the chromosomal level with atsR), ∆atsR∆cepI, 
∆atsR∆cepI::atsR, ∆atsT::atsT and ∆atsT∆cepI::atsT (Table 3.1). Overnight cultures 
were diluted into fresh medium with trimethoprim 100 mg/ml at OD600 of 0.05. Three 
hundred μl of sample was loaded in triplicate in a 100-well honeycomb microtitre plate 
for Bioscreen C automated microbiology growth curve analysis. Growth rates were 
followed by measuring the OD600 at 37 °C every hour under continuous shaking. At 6 h, 9 
h, 12 h, 15 h and 18 h post-inoculation, the Bioscreen was paused and three aliquots from 
each strain were transferred into a flat bottom 96-well microtiter plate (Microfluor 
2White, Thermo Scientific) and luminescence (in RLU) was measured using a Fluoroskan 
Ascent FL (Thermo Labsystems). Expression levels of each gene of interest in the 
different strain backgrounds were calculated as RLU/OD600 for each of the six time-
points. Each experiment was repeated independently two times. 
3.2.8 Protein purification and Electromobility Shift Assays 
 C-terminal His-tagged AtsT and AtsR expressed in E. coli BL21 were purified by 
affinity chromatography as described before (13). Five-prime oligos labeled with 





purified with QIAquick PCR purification kit (Qiagen) and incubated with various 
concentrations of AtsT-His in the presence of poly dI-dC and run on a native 
polyacrylamide gel (8%) in 1X TBE buffer. Band shifts were visualized by Odyssey 
imaging system (Licor Biosciences). Experiments were repeated three times.  
3.2.9 Non-radioactive DNase I footprinting  
To examine AtsT binding sites identified by ChIP-seq, we used fluorescently labeled 
primers in standard DNase I protection assays using an Applied BioSystems 3730xl DNA 
analyzer. DNA fragments (approximately 250 bp in size) containing predicted AtsT 
binding sites were amplified using a primer labeled with the 6-carboxyfluorescein (6-
FAM) fluorescent dye. PCR products were purified using the QIAquick PCR purification 
kit (Qiagen). Binding reaction mixtures consisted of 150 ng of labeled DNA probe and 5-
10 µM AtsT in binding buffer (30 mM Tris-HCl pH 7, 1 mM MnCl2, 120 mM KCl, and 1 
mM MgCl2). These were incubated at 37 °C for 10 min, transferred to room temperature, 
and allowed to cool for 2 min. DNase I (0.1 U or 0.2 Unit enzyme; New England 
BioLabs) was added to the reaction mixtures and digestion was allowed to proceed for 2 
min at room temperature. The reaction was stopped by the addition of DNase I stop 
solution (20 mM EDTA pH 8, 1% SDS, and 200 nM NaCl). The DNA was purified with 
QIAquick PCR purification kit (Qiagen) and submitted to the Carver Biotechnology 
center at Illinois University for fragment analysis on an Applied BioSystems 3730xl DNA 
analyzer. The results were visualized using Gene mapper Software.  
3.2.10 Gene expression profiling with microarray 





Diluted cultures of B. cenocepacia K56-2 and the K56-2 atsR::pDA27 mutant, DFA21, 
were grown at 37 °C until exponential phase, harvested and immediately used for RNA 
extraction. Total RNA was isolated using a RiboPure-Bacteria kit (Ambion, Austin, TX), 
according to the manufacturer’s instructions. RNA samples were treated with 8 U of 
DNaseI, which was inactivated using DNase inactivation reagent (Ambion, Austin, TX). 
RNA was concentrated with LiCl and the concentration of RNA samples was measured 
using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Wilmington, 
DE). RNA integrity was assessed by agarose gel electrophoresis and by measuring the 
ratio of absorbance at 260 nm to 280 nm (values obtained between 2.0 and 2.2). RNA was 
prepared in three independent experiments for microarray analysis. Labeled cDNA was 
synthesized from RNA using CyScribe Post Labeling kit (GE Healthcare) and hybridized 
to custom B. cenocepacia microarrays (Agilent Technologies, Santa Clara, CA, USA) 
according to the Agilent 60-mer oligonucleotide microarray processing protocol, and 
scanned by the Mahenthiralingam Laboratory, Cardiff University, Wales as previously 
described (26). The raw Data was imported into GeneSpring (version 7.3.1) and 
normalized using the "Agilent FE" procedure. The t-test p-value (< 0.05) was used to 
filter the genes of confidence with application of two multiple testing correction 
parameters Benjamini-Hochberg false discovery rate (BH_FDR) and “Bonferroni” 
correction. An arbitrary cutoff value of 2-fold ratio change (either upregulation or 
repression) was chosen to identify genes that were differentially expressed between K56-
2 wild type and K56-2 atsR::pDA27. 
3.3 Results and discussion 





I previously characterized the global role of AtsR in regulating QS signalling and the 
expression of QS regulated virulence factors (12). To identify the AtsR regulon, 
microarray analysis was conducted by comparing the gene expression profiles in wild 
type and atsR mutant strains. ORFs that showed a >2-fold difference were considered to 
be differentially expressed. Overall, 36 ORFs and 8 intergenic regions were upregulated 
(Fig. 3.1A&B) and 89 ORFs and 16 intergenic regions were downregulated (Fig. 3.1B) in 
the absence of a functional AtsR. The upregulated regions encoded 16 conserved 
hypothetical proteins with unknown functions, 3 putative lipoproteins, 2 T6SS related 
genes including Hcp (+6-fold) and BCAL1294 (VgrG, +3-fold), and other genes involved 
in QS, chemotaxis, transport and regulatory functions (Table 3.3). Notably, we observed a 
significant fold change among genes encoding the putative lipoproteins Bcam0382 and 
Bcas0627 with up to 102 and 99-fold increase, respectively. Also, a 30-fold increase in 
the expression of CepR2 (Bcam0188) was observed. CepR2 is a regulator of QS genes 
including zinc metaloproteases and of the Bcam0192 operon (27), which is also detected 
in our microarrays. Of the 105 downregulated regions, 12 genes were flagella-related, 
implying a role of AtsR to stimulate flagellum formation or motility. Six genes encode 
chemotaxis related proteins including CheY and CheZ and 9 DNA binding regulatory 











Table 3.3: List of genes differentially upregulated in AtsR microarray analysis 
Gene Name Normalized 
Data 
Description 
BCAL0343 6.972 type VI secretion system protein TssD 
BCAL0358 3.917 family M1 metalopeptidase /aminopeptidase N 
BCAL1294 3.094 type VI secretion system secreted protein VgrG 
BCAL1295 2.637 conserved hypothetical protein 
BCAL1387 4.638 putative phosphatase 
BCAL1952 2.595 LysM domain/BON superfamily protein 
BCAL3228 2.688 hypothetical protein 
BCAM0067 2.226 putative short chain dehydrogenase 
BCAM0068 2.887 Major Facilitator Superfamily protein 
BCAM0069 3.061 conserved hypothetical protein 
BCAM0070 2.798 putative hydrolase 
BCAM0188 2.005 N-acylhomoserine lactone dependent 
regulatory 
BCAM0192 31.04 conserved hypothetical protein 
BCAM0194 29.7 conserved hypothetical protein 
BCAM0196 15.44 conserved hypothetical protein 
BCAM0200 7.265 efflux system transport protein 
BCAM0202 2.031 conserved hypothetical protein 
BCAM0382 87.05 putative lipoprotein 
BCAM0384 44.55 putative lipoprotein 
BCAM0633 2.091 conserved hypothetical protein 
BCAM0785 2.301 conserved hypothetical protein 
BCAM0821 2.575 putative methyl-accepting chemotaxis protein 
BCAM0835 3.252 AraC family regulatory protein 
BCAM1023 2.082 putative selenocysteine-specific elongation 
BCAM1103 3.128  
BCAM1106 2.928 putative oxidoreductase 
BCAM1345 2.729 conserved hypothetical protein 
BCAM1869 2.173 conserved hypothetical protein 
BCAM2153 2.088 putative cytochrome P450 oxidoreductase 
BCAM2154 2.715 conserved hypothetical protein 
BCAM2425 2.292 conserved hypothetical protein 
BCAS0153 2.27 conserved hypothetical protein 
BCAS0627 99.35 putative lipoprotein 
BCAS0664 2.88 conserved hypothetical protein 
BCAS0666 2.446 putative ankyrin-repeat exported protein 
IG1_1411086 2.955 upstream of BCAL1297 / 
interG_chr1_pos_767_1411086:1411195 
IG1_2151274 4.529 upstream of BCAL1952 
/interG_chr1_pos_1124_2151274:2151732 






IG1_368927 4.551 upstream of BCAL0343 (Hcp)/ 
interG_chr1_pos_243_368927:368996 
IG2_1491140 3.083 Spans BCAM1343-1348 / 
interG_chr2_pos_769_1491140:1498982 
IG2_2676155 2.241 BCAM2377 + surroundings / 
interG_chr2_pos_1268_2676155:2677543 
IG2_429106 116.1 Spans AtsR-AtsT+ upstream of BCAM0382 
(putative lipoprotein)/ 
interG_chr2_pos_211_429106:432827 
IG2_433416 102.1 upstream BCAM0383 (putative lipoprotein) 
interG_chr2_pos_212_433416:433537 






















3.3.2 Promoter activity assay 
According to our microarray data, Bcas0627 is one of the most upregulated genes in 
absence of AtsR. To confirm and validate our microarray results, the promoter activity of 
Bcas0627 was monitored in WT and single ∆atsR or double mutant ΔcepIΔatsR strains 
using a luciferase reporter system. We showed previously that several virulence factors, 
including swarming motility and the secretion of zinc metalloproteases are positively 
regulated by CepI and negatively regulated by AtsR (12). As shown in Fig. 3.1C, 
Bcas0627 maximum expression occurs in the absence of AtsR at 9 h. Bcas0627 
expression in ΔcepIΔatsR followed the same pattern as in ΔatsR except that expression 
levels were consistently higher. Interestingly, Bcas0627 promoter activity was almost null 
in the presence of AtsR either in WT strain or ΔcepIΔatsR::atsR and ΔatsR::atsR mutants 
that are complemented with atsR. Together, these results confirm our microarrays data 
regarding Bcas0627, which its expression is indeed upregulated in the absence of AtsR.  
I previously showed that ΔatsT and ΔatsR mutants have similar phenotypes including 
increased biofilm formation, upregulation of T6SS activity and increased extracellular 
proteolytic activity (13) and showed that AtsR/AtsT pair act as a two-component system 
both in vivo and in vitro (13). Since AtsT and AtsR are in the same regulatory pathway, 
we expect that regulatory role of AtsR on lipoproteins takes place via AtsT. To determine 
if the putative lipoprotein BCAS0627 is indeed regulated by AtsT, the 
Bcas0627::luxCDABE transcriptional fusion was introduced into ΔatsT, ΔatsT::atsT, 
ΔcepIΔatsT and ΔcepIΔatsT::atsT mutant strains. Interestingly, the relative light unit 
(RLU)/OD600 values in the ∆atsT background are similar to ∆atsR, indicating that there is 





(Fig.3.1C&D). The highest luminescence was detected in the K56-2∆atsT∆cepI double 
mutant where atsT and cepI are both deleted. Similarly, the K56-2∆atsT single mutant has 
high levels of promoter activity; whereas, mutants complemented with atsT have reduced 
levels of luminescence (Fig.3.1D). Together, these data confirm that the expression of 
Bcas0627is regulated by AtsR/AtsT two component system and that AtsT works 
downstream of AtsR. 
3.3.3 Confirmation of AtsT binding via electromobility gel shift assay  
To investigate whether the AtsT binds directly to the DNA sequences upstream of Bcam0382, 
Bcas0627 and Bcam0192 identified by microarray, we carried out electrophoretic mobility shift 
assays (EMSA) with His-tagged AtsT protein. IRDYE682 labeled PCR fragments of about 190-
360 bp in size were purified and incubated with various concentrations of AtsT-His (0-40 μM) 
with a DNA concentration of 150 ng. This varied protein to DNA ratio was necessary to address 
relative affinity differences between the promoter fragments. We detected higher molecular 
weight bands for Bcam0382 and Bcas0627 promoter regions when incubated with AtsT protein. 
Only 2 μM and 10 μM of AtsT was sufficient for Bcam0382 and Bcas0627 DNA sequences 
respectively to obtain an almost complete shift, whereas such shift was minimal for Bcam0192 
even with a concentration of 20 μM of AtsT protein in the reaction. Further experiments revealed 
that the Bcam0192 promoter sequence has lower affinity for AtsT and binding occurs in the 
presence of higher concentration of AtsT (Fig. 3.2A). To test if DNA-binding ability of AtsT is 
dispensable from its phosphorylation status, Bcam0382 and Bcas0627 promoter regions where 
incubated with phosphorylated protein and band shifts were compared to that of the reaction 
where DNA was incubated with unphosphorylated AtsT. Interestingly, DNA shifts were 
comparable for both promoter sequences regardless of AtsT phosphorylation status (Fig. 3.2B). 






Figure 3.1: Expression of Bcas0627 is dependent on the presence of functional AtsR and 
AtsT. A) Expression profiles of representative genes upregulated >3 folds in the absence 
of a functional AtsR. B) Pie chart representing percentage of up or downregulation of 
expression profiles regarding their genomic position in atsR mutant strain. Promoter 
activity assay of Bcas0627 in the presence or absence of AtsR (C) or AtsT (D). Bacterial 
growth (OD600, lines) and luminescence (RLU/OD600, bars) reflecting Bcas0627 
expression in the different strain backgrounds were measured. Values are average ± SD 





with varying affinities which may have an impact on the sensitivity of promoters to the 
phosphorylation state of AtsT. In other words, the different binding affinities to the three 
promoters we tested here may allow the fine-tuning of expression in response to AtsT-P 
levels with varying levels of signaling molecule(s).  
 To test the specificity of AtsT binding to the promoter sequences, DNA binding was 
carried out in the presence of varying concentrations of unlabeled promoters (as specific 
competitor). A 100-fold excess of DNA was required to reverse the band shift for 
Bcam0382 indicating higher affinity of AtsT for this promoter sequence (Fig. 3.2C, lane 
9), whereas, AtsT binding to the labeled Bcas0627 promoter was reduced by adding a 50-
fold excess of unlabeled probe (Fig. 3.2D, lane 7). Further support for the specificity of 
the interaction with DNA was provided by experiments in which a nonspecific fragment 
corresponding to the Bcal3310 upstream sequence was used, and as expected, no shift in 
DNA mobility was detected with an identical fold excess of nonspecific competitor DNA 












Figure 3.2: Electrophoretic mobility shift in vitro with the Bcam0382, Bcas0627 and 
Bcam0192 promoter fragments and purified AtsT-His protein.  A) The DNA fragments 
(150 ng) from promoter regions of Bcam0382 (380 bp), Bcas0627 (200 bp) and 
Bcam0192 (190 bp) were incubated with AtsT-His in the presence of poly dI-dC and run 
on a native polyacrylamide gel (8%), in 1X TBE buffer. AtsT binding was assessed on 





concentrations of AtsT-His. B) The DNA fragments (150 ng) from promoter regions of 
Bcam0382 and Bcas0627 were incubated with 5 µM or 10 µM of either unphosphorylated 
AtsT-His or phosphorylated AtsT-His in a reaction containing 10 µM AtsR and 100 mM 
ATP and run on a native polyacrylamide gel (8%), in 1X TBE buffer.  C) Specificity of 
AtsT binding to Bcam0382 promoter sequence in the presence of specific (left panel) and 
non-specific sequence (right panel) were tested with increasing concentration of DNA in 
the reaction from 10x (lane 3 and 6), 20x (lane 4 and 7), 50x (lane 5 and 8) to 100x (lane 
9). D) Specificity of AtsT binding to Bcas0627 promoter sequence in the presence of 
specific (lanes 2-7) and non-specific sequence (lanes 8-10) were tested with increasing 
concentration of DNA in the reaction from 2x (lane 3), 5x (lane 4), 10x (lane 5 and 8), 


















3.3.4 Confirmation of AtsT binding via DNAse I footprinting  
To examine and validate the AtsT binding site in the promoter regions of Bcas0627 and 
Bcam0382, we used fluorescently labeled primers for DNase I protection assays. DNA 
fragments containing potential AtsT binding sitee were amplified using a primer labeled 
with the 6-carboxyfluorescein (6-FAM) fluorescent dye. PCR products were purified and 
digested by DNase I in a binding reaction mixture. The results were visualized using 
Gene mapper Software. Protein binding sites were indicated by the disappearance of the 
peaks. As shown in Fig. 3.3, AtsT protected a region from DNase I digestion which is 
located upstream of the Bcas0627 and the Bcam0382 start codons, respectively (Fig. 
3.3A&B upper panels). When the same experiment was performed in the absence of Atst, 
theses regions were not protected (Fig. 3.3A&B lower panels).   
3.3.5 Isolation of DNA fragments associated with AtsT 
Our aim was to use ChIP to measure the distribution of AtsT across the genome of B. 
cenocepacia. Using the CLC genomics workbench, we analyzed three independent ChIP-
seq runs using BSA ChIP as a control. We mapped a total of 17,241,315 reads to the B. 
cenocepacia J2315 genome compared to 238,990 reads for control experiment. After 
mapping the reads to the reference genome, the ChIP-Seq analysis was done by calling 
peaks based on detection of signals to identify genomic regions with significantly 
enriched read coverage and a read distribution with a characteristic shape such as shown 
in Fig. 3.4A. We combined the peaks generated from all three samples and required that a 
peak be called in at least two of the three experiments to be considered an AtsT binding 









Figure 3.3: Fragment analysis of AtsT-binding site by DNaseI footprinting.  Graphs 
indicate the interaction of 10 or 15 µM AtsT or BSA (no AtsT panel) with promoter 
regions of Bcas0627 (A) and Bcam0382 (B). Arrows point to the missing peaks in both 
top panels of A and B graphs where AtsT is present in the reaction. This suggests a 
binding site for AtsT in those areas that is protected from digestion. These pictures are 








values annotated with J2315 genome are shown in Fig. 3.4B. A total of 380, 218 and 93 
enriched regions were identified for threshold p-values of 0.001, 0.0005 and 0.0001, 
respectively. We focused on analysing the regions obtained from the p-value setting of 
0.0005 and these enriched sequences were extracted. Of these 218 regions, almost 46% 
were intergenic (Fig. 3.4C) were chosen for further characterization. The rest are inside 
















Figure 3.4: Pattern of AtsT ChIP-Seq peaks identified upstream of the AtsT-regulated 
genes (A).  Representative image of genome-wide binding sites of AtsT with 3 different 
threshold settings (B). Pie chart of AtsT-binding peaks annotated relatively to the nearest 



















Region Length 5' gene 3' gene Function 
NC_011000 3253014..3253166 153 BCAL2969 BCAL2969a hypothetical protein 
NC_011000 3247579..3247713 135 BCAL2965C BCAL2965D hypothetical protein 
NC_011000 3247833..3248013 181 BCAL2965D BCAL2966 hypothetical protein; 
K06919 putative DNA 
primase/helicase 
NC_011000 3244246..3244373 128 BCAL2962a BCAL2962b hypothetical protein 
NC_011000 3245237..3245374 138 BCAL2962b BCAL2963 putative phage-related 
DNA-binding protein 
NC_011000 3252472..3252600 129 BCAL2969 BCAL2969a hypothetical protein 
NC_011000 3244006..3244151 146 BCAL2962 BCAL2962a hypothetical protein 
NC_011000 3254478..3254652 175 BCAL2971 BCAL2971a hypothetical protein 
NC_011002 36502..36690 189 BCAS0033 BCAS0034 metallo-beta-lactamase 
superfamily protein 
NC_011000 3246856..3246992 137 BCAL2965 BCAL2965a hypothetical protein 
NC_011002 204538..204677 140 BCAS0188A BCAS0189 hypothetical protein; 
K11312 cupin 2 domain-
containing protein 
NC_011000 3241596..3241765 170 BCALr2960 BCAL2961 putative integrase 
NC_011000 3247147..3247344 198 BCAL2965a BCAL2965b hypothetical protein 
NC_011001 432522..432657 136 BCAM0381 BCAM0382 hypothetical lipoprotein 
NC_011000 3253510..3253673 164 BCAL2970 BCAL2971 hypothetical protein 
NC_011002 716403..716546 144 BCAS0654 BCAS0656 putative transposase 
NC_011002 130355..130492 138 BCAS0117 BCAS0118 putative H-NS family DNA-
binding protein; K03746 
DNA-binding protein H-NS 
NC_011000 253951..254114 164 BCAL0218c tufA1 elongation factor Tu 
NC_011002 422485..422621 137 BCAS0360 BCAS0361 LysR family regulatory 
protein 
NC_011000 3737727..3737897 171 BCAL3411 mtgA monofunctional 
biosynthetic peptidoglycan 
transglycosylase 





NC_011000 812763..812898 136 BCAL0747 BCAL0748 hypothetical protein 
NC_011002 710870..711047 178 BCAS0649 BCAS0650 putative transposase 
NC_011000 365924..366070 147 BCAL0339 BCAL0340 putative lipoprotein 




NC_011001 3025995..3026135 141 BCAM2678 BCAM2679 hypothetical protein 
NC_011002 138427..138569 143 BCAS0124 BCAS0125 hypothetical protein 
NC_011001 2790921..2791083 163 BCAM2466 BCAM2467 putative transposase 









NC_011002 390461..390594 134 BCAS0334 BCAS0335 putative haemagglutinin-
related autotransporter 
protein 
NC_011000 596436..596589 154 BCAL0543 dppA putative periplasmic 
dipeptide transport protein; 
K12368 dipeptide transport 
system substrate-binding 
protein 
NC_011002 713043..713195 153 BCAS0650b BCAS0652 putative transposase 
NC_011000 34503..34658 156 atpB atpE F0F1 ATP synthase 




NC_011001 7278..7422 145 BCAM0005A BCAM0006 hypothetical protein 
NC_011002 11987..12129 143 BCAS0010 BCAS0011 hypothetical protein 
NC_011001 2720007..2720185 179 BCAM2415 BCAM2416 hypothetical protein 
NC_011002 788081..788216 136 BCAS0717 BCAS0718 transposase; K07497 
putative transposase 
NC_011002 748460..748598 139 BCAS0680 BCAS0683  
NC_011000 1246576..1246713 138 BCAL1146 BCAL1147 glycosyltransferase 




NC_011002 629782..629939 158 BCAS0577 ansP L-asparagine permease; 
K11738 L-asparagine 
permease 
NC_011000 3504662..3504804 143 BCAL3208 BCAL3208a hypothetical protein 
NC_011001 2739339..2739504 166 BCAM2426 BCAM2427 hypothetical protein 
NC_011001 3070082..3070253 172 BCAM2713 BCAM2714 putative transposase 
NC_011000 657042..657190 149 BCAL0601 BCAL0602 MerR family regulatory 
protein 
NC_011002 754523..754670 148 BCAS0688 BCAS0689 metallo-beta-lactamase 
superfamily protein 
NC_011000 3474261..3474410 150 BCAL3177 BCAL3178 LysR family regulatory 
protein 
NC_011002 370809..370953 145 BCAS0321 BCAS0321a hypothetical protein 
NC_011000 203026..203161 136 BCAL0181 BCAL0182 putative plasmid 
recombinase 
NC_011001 2912664..2912801 138 aer BCAM2565 putative methyltransferase 
NC_011002 333449..333583 135 BCAS0297 BCAS0298 flp type pilus subunit; 
K02651 pilus assembly 
protein Flp/PilA 
NC_011002 810233..810398 166 BCAS0735 BCAS0736 TetR family regulatory 
protein; K09017 TetR/AcrR 
family transcriptional 
regulator 
NC_011002 390719..390843 125 BCAS0334 BCAS0335 putative haemagglutinin-
related autotransporter 
protein 









NC_011001 24329..24498 170 adc BCAM0024 putative undecaprenyl-
diphosphatase 
NC_011002 687343..687498 156 BCAS0626 BCAS0627 putative lipoprotein 
NC_011002 712628..712787 160 BCAS0650a BCAS0650b pseudogene 
NC_011000 400302..400447 146 cspD BCAL0369 putative amino acid 
permease 
NC_011001 506891..507029 139 BCAM0451 BCAM0452 family S10 serine 
peptidase 
NC_011002 400289..400485 197 BCAS0342 BCAS0343 Major Facilitator 
Superfamily protein 
NC_011000 567233..567372 140 BCAL0515 BCAL0516 hypothetical protein 
NC_011000 136340..136504 165 fliC rpsU rpsU; 30S ribosomal 
protein S21; K02970 small 
subunit ribosomal protein 
S21 
NC_011001 3069020..3069154 135 BCAM2711 BCAM2712 hypothetical protein 
NC_011000 1704707..1704879 173 BCAL1538 BCAL1539 hypothetical protein 
NC_011000 452189..452342 154 BCAL0412 BCAL0413 hypothetical protein 
NC_011001 90660..90811 152 BCAM0080 BCAM0081 putative outer membrane 
protein-OmpW family 
NC_011002 500495..500632 138 BCAS0432 BCAS0433 putative DNA-binding 
protein 
NC_011002 751453..751614 162 BCAS0682 BCAS0684 pseudogene 
NC_011000 146554..146750 197 BCAL0123 flhD transcriptional activator 
FlhD; K02403 flagellar 
transcriptional activator 
FlhD 
NC_011000 1405446..1405606 161 BCAL1292 BCAL1293 (here bcal1294 is in the 
microarray VgrG protein) 
NC_011002 748152..748291 140 BCAS0679A BCAS0680 putative TniB-like 
transposition protein 
NC_011000 159157..159313 157 cheZ BCAL0137 hypothetical protein 
NC_011002 4443..4616 174 BCAS0003 BCAS0004 putative transposase; 
K07486 transposase 




NC_011000 32943..33127 185 BCAL0028 BCAL0029 putative ATP synthase 
protein I AtpI; K02116 ATP 
synthase protein I 
NC_011002 869202..869370 169 BCAS0769 BCAS0770 LysR family regulatory 
protein 





NC_011000 3375805..3375977 173 BCAL3083 BCAL3084 putative guanine/cytidine 
deaminase 
NC_011000 3496591..3496745 155 BCAL3199 tolQ putative TolQ transport 
transmembrane protein; 
K03562 biopolymer 





NC_011000 3297325..3297457 133 cspA BCAL3007 hypothetical protein 
NC_011001 3136490..3136633 144 BCAM2772 BCAM2773 putative DNA-binding 
protein 
NC_011002 708654..708802 149 BCAS0646 BCAS0646A putative DNA-binding 
protein 
NC_011002 723986..724116 131 BCAS0661C BCAS0662 hypothetical protein 
NC_011000 1147412..1147552 141 BCAL1058 argD bifunctional N-
succinyldiaminopimelate-
aminotransferase/acetylorn
ithine transaminase protein 
NC_011001 1018568..1018719 152 BCAM0922 BCAM0923 putative lipoprotein 
NC_011002 784816..784973 158 BCAS0716 BCAS0717 hypothetical protein 
NC_011000 562335..562477 143 BCAL0510 BCAL0511 putative deoxygenases; 
K00477 phytanoyl-CoA 
hydroxylase 
NC_011001 1173919..1174053 135 BCAM1078 BCAM1079 hypothetical protein 
NC_011002 209614..209811 198 BCAS0194 BCAS0195 putative transcriptional 
regulator 
NC_011000 3671381..3671556 176 BCAL3352 BCAL3353 putative outer membrane 
autotransporter 
NC_011000 3529532..3529665 134 BCAL3227 BCAL3228 hypothetical protein 
NC_011000 3532227..3532381 155 BCAL3228 BCAL3229 hypothetical protein 
NC_011002 149887..150045 159 BCAS0135 BCAS0136 putative amino acid 
permease 
NC_011002 135581..135723 143 BCAS0122 BCAS0123 putative transcriptional 
regulator 
NC_011002 466699..466882 184 BCAS0398 citH citrate-proton symporter; 









NC_011001 2521772..2521943 172 BCAM2251 BCAM2251A hypothetical protein 
NC_011002 357264..357459 196 iorA BCAS0321 hypothetical protein 
NC_011002 714169..714365 197 BCAS0652 BCAS0653 putative transposase 
NC_011000 139291..139424 134 rpsU BCAL0117 hypothetical protein 
NC_011000 179296..179450 155 BCAL0153 BCAL0154 histone-like nucleoid-
structuring (H-NS) protein; 
K03746 DNA-binding 
protein H-NS 
NC_011000 257756..257891 136 rplA rplJ rplJ; 50S ribosomal protein 
L10; K02864 large subunit 
ribosomal protein L10 








3.3.6 Motif identification from ChIP-seq data 
The extracted sequences of all 101 intergenic AtsT binding regions for the threshold p-
value of 0.0005 were searched for a common motif using MEME-ChIP. The software 
identified 3 predicted motifs that were enriched in ChIP-Seq peak regions and 
corresponding sequence logos were built. Inspection of the alignment reveals a match for 
the first predicted motif to the binding area obtained from DNAse I footprinting for 
Bcam0382 and Bcas0627 upstream sequences. This motif has a position p-value less than 
0.0001 which has 21 nucleotides that the first 4 bases (TTGC) and G at position 12 are 
the most conserved bases (Fig. 3.5A). Alignment with upstream regions of annotated 
genes indicated that this motif is found in all 101 enriched ChIP-Seq peak sequences. A 
screenshot of this alignment is shown in Figure 3.5B. 
3.3.7 Comparison with genes differentially transcribed in microarray data 
A detailed transcriptome analysis comparing wild-type and AtsR mutant described AtsR 
dependent gene regulation during exponential growth in LB media. To identify direct 
relevant target genes, we analyzed the AtsT ChIP-seq dataset against transcriptional 
profiling data of control and atsR mutant strains. Of the 101 upstream sequences that 
were enriched, only 6% were associated with genes differentially transcribed in the 
microarray experiment. Two of these genes that encode putative lipoproteins (Bcas0627 
and Bcam0382) have been shown by footprinting assay to bind AtsT directly (Fig. 3.3). 
Also, several of these genes are the first in apparent operons containing additional genes 
that are derepressed in the atsR mutant strain. For example, the upstream region of 
Bcal0340 may serve dually as a binding site for T6SS gene cluster located both 







Figure 3.5: Sequence logos generated by MEME-ChIP. A) The most highly significant 
motif identified in all 101 ChIP-Seq peaks with a p-value of less than 0.0001. The height 
of each letter represents the relative frequency of each base at each position in the 
consensus sequence. B) Representative alignments of the predicted motif against enriched 











Bcal0340 including genes encoding TssJ to L proteins. Bcal0343 encodes Hcp protein 
and is a recognized AtsR-regulated gene (11). The remaining sites include sequence 
regions of a hypothetical protein (BCAM2425), a putative phage integrase (BCAM1024), 
BCAL1293 which is in the vicinity of the putative type six secreted VgrG protein 
BCAL1294  and BCAS0667 (type six secreted VgrG protein ortholog). 
3.3.8 Validation of ChIP-Seq results by qRT-PCR  
To validate binding of AtsT to these loci, we chose a subset of 15 genes and used 
quantitative RT-PCR (qRT-PCR) to determine the fold enrichment of their transcripts in 
WT versus ∆atsT strains. Quantification of fold enrichment of 14 genes identified by 
ChIP-seq showed greater enrichment in the ∆atsT mutant than the WT parental strain 
except for the FliC and FlhD genes that were expressed slightly more in WT strain (Fig. 
3.6). These results support our ChIP peaks as authentic AtsT binding sites and are in line 
with our previous finding on the negative regulatory role of AtsR/AtsT on swarming 
motility (12, 13). 
3.4 Conclusion 
We have defined the direct and indirect AtsR/AtsT regulon by comparing the expression 
profiling of an AtsR mutant with a modified chromatin-IP procedure, to experimentally 
identify sites bound by AtsT throughout the B. cenocepcia genome. ChIP-seq is a method 
of choice for identifying regulator-binding sites in eukaryotic systems, and we show here 
its utility for mapping the genomic binding sites of a bacterial transcriptional regulator. 
Since the expression level of a transcriptional regulator may vary depending on 









Figure 3.6: Transcript expression analysis by qRT-PCR. The expression levels of 16 
genes identified by ChIP-Seq analysis were studied in K56-2 WT and ∆atsT and their 











approach of ChIP method to overcome these difficulties in genome-wide binding 
analysis. In this modified ChIP method we have the benefit of pulling down DNA with 
the purified regulator protein in which the transcriptional regulator has a greater potential 
to bind low affinity sites and outcompete interfering proteins under in vivo conditions. On 
the other hand, using a purified transcriptional regulator renders the possibility of 
producing false-positive ChIP peaks by binding to nonspecific sites. To address this issue 
we used BSA as a control and had a stringent setting for analysing our high throughput 
sequencing results. We identified 101 binding sites that are the AtsT target regulon (Table 
3.4). The function of nearly 30% of these genes is unknown as they are listed as 
hypothetical proteins. The remainder have known or predicted functions in a wide range 
of cellular processes as indicated in Table 3.4. Although we aimed to identify genes 
directly regulated by AtsT, transcriptome analyses of the atsR mutant strain identified 
several genes regulated by AtsR, including genes encoding regulators that might function 
as intermediates in regulatory cascades (Table 3.3). A comparative analysis of these genes 
with ChIP-Seq data showed that there are only a few genes in common. This result 
reflects the possibility that AtsT might be involved in other signalling pathways and act as 
a regulatory arm for several receptor proteins besides AtsR. Indeed, as AtsT plays a key 
role in the regulation of greater number of genes compared to AtsR, its activity levels 
may vary with the nature of the stimulus that might be perceived by multiple sensor 
proteins. Furthermore, we studied in depth the Bcas0627 and Bcam0382 genes which 
were shown to be upregulated in transcriptomic studies in the absence of a functional 
AtsR (Table 3.3). We confirmed AtsT peaks by EMSA and identified the binding site by 





consensus sequence. This prediction was consistent with the results obtained from DNAse 
I footprinting and the EMSA of the same locus.  
Overall, combining this AtsT binding location analysis with expression analysis of atsR 
mutant strain, our results indicate that AtsT directly regulates the expression of nearly 100 
genes that are spread across all three chromosomes of B. cenocepacia and include 
metabolic, regulatory, transport, cell-surface associated and environmental information 
processing genes as well as conserved genes of unknown function for which differences 
in expression have been observed in atsT mutant versus wild-type strains. Furthermore, 
our bioinformatic and DNase I footprinting analyses reveal the AtsT binding site 
architecture that likely has important implications for global gene regulation in B. 
cenocepacia. 
This study is the first to characterize the AtsR/AtsT regulon in B. cenocepacia, an 
important regulatory pathway for QS and T6SS related genes, and is one of only a few 
studies to apply ChIP-seq to bacterial regulators. This significantly expands our 
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In bacteria, two-component systems (TCS) play critical roles in transducing 
environmental stimuli into the cell to regulate cellular functions (1). A classical TCS is 
composed of a transmembrane sensor histidine kinase that autophosphorylates in response 
to specific signals and consequently regulates the activity of a cytoplasmic response 
regulator which can control transcription through DNA binding (2). We previously 
identified AtsR, a membrane protein of Burkholderia cenocepacia, that negatively 
regulates quorum sensing and virulence factors such as biofilm, type 6-secretion and 
protease secretion (3, 4). The in silico structural analysis of AtsR reveals that this protein 
is a hybrid sensor kinase, which falls in the category of TCSs. Based on secondary 
structure prediction, AtsR consists of two transmembrane domains, a periplasmic 
“sensing” domain and a cytoplasmic C-terminal domain carrying a transmitter domain 
with a conserved histidine (5) residue and a catalytic domain. In our previous work we 
studied the individual domains of the cytoplasmic C-terminus end of this protein and 
identified the conserved residues within its kinase domain that are absolutely required for 
its biological function. Furthermore, we identified its cognate response regulator AtsT 
and characterized the phosphotransfer mechanism in AtsR/AtsT signalling pathway (6).  
Topology is a fundamental aspect of the structure of membrane proteins. Since AtsR is a 
membrane-bound receptor and regulates virulence factors in B. cenocepacia, studying the 
structure of this protein is crucial. Knowledge of AtsR topology and its functional 
residues will provide insight into the potential signals perceived by this protein and its 
role in pathogenicity and host adaptation. Here, we report a topological analysis of AtsR 





introduced into a cysteine-less AtsR by PEGylation. We further identify the functional 
residues within the periplasmic loop that are required for AtsR function in vivo. Our 
results confirm that the experimental topological model of AtsR is in agreement with the 
predicted model.  
4.2 Materials and methods 
4.2.1 Bacterial strains, plasmids and growth conditions 
Bacterial strains and plasmids used in this study are listed in Table 4.1. Bacteria were 
grown in Luria broth at 37 °C unless indicated otherwise. E. coli cultures were 
supplemented, as required, with the following antibiotics final concentrations: 
tetracycline 30 μg/ml, kanamycin 30 μg/ml and trimethoprim 50 μg/ml. B. cenocepacia 
cultures were supplemented, as required, with trimethoprim 100 μg/ml, tetracycline 150 
μg/ml, ampicillin 200 μg/ml and polymyxin B 20 μg/ml. The β-galactosidase (LacZ) or 
alkaline phosphatase (PhoA) activities were assessed by examining the blue-colony 
phenotypes on LB plates containing a final concentration of 40 mg/ml of 5-bromo-4-
chloro-3-indolyl-b-D-galactopyranoside (X-Gal) and 5-bromo-4-chloro-3-
indolylphosphate (XP), respectively. 
4.2.2 General molecular techniques 
DNA manipulations were performed with T4 DNA ligase (Roche Diagnostics, Laval, 
Quebec, Canada) and Antarctic phosphatase (New England Biolabs, Pickering, Ontario, 
Canada) were used as recommended by the manufacturers. Transformation of 
Escherichia coli DH5α and GT115 was done using the calcium chloride method (10). 





Table 4.1. List of strains and plasmids 
 





CC118 Δ(ara leu) Δlac phoA galE galK thi rpsL rpsB argE recA Laboratory stock 




) nupG thi 










) gal λ(DE3) Laboratory stock 
GT115 F
– 
mcrA ∆(mrr-hsdRMS-mcrBC) 80∆lacZ∆M15 
∆lacX74 recA1 rpsL endA1∆dcm uidA(∆MluI)::pir-116 
∆sbcC-sbcD 
Laboratory stock 
Plasmids   
pAH01 pBAD vector expressing Flag-Wzx-K367-PhoA (7) 
pAH18 pBAD vector expressing Flag-PhoA (7) 
pAH1809 pBAD vector expressing Flag-Wzx-T242-PhoA (7) 
pBADNTF pBAD24 vector for N-terminal Flag fusions, AmpR (7) 
pMH447 pGPI-SceI derivative used for chromosomal 
complementation 
(8) 











, expressing I-SceI, SacB (8) 
pMK23 pBAD expressing Flag-AtsR-S100-PhoA This study 
pMK24 pBAD expressing Flag-AtsR-Y160-PhoA This study 
pMK25 pBAD expressing Flag-AtsR-Q215-PhoA This study 
pMK26 pBAD expressing Flag-AtsR-T300-PhoA This study 
pMK27 pBAD expressing Flag-AtsR-L402-PhoA This study 
pMK28 pBAD expressing Flag-AtsR-S100-LacZ This study 
pMK29 pBAD expressing Flag-AtsR-Y160-LacZ This study 
pMK30 pBAD expressing Flag-AtsR-Q215-LacZ This study 





pBAD expressing AtsR-L402-LacZ 
promoter of bcas0627 cloned in front of full lacZ 








pMZ25 pET28a(+) expressing AtsR-His (6) 
pMK37 pET28a(+) expressing AtsRcycless-His This study 
pMK40 pET28a(+) expressing AtsRcycless-V14C-His This study 
pMK41 pET28a(+) expressing AtsRcycless-M21C-His This study 
pMK42 pET28a(+) expressing AtsRcycless-V38C-His This study 
pMK43 pET28a(+) expressing AtsRcycless-G41C-His This study 
pMK44 pET28a(+) expressing AtsRcycless-G49C-His This study 
pMK45 pET28a(+) expressing AtsRcycless-G120C-His This study 
pMK46 pET28a(+) expressing AtsRcycless-Q181C-His This study 
pMK47 pET28a(+) expressing AtsRcycless-A182C-His This study 
pMK48 pET28a(+) expressing AtsRcycless-G187C-His This study 
pMK50 pET28a(+) expressing AtsRcycless-M205C-His This study 
pMK51 pET28a(+) expressing AtsRcycless-A328C-His This study 





pFT159 pBAD expressing AtsR-His This study 
pFT160 pBAD expressing AtsRcycless-His This study 
pFT205 pBAD expressing AtsRcycless-V14C-His This study 
pFT183 pBAD expressing AtsRcycless-M21C-His This study 
pFT184 pBAD expressing AtsRcycless-V38C-His This study 
pFT185 pBAD expressing AtsRcycless-G41C-His This study 
pFT186 pBAD expressing AtsRcycless-G49C-His This study 
pFT187 pBAD expressing AtsRcycless-G120C-His This study 
pFT188 pBAD expressing AtsRcycless-Q181C-His This study 
pFT206 pBAD expressing AtsRcycless-A182C-His This study 
pFT189 pBAD expressing AtsRcycless-G187C-His This study 
pFT190 pBAD expressing AtsRcycless-M205C-His This study 
pFT191 
pFT192 
pBAD expressing AtsRcycless-A328C-His 
pBAD expressing AtsRcycless-G484C-His 
This study 
 This study 
pMK76 pBAD expressing AtsR-Q56A-His This study 
pMK77 pBAD expressing AtsR-Y61A-His This study 
pMK78 pBAD expressing AtsR-D65A-His This study 
pMK79 pBAD expressing AtsR-F79A-His This study 
pMK80 pBAD expressing AtsR-D80A-His This study 
pMK81 pBAD expressing AtsR-S103A-His This study 
pMK82 pBAD expressing AtsR-W105A-His This study 
pMK83 pBAD expressing AtsR-K127A-His This study 
pMK84 pBAD expressing AtsR-N155A-His This study 
pMK85 pBAD expressing AtsR-R162A-His This study 
pMK86 pBAD expressing AtsR-Q56N-His This study 
pMK87 pBAD expressing AtsR-Q56R-His This study 
pMK88 pBAD expressing AtsR-D65E-His This study 
pMK89 pBAD expressing AtsR-D65K-His This study 
pMK90 pBAD expressing AtsR-S103T-His This study 
pMK91 pBAD expressing AtsR-S103V-His This study 
pMK92 pBAD expressing AtsR-R162K-His This study 




K56-2 ET12 clone related to J2315, CF clinical isolate 
b
BCRRC 
K56-2atsR  Deletion of atsR in K56-2 (6) 
K56-2atsR::atsR Chromosomal atsR integration in K56-2 atsR (6) 
MK93 Chromosomal atsRcycless integration in K56-2 atsR This study 
MK94 Chromosomal atsR integration in K56-2 atsRQ56A This study 
MK95 Chromosomal atsR integration in K56-2 atsRQ56N This study 
MK96 Chromosomal atsR integration in K56-2 atsRQ56R This study 
MK97 Chromosomal atsR integration in K56-2 atsRD65A This study 
MK98 Chromosomal atsR integration in K56-2 atsRD65K This study 
MK99 Chromosomal atsR integration in K56-2 atsRD65E This study 
MK100 Chromosomal atsR integration in K56-2 atsRS103A This study 
MK101 Chromosomal atsR integration in K56-2 atsRS103T This study 
MK102 Chromosomal atsR integration in K56-2 atsRS103V This study 
MK103 Chromosomal atsR integration in K56-2 atsR162A This study 





MK105 Chromosomal atsR integration in K56-2 atsRF79A This study 
MK106 Chromosomal atsR integration in K56-2 atsRD80A This study 
MK107 Chromosomal atsR integration in K56-2 atsRK127A This study 
MK108 Chromosomal atsR integration in K56-2 atsRN155A This study 
MK109 Chromosomal atsR integration in K56-2 atsRW105A This study 




, trimethoprim resistance, Kan
R
, kanamycin resistance, Tet
R
, tetracycline resistance. 
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K56-2 was performed by triparental mating using E. coli DH5α carrying the helper 
plasmid pRK2013. DNA amplification by PCR was performed using Bio-Rad C1000
TM
 
Thermal Cycler with Taq or HotStar HiFidelity DNA polymerases (Qiagen, Canada). 
DNA sequences of all primers used in this study are described in Table 4.2. DNA 
sequencing was performed at the DNA sequencing Facility of York University, Toronto, 
Canada. BLAST was used to analyse the sequenced genome of B. cenocepacia strain 
J2315.  
4.2.3 Plasmid construction and chromosomal complementation  
To create His-tagged fusions of AtsR and its derivatives, sequences were amplified from 
B. cenocepacia K56-2 genomic DNA using primers mentioned in Table 4.2. Amplicons 
were digested with the appropriate restriction enzymes and ligated into similarly digested 
pET28a cloning vector (Novagen) to engineer C-terminally His-tagged proteins. Site-
directed mutagenesis was performed using the QuikChange Site-Directed Mutagenesis 
Kit from Stratagene (Santa Clara, California), as recommended by the supplier. Primers 
were designed with 15-20 nucleotides flanking each side of the targeted mutation. 
Plasmids expressing AtsR derivatives in pET28a were used as a template to clone His-
tagged AtsR versions into pBAD24 using 4632-7266 primer set. The resulting PCR 
products were digested with DpnI and introduced into E. coli DH5α. All constructs and 
replacement mutants were confirmed by sequencing. Chromosomal complementations of 
∆atsR were performed using the pMH447 plasmid as described previously (8). Primers 
7351-4632 was used to PCR amplify atsR and its mutated versions. PhoA fusions to 
residues S100, Y160, P215, N300, and K402 were constructed by amplifying the AtsR 





Table 4.2. Oligonucleotide primers 
Primer No. Primer Name 5’-3’ Primer sequence 
252 
 
pBAD Forward  GATTTAGCGGATCCTACCTGA 
258 pBAD Reverse GACCGCTTCTGCGTTCTGAT 
4632 AtsR-For-NdeI AAAACATATGACGCGGCGGCGATGGAAGAA 
5033 PhoA-NotI-For TATGCGGCCGCACCTGTTCTGGAAAACCGGGCTG 
5034 PhoA-NotI-Rev CTATGCGGCCGCTTTCAGCCCCAGAGCGGCTT 
5640 LacZ-For-XbaI CGACTCTAGAATTACGGATTCACTGGCCG 
5866 AtsR-REV-XbaI TTTTTCTAGAGCTTTGTTAGCAGCCGGATC 
5885 MH447-For TTGATGGCGAGCGATTCTTC 
5886 MH447-Rev CCAGTTCTTCAGCGTGACGA 
6423 LacZ-Rev-HindIII AAAAAGCTTTCAGCGCCATTCGCCATTC 
6693 AtsR-100-Rev- XbaI TTTTTCTAGACGACGGCCGCTGCAGGAA 
6694 AtsR-160-Rev- XbaI TTTTTCTAGAGTAGTTCGCGAGGCCGTTAACT 
6696 AtsR-215-Rev- XbaI TTTTTCTAGAGTTTTGCCGTTCGAGCAGGTCG 
6743 AtsR-300-Rev-XbaI TTTTTCTAGACGTCGAGCGCAGCTTGATGTA   
6697 AtsR-402-Rev-XbaI TTTTTCTAGAGCAGATGTTGTTTCGCGATGCCG   
6719 AtsR-Fl-For-BamHI AAAAGGATCCTATGACGCGGCGGCGATG  
6728 AtsR-For-C255A CCGCTGCAGGCGATCGCGGGATCGATCGAGATC 
6729 AtsR-Rev-C255A GATCTCGATCGATCCCGCGATCGCCTGCAGCGG 
6730 AtsR-For-C515A GACGCCGATCTGGCGGGCACCGGGCAG 
6731 AtsR-Rev-C515A CTGCCCGGTGCCCGCCAGATCGGCGTC 
6763 AtsR-For-C195A GGTGTGCTCCTGGCAGCGCTGTTCCTG 
6764 AtsR-Rev-C195A CAGGAACAGCGCTGCCAGGAGCACACC 
6771 AtsR-For-M21C GGCTCGCTGTGGATCTGTGGGTTCGCCGCGTGG 
6772 AtsR-Rev-M21C CCACGCGGCGAACCCACAGATCCACAGCGAGCC 
6773 AtsR-For-G49C GAGGGGCCGCGCGAATGTGTGTTCTGGACCGCC 
6774 AtsR-Rev-G49C GGCGGTCCAGAACACACATTCGCGCGGCCCCTC 
6775 AtsR-For-A328C CGCGAGAAGATCGTCTGCAAACGGATCGCGGTC 
6776 AtsR-Rev-A328C GACCGCGATCCGTTTGCAGACGATCTTCTCGCG 
6777 AtsR-For-G484C GCGCTGGCGTACCACTGTCGGCGCGCGCTGGTG 
6778 AtsR-Rev-G484C CACCAGCGCGCGCCGACAGTGGTACGCCAGCGC 
6835 AtsR-For-V14C AGAAAAATCATCCTGTGTCTCGGCTCGCTGTGG 
6836 AtsR-Rev-V14C CCACAGCGAGCCGAGACACAGGATGATTTTTCT 
6837 AtsR-For-V38C CTCCTCGCCACCTCGTGTAACGAGGGCGTGCTC 
6838 AtsR-Rev-V38C GAGCACGCCCTCGTTACACGAGGTGGCGAGGAG 
6839 AtsR-For-G41C ACCTCGGTCAACGAGTGTGTGCTCGAGGGGCCG 
6840 AtsR-Rev-G41C CGGCCCCTCGAGCACACACTCGTTGACCGAGGT 
6841 AtsR-For-A182C AAGGACAAACAGCGCTGTATCCTGATCCTCGGC 
6842 AtsR-Rev-A182C GCCGAGGATCAGGATACAGCGCTGTTTGTCCTT 
6843 AtsR-For-Q181C CAACTGAAGGACAAATGTCGCGCGATCCTGATC 





6845 AtsR-For-G187C GCGATCCTGATCCTCTGTATCGTGCTCGGTGTG 
6846 AtsR-Rev-G187C CACACCGAGCACGATACAGAGGATCAGGATCGC 
6847 AtsR-For-L201C GCGCTGTTCCTGCTGTGTCTCTATACGATGCGC 
6848 AtsR-Rev-L201C GCGCATCGTATAGAGACACAGCAGGAACAGCGC 
6849 AtsR-For-M205C CTGCTGCTCTATACGTGTCGCACGCGCGACGAC 
6850 AtsR-Rev-M205C GTCGTCGCGCGTGCGACACGTATAGAGCAGCAG 
6873 AtsR-For-G120C GAGATCGACGCGCTGTGTGAATTCATGACGCGC 
6874 AtsR-Rev-G120C GCGCGTCATGAATTCACACAGCGCGTCGATCTC 
7266 AtsR-Rev-HindIII AAAAGCTTTCAGTGGTGGTGGTGGTGGTGCTCG 
7322 AtsR-Gln56A-For TTCTGGACCGCCGCGGCATACCGCAACGTGTAT 
7323 AtsR-Gln56A-Rev ATACACGTTGCGGTATGCCGCGGCGGTCCAGAA 
7324 AtsR-Tyr61A-For CAATACCGCAACGTGGCAACGCGCTTCGATCGT 
7325 AtsR-Tyr61A-Rev ACGATCGAAGCGCGTTGCCACGTTGCGGTATTG 
7326 AtsR-Asp65A-For GTGTATACGCGCTTCGCACGTCAGCTGATTCTT 
7327 AtsR-Asp65A-Rev AAGAATCAGCTGACGTGCGAAGCGCGTATACAC 
7328 AtsR-Phe79A-For CGCGAGGACGAAGACGCAGATCACCTGCAGATG 
7329 AtsR-Phe79A-Rev CATCTGCAGGTGATCTGCGTCTTCGTCCTCGCG 
7330 AtsR-Asp80A-For GAGGACGAAGACTTCGCACACCTGCAGATGCAG 
7331 AtsR-Asp80A-Rev CTGCATCTGCAGGTGTGCGAAGTCTTCGTCCTC 
7332 AtsR-Ser103A-For CGGCCGTCGGAAGTGGCACAATACTGGCTGCGC 
7333 AtsR-Ser103A-Rev GCGCAGCCAGTATTGTGCCACTTCCGACGGCCG 
7334 AtsR-Tyr106A-For GAAGTGTCCCAATACGCACTGCGCATCCCGCGC 
7335 AtsR-Tyr106A-Rev GCGCGGGATGCGCAGTGCGTATTGGGACACTTC 
7336 AtsR-Lys127A-For ATGACGCGCCTGGCACGCGAGGTGCCG 
7337 AtsR-Lys127A-Rev CGGCACCTCGCGTGCCAGGCGCGTCAT 
7338 AtsR-Asn155A-For TATTGGCCGAAAGTTGCCGGCCTCGCGAACTAC 
7339 AtsR-Asn155A-Rev GTAGTTCGCGAGGCCGGCAACTTTCGGCCAATA 
7340 AtsR-Arg162A-For CTCGCGAACTACTTCGCCGCGATCGAAATGGCT 
7341 AtsR-Arg162A-Rev AGCCATTTCGATCGCGGCGAAGTAGTTCGCGAG 
7448 AtsR-Arg162D-For CTCGCGAACTACTTCGATGCGATCGAAATGGCT 
7449 AtsR-Arg162D-Rev AGCCATTTCGATCGCATCGAAGTAGTTCGCGAG 
7450 AtsR-Arg162K-For CTCGCGAACTACTTCAAAGCGATCGAAATGGCT 
7451 AtsR-Arg162K-Rev AGCCATTTCGATCGCTTTGAAGTAGTTCGCGAG 
7452 AtsR-Gln56N-For TTCTGGACCGCCGCGAATTACCGCAACGTGTAT 
7453 AtsR-Gln56N-Rev ATACACGTTGCGGTAATTCGCGGCGGTCCAGAA 








with SmaI and XbaI, purified and ligated together using T4 ligase. Similarly, AtsR-LacZ 
fusions were constructed and inserted in pLA23 after removing the inserted WcaJ protein 
with primer 5640 and reverse primers mentioned in Table 4.2 for each truncated version 
of the AtsR protein.  
4.2.4 Protein expression, membrane preparation and Western blot analysis 
For expression of recombinant proteins, a single colony was inoculated in LB broth 
supplemented with appropriate antibiotics and grown at 37 °C. Optical Density (OD600) 
was monitored until it reached 0.6. The culture was then shifted to 30 °C and arabinose 
was added to a final concentration of 0.2% (w/v) to induce the expression of proteins. 
Cultures were incubated for an additional 4 h. Cells were harvested by centrifugation at 
8,000 xg for 10 min. Cell pellets were resuspended in lysis buffer containing [50 mM 
Tris-HCl, pH 8 and 1X of EDTA-free protease inhibitor cocktail (Sigma)], and disrupted 
by One Shot cell disruptor (Thermo Scientific, Rockville, MD, USA). Total membranes 
were isolated by centrifugation at 40,000 xg and resuspended in 50 mM Tris-HCl, pH 8. 
Protein concentration was determined by the Bradford protein assay (Bio-Rad). Total 
membrane preparations were used for immunoblotting and PEGylation. Membrane 
proteins were separated by 14% SDS-PAGE. Proteins were transferred to nitrocellulose 
membrane. The primary anti-FLAG monoclonal antibody (Sigma, Saint Louis, MO, 
USA), was diluted to 1: 10,000 and applied, then the secondary antibody goat anti-mouse 
Alexa fluor 680 IgG antibodies (Invitrogen Molecular Probes, Eugene, OR, USA) was 
diluted to 1: 20,000 and applied. For detection of 6xHis-tagged proteins, membranes were 
incubated with a 1:10,000 dilution of anti-His IgG2a monoclonal antibodies (Amersham, 





Immunoblots were developed using LI-COR Odyssey infrared imaging system (LI-COR 
Biosciences, Lincoln, NE, USA).  
4.2.5 Protease assay 
Protease assays were performed according to Aubert et al., (2013). Briefly, 18 h cultures 
were normalized to an OD600 of 1. The bacterial suspension (3 μl) was spotted onto 
dialysed brain heart infusion (D-BHI) agar plates containing 1.5% carnation milk. The 
plates were incubated at 37 °C and examined for zones of clearing around the bacterial 
spots at 48 h.  
4.2.6 Alkaline phosphatase (PhoA) fusions and alkaline phosphatase assay 
β-galactosidase and alkaline phosphatase activities were quantitated as previously 
described (11). 
4.2.7 Thiol-specific chemical blocking and modification 
Thiol-specific chemical blocking with N-ethylmaleimide (NEM) followed by 
modification with methoxypolyethylene glycol maleimide (PEG-mal) under 
nondenaturing and denaturing conditions was performed as described previously (12). For 
modification under nondenaturing conditions, membrane protein was split in three 
equally parts for three treatments: 1) 1-h incubation at room temperature with 1 mM 
PEG-mal, followed by addition of dithiothreitol (DTT) to 45 mM and further incubation 
for 10 min to quench the reaction; 2) 30-m incubation with 5 mM NEM to block 
accessible sulfhydryl groups, followed by immediate ultracentrifugation (16,000 × g, 1 





mM MgCl2 plus protease inhibitors buffer to remove excess NEM. After another 
ultracentrifugation, the pellet was resuspended in 40 μl of resuspension buffer followed 
by reacting with 1 mM PEG-mal and quenching with DTT as above; 3) untreated control.  
For modification under denaturing conditions, membranes were divided into 2 aliquots. 
One was directly treated with 1 mM PEG-mal in the presence of 2% SDS followed by 
addition of DTT and incubation for 10 min as described above. The other half was first 
incubated with 5 mM NEM for 30 min in the absence of SDS and washed as above. The 
sample was then incubated with 1 mM PEG-mal in the presence of 2% SDS at room 
temperature for 1 h. The reaction was finally quenched by incubation with 45 mM DTT 
for 10 min. All aliquots were mixed with sample buffer and subjected to SDS-PAGE.  
4.3 Results and discussion 
4.3.1 In silico analysis of AtsR topology  
We used available TOPCONS (v2.0) web server for consensus prediction of membrane 
protein topology that implements 5 different algorithms including, OCTAPUS, PRO, 
PROVID, SCAMPI-seq and SCAMPI-msa to predict the membrane topology of AtsR 
(13). Topology prediction is mainly based on three attributes including number of TMs, 
TM-position, and periplasmic or cytoplasmic location of N- and C-terminal domains. 
According to all these algorithms AtsR has two predicted transmembrane domains from 
residues 10–30 (in-to-out) and residues 184–204 (out-to-in) separated by a large 
periplasmic loop (Fig. 4.1A). The prediction also suggests a short cytoplasmic N-terminus 












Figure 4.1: Graphical representation of the topological predictions of AtsR based on 
TOPCON web server. The numbers indicate the position of the amino acid residues (606 
amino acids for AtsR). The location of cytosolic and periplasmic regions and the 










4.3.2 Topological analysis of AtsR using LacZ and PhoA reporter fusions 
To validate the in silico predicted membrane topology of AtsR we employed a dual 
reporter fusion strategy based on LacZ and PhoA reporters, which were C-terminally 
fused to Flag-tagged AtsR derivatives that are truncated at various residues and expressed 
in E. coli strains CC118 lacking phoA and DH5α (lacZΔM15), respectively (Fig. 4.2A). 
Membrane expression of fusion proteins were tested by Western blot to make sure that 
fusion proteins are properly expressed (Fig. 4.2B). LB-agar plates were supplemented 
with chromogenic substrates X-P or X-Gal and colonies were examined for blue or white 
phenotypes. Also, the alkaline phosphatase and β-galactosidase activities were measured. 
If the PhoA reporter locates in the periplasm, the enzyme will be active as it requires a 
reducing environment to form disulphide bonds and will cleave the X-P substrate and 
therefore, bacterial colonies will turn blue (14). If PhoA locates in the cytoplasm, the 
enzyme is inactive, and bacterial colonies will be colourless. In contrast to PhoA, LacZ 
functions only in the cytosol generating blue colonies indicative of locations that are in 
the cytoplasmic space. Flag-tagged AtsR-LacZ fusions at residues S100 and Y160, which 
are located in the predicted periplasmic domain, did not exhibit β-galactosidase activity in 
vivo or in vitro (Fig. 4.3B). On the contrary, the corresponding Flag-AtsR-PhoA fusions 
at the same positions had a positive alkaline phosphatase enzymatic activity in vitro (1313 
± 50, 599 ± 42 Miller units) and strong blue colonies in the presence of X-P substrate 
(Fig. 4.3A), suggesting that S100 and Y160 reside in the periplasmic space. Despite 
relatively low in vitro activity (29 ± 90, 18 ± 43 Miller units), the LacZ fusion to T300 
and L402, residues predicted to be in the cytosol, yielded blue colonies on X-gal plates, 









Figure 4.2: A) Schematic drawing of Flag-tagged AtsR truncated proteins fused to either 
PhoA or LacZ from C-terminus. Blue circle represents Flag tag, red boxes represent TMs 
and numbers correspond to the amino acids where fusion occurs.  B) Membrane 
expression of Flag-AtsR-PhoA or -LacZ fusion proteins in CC118 (left) or DH5α cells 
(right). Flag-AtsR-PhoA or -LacZ proteins were expressed from the arabinose-inducible 
vector pBADNTF. Total membranes were isolated from cells expressing constructs and 















Figure 4.3: Alkaline phosphatase (A) and β-galactosidase (B) results of Flag-AtsR-
PhoA/LacZ fusion proteins expressed in CC118 or DH5α cells. In vitro alkaline 
phosphatase and β-galactosidase assay were measured by the hydrolysis of PNPP and 
ONPG, respectively. Plate assays are shown in the bottom panel indicating the cleavage 









residues are exposed to the cytosolic space (Fig. 4.3B). These results are in agreement 
with the predicted topology of AtsR. Based on our plate assay we obtained inconclusive 
results for LacZ and PhoA fusions at Q215 as both produce colonies with blue phenotype 
(Fig. 4.3 lower panel). This observation is not uncommon in fusions to amino acids 
located at the borders of TMs (15). However, Q215 yields very low in vitro β-
galactosidase enzymatic activity (14 ± 21 Miller units) and no alkaline phosphatase 
activity (Fig. 4.3A&B). Here, the enzymatic data provide topological information for this 
residue which is predicted to be in the cytoplasmic face of the second TM. Taken 
together, these results confirm the in silico predicted topology of AtsR protein suggesting 
that AtsR is an inner membrane protein with a sensor domain facing the periplasm and a 
C-terminal cytoplasmic domain.  
4.3.3 Topological analysis of AtsR using sulfhydryl reactive chemistry 
To examine the borders of TMs in a more detailed analysis, we used a substituted 
cysteine labeling approach using sulfhydryl reactive reagents. In this method, the cysteine 
(Cys) residues are modified by the covalent attachment of PEG-Mal in the presence of a 
water molecule and the labeled proteins can be readily detected by Western blot by an 
increase of approximately 5 kDa to their apparent molecular mass (16, 17). Using this 
strategy the native structure of the protein is maintained with minimal disruption 
compared to reporter fusion method. We replaced the three native cysteines in AtsR at 
positions 195, 255 and 515 with alanine (Ala) residues to create a cysteine-less protein, 
AtsRcysless. To make sure that the cysless version of AtsR is functionally active, the K56-
2∆atsR mutant was chromosomally complemented with AtsRCysless and its corresponding 





levels to the WT strain (Fig. 4.4A&B) indicating that it has a similar structure to the 
native AtsR protein and the three cysteine residues are dispensable for the function. 
Following this, several residues were replaced and novel cysteines were introduced at 
various positions around and within TMs by site-directed mutagenesis (Fig. 4.5). 
Labeling was performed in total membrane preparations with and without treatment with 
NEM (permeable to both inner and outer membrane) under denaturing and nondenaturing 
conditions to distinguish between exposed residues and those hidden in the lipid bilayer. 
NEM can permeate membranes and blocks the cysteine residues prior to PEG-mal 
modification in either side of the membrane to prevent them from becoming accessible to 
PEG-mal and causing a band shift.  This property is useful to detect buried cysteine 
residues within TMs because NEM needs water molecules to be reactive and therefore, 
cysteine residues in the TM can be characterized by a band shift only after PEG-mal 
treatment in the presence of SDS. If a cysteine resides in the periplasm, PEG-mal can 
attach to the residue causing a clear band shift in both SDS denaturing and nondenaturing 
conditions. This band shift will not appear if NEM blocks the cysteine before PEG-mal 
treatment. On the contrary, if a cysteine resides in the cytosol, it can only be exposed to 
PEG-mal if membranes are disrupted by SDS. As shown in Fig. 4.6A, with PEG-Mal 
treatment, there is a distinct band shift observed in the WT AtsR protein that is not 
present in the control condition. This band shift is more pronounced under denaturing 
condition as C195 that is supposedly hidden in the membrane is exposed and therefore 
two shifts occur. As expected the AtsRcysless does not generate any band shift in any 
treatment. Interestingly, residues M21C and G187C were not labeled by PEG-mal in the 
absence of SDS suggesting that these residues were blocked by NEM and therefore 





and G187C are buried in the membrane as predicted by the in silico topological model. 
Labeling of membranes with PEG-Mal under non-denaturing or SDS-denaturing 
conditions resulted in a band shift for AtsR protein carrying novel cysteines at V38C, 
G41C, G49C and G120C indicating their accessibility to PEG-mal suggesting a 
periplasmic location for these residues (Fig. 4.6C).  
Furthermore, we investigated the residues around the membrane hinges by introducing 
novel cysteines at positions V14C, A182C, G180C and M205C. None of the introduced 
cysteines were labeled when treated with NEM; however, they all have a band shift when 
treated with PEG-mal under denaturing condition in the presence of SDS (Fig.4.7A). This 
might be due to close proximity of these residues to the membrane bilayer borders where 
are accessible to NEM but not to PEG-mal in non-denaturing condition. Finally, after 
treatment of membranes novel cysteines at residues A328C and G484C were modified by 
PEG-mal in the presence of SDS but did not show a band shift when pretreated with 
NEM suggesting they are on the cytosolic face of the membrane (Fig. 4.7B). This 
observation corresponds to the PhoA/LacZ reporter fusions. The Western blotting 
analysis suggested all single cysteine AtsR proteins were expressed at levels comparable 
with that of the WT and localized in the membrane fraction with the expected molecular 
mass of 68 KDa (Fig. 4.6&7). Therefore, we concluded that the effect of cysteine residue 
replacement in each mutant is tolerated and does not cause structural changes in the 
protein. Collectively, our data from LacZ/PhoA reporter fusions combined with PEG-mal 
experiments support the predicted topology of AtsR. However, the predicted TM borders 
shown in Fig. 4.1B need to be refined based on our PEGylation data as follows: the first 








Figure 4.4: Proteolytic activity of K56-2, K56-2∆atsR, K56-2∆atsR::atsR, K56-
2∆atsR::atsR-cycless mutant strains on milk agar plates (A) and quantification of protease 
activity of the same strains (B). Proteolysis was tested on D-BHI milk agar plates. The 
plates shown are representatives of three experiments performed in triplicate. Zones of 
clearing around the colonies were measured at 48 h of incubation at 37 °C. Values are 
average radius ± standard deviation in centimeters of three experiments performed in 
triplicate.  Statistical analysis was performed by paired t-test using two-tailed P-values. 
Significant differences in comparison with B. cenocepacia parental strain (K56-2) as 












Figure 4.5: Schematic topology of AtsR predicted by in silico programs and validated by 
reporter fusion studies. Yellow stars represent native cysteine residues in AtsR protein 
and red stars indicate point mutations to introduce novel cysteines. Green circles 
correspond to the location of LacZ or PhoA fusion. Numbers indicate corresponding 
amino acid residues. Abbreviations: V: valine, M: metionine, G: glycine, S: serine, Q: 












Figure 4.6: PEG-mal labeling of AtsRcysless proteins carrying cysteine replacements with 
amino acids in periplasmic and TM domains. A, B, and C) Cells were harvested and total 
membrane fractions were isolated by centrifugation and resuspended in HEPES/MgCl2 
buffer. Membrane was incubated with buffer alone or 1 mM PEG-mal with or without 1% 
SDS for 1 h at room temperature or pretreated with NEM for 30 min at room temperature. 
Proteins were separated by SDS-PAGE and transferred to nitrocellulose membranes, 








Figure 4.7: PEG-mal labeling in total membrane preparations expressing AtsRcysless 
proteins with cysteine replacement with amino acids in periplasmic hinges and 
cytoplasmic domain. A and B) Cells were harvested and crude membrane fractions were 
isolated by ultracentrifugation and resuspended in HEPES/MgCl2 buffer. Membrane was 
incubated with buffer alone or 1 mM PEG-mal with or without 1% SDS for 1 h at room 
temperature or pretreated with NEM for 30 min at room temperature. Proteins were 
separated by SDS-PAGE and transferred to nitrocellulose membranes, followed by 









4.3.4 Analysis of functional residues within periplasmic loop  
While the histidine kinase and ATPase domains of AtsR have typical residues of TCS 
proteins, the predicted periplasmic region is unique to Burkholderia species. Examination 
of the predicted secondary structure of the periplasmic loop of AtsR using the PSI-PRED 
program (18) revealed the presence of five α-helices (Fig. 4.8), supporting the idea that 
the periplasmic loop of AtsR could form a pocket to interact with a signalling molecule 
itself. Therefore, we investigated whether replacing conserved amino acids within 
predicted periplasmic loop could affect the function of AtsR. 
To identify functional residues within the periplasmic loop, the sequence was aligned 
with corresponding loop of AtsR homologues proteins within Burkholderia cepacia 
complex and 10 conserved residues including Q56, Y61 and D65 residing in the first α-
helix, F79 and D80 from the second α-helix, S103, W105 and K127 from the third α-
helix, and N155 and R162 from the fourth α-helix were replaced by alanine using site-
directed mutagenesis and then introduced into K56-2∆atsR mutant strain of B. 
cenocepacia at chromosomal level. These mutant derivatives of AtsR were tested and 
their protease activity was measured. As shown in Fig. 4.9, results are statistically 
significant only for mutants carrying Q56A, D65A, S103A and R162A substitution 
compared to the WT indicating the importance of these residues. To make sure that such 
phenotype is robust, proteolytic activity of three different colonies for each mutant strain 
were quantified all exhibiting reproducible data. R162 and D65 are charged amino acids, 
whereas S103 and Q56 are non-charged polar amino acids. To investigate whether the 
charge or the nature of the amino acid is important at these positions we replaced D65 






Figure 4.8: PSIRED model representing AtsR periplasmic loop (starting from amino acid 
33 to 180) with 5 predicted α-helices. Pred represents graphical representation of the 
structural prediction that includes α-helical regions (pink cylinders) and coils (black 
lines). Blue boxes indicate the confidence of prediction for each residue as indicated by 
the height of each rectangle. The amino acid numbers correspond to the position in the 





asparagine (N) and R. Interestingly, neither S103 replaced with V nor Q56 replaced with 
R could restore the protease activity of ΔatsR phenotype indicating that the nature of 
amino acid is important at these positions since replacing the hydroxylic S with aliphatic 
V at position 103 and Q with positively charged R at position 56 might have changed the 
nature and structure of the protein resulting in a non-functional AtsR. In contrast, 
replacement of Q56 with N and S103 with T restored the protease activity of mutant 
strain to WT levels (Fig. 4.9B). Furthermore, D65 substitution with opposite or same 
charge amino acids does not complement the ΔatsR phenotype. This result together with 
the increased protease activity observed in D65 to Ala substitution indicates that the 
nature and size of the amino acid is important other than charge. Nevertheless, together 
these data suggest that S103, D65 and Q59 are indispensable for AtsR function by 
maintaining the tertiary structure of the protein making contacts with the signal or 
interacting with auxiliary periplasmic proteins to sense the environmental cues and 
initiate the AtsR signaling pathway. 
4.4 Conclusion 
This study provides evidence of the topology of AtsR, demonstrating the agreement 
between predicted topology with our experimental analysis. A combination of fusion 
reporters to the LacZ and PhoA proteins and labeling of cysteine replacement mutants 
with sulfhydryl reactive reagents allowed us to experimentally validate topological model 
for AtsR that is composed of a short N-terminal cytoplasmic region, a periplasmic loop 
flanked by 2 TM helices, and a C-terminal cytoplasmic domain. A cys-less version of 
AtsR localized to the membrane and remained functional indicating that the native 






Figure 4.9: Protease activity of K56-2∆atsR strains complemented with AtsR mutants at 
chromosomal level. Quantifications of proteolytic activity of mutants with alanine 
substitution (A) or with the same or opposite charged or uncharged amino acids (B). 
Results obtained based on 3 individual experiments in triplicate for each mutant. 
Statistical analysis was performed by paired t-test using two-tailed P-values for mutants 
in comparison with B. cenocepacia parental strain (K56-2) (*** corresponds to p<0.0005, 
** corresponds to p<0.005 and * corresponds to p<0.05). Similar stats were obtained with 





periplasmic region of AtsR that are absolutely required for the functionality of the 
protein. While the histidine kinase domain and the ATPase domain at the cytoplasmic C-
terminus are highly conserved features in all histidine kinases, the predicted periplasmic 
domains are variable elements suggesting their potential role in signal perception. Based 
on PSIPRED modeling system the periplasmic region of AtsR has five α-helices (Fig. 
4.8) and is likely involved in sensing environmental cues. Further studies will provide 
additional insights into the structural or functional significance of these residues within 
the periplasmic loop regarding facilitating an interaction with a signalling molecule or 
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Burkholderia cepacia complex (Bcc) denotes a group of ubiquitous Gram-negative 
bacterial species isolated from water, soil, plants, insects, industrial settings and hospital 
environments (1). Some Bcc strains have beneficial traits, as they utilize complex carbon 
sources to degrade toxic compounds in pesticides and herbicides, while others serve as 
bioremediation agents (2). However, Bcc strains are opportunistic pathogens causing 
serious infections in immunocompromised humans, including chronic lung infection in 
cystic fibrosis (CF) patients (3). The most common Bcc clinical isolates are B. 
cenocepacia and B. multivorans. In particular, B. cenocepacia has gained notoriety for its 
ability to cause lethal necrotizing pneumonia and its transmissibility among CF patients 
(3). 
The opportunistic nature of infections by B. cenocepacia makes it difficult to study the 
pathogenic mechanisms of this bacterium, since "virulence" depends on the host's context 
and its innate susceptibility to infection. Several infection models for B. cenocepacia have 
been established, which include mice and rats (4), zebrafish embryo (5), the nematode 
Caenorhabditis elegans (6), Galleria mellonella moth larvae (7, 8), and plants like alfalfa 
(4) and duckweed (9). Plants have evolved sophisticated mechanisms to perceive and 
respond to nearly constant attacks from potential pathogens (10). These mechanisms 
involve passive protection, such as that provided by the waxy cuticular skin layer, and 
innate immune responses. As with the innate immune system in mammals and insects, the 
plant immune system also perceives and responds to various elicitor molecules, which are 
conserved microbial structures referred to as microbe- or pathogen-associated molecular 





lipoteichoic acid, and fungal chitin and ergosterol (11). LPS consists of lipid A, 
embedded in the outer leaflet of the outer membrane, which is linked to core 
oligosaccharide and polymeric O antigen (12), while flagellin is the building block of the 
flagellar filament essential for bacterial motility. LPS and flagellin are typical PAMPs 
that stimulate plant cells and tissues to generate reactive oxygen species (ROS), 
alkalinisation of the extracellular medium, callose deposition, and nitric oxide (NO) burst 
(13-15). These responses lead to programmed cell death localized to the tissue 
surrounding the infection site, which is known as the hypersensitive response (11, 16).  
Arabidopsis thaliana is an established model organism for plant biology, but also a tool to 
understand molecular mechanisms of human diseases (17, 18), particularly concerning the 
initial stages of infection (10, 19). Previous work by others reported a rapid burst of NO 
after treatment of A. thaliana cultured cells and leaves with B. cepacia lipid A 
preparations, which was associated with the transcriptional activation of defense-related 
genes (20). Further, treatment with B. cepacia purified lipid A and core oligosaccharide 
LPS components resulted in different plant transcriptional responses (21), suggesting that 
plant cells perceive LPS components differently. Lipid A structural modifications alter 
recognition and responses by the innate immune system in mammals (22) and in plants 
(23). LPS contributes to reduce the permeability of the outer membrane of Gram-negative 
bacteria, acting as a barrier for plant-derived antimicrobial substances (24). B. 
cenocepacia exhibits extraordinary intrinsic resistance to antimicrobial peptides and other 
antibiotics (25). We have shown that the B. cenocepacia lipid A and one of the sugars of 
the inner core oligosaccharide are modified by the incorporation of L-Ara4N, and this 
modification is not only essential for bacterial survival (26) but is also the major 





modification by L-Ara4N suggests the possibility that this amino sugar could also 
contribute to modulate innate immune responses.  
Flagellin is a major activator of innate immunity in animals, where is recognized by the 
Toll-like receptor 5 (TLR5) (28), and in plants (29, 30). Recognition of flagellin by plants 
activates disease resistance mechanisms through an oxidative burst during early stages of 
infection (13, 15). The A. thaliana Flagellin Sensing2 (FLS2) protein is a PAMP receptor 
kinase with an extracellular domain containing 28 leucine-rich repeats, a transmembrane 
domain, and an intracellular serine/threonine kinase domain (31, 32). These interactions 
activate production of ROS , triggering a complex defense response including induction 
of pathogenesis-related genes (15). We have recently shown that the B. cenocepacia 
flagellin is glycosylated and its glycosylation status modulates innate immune responses 
in mammalian cells (33), but the role of flagellin glycosylation in plant immune responses 
to B. cenocepacia infection has not been examined. 
In this work, we investigated the pathogenicity of B. cenocepacia in A. thaliana and 
evaluated the significance of LPS modification with L-Ara4N and flagellin glycosylation 
in virulence and in Arabidopsis-B. cenocepacia interactions by studying innate immune 
responses by wild type and mutant plants. Further, we compared bacterial virulence in 
planta and in the Galleria mellonella infection model to clarify the global role of flagellin 
glycosylation and LPS modification on pathogenesis. We demonstrate that flagellin 
glycosylation and LPS modification with L-Ara4N play a significant role on bacterial 
survival upon infection, but do not alter the perception of these molecules by the plant 






5.2 Materials and methods 
5.2.1 Plants and growth conditions 
 Seeds of Arabidopsis thaliana, ecotype Columbia (Col-0), Atnoa1 (SALK number: 
CS6511), fls2 (SALK number: 121477), and dnd1-1 (SALK number: 066908C) mutants 
were surface-sterilized by sequential soaking in 75% ethanol for 1 min, rinsing three 
times with sterile water, soaking in 20% bleach for 15 min, and rinsing five times with 
sterile water. Sterilized seeds were kept at 4 °C in the dark for 3 days for vernalization 
and were planted in magenta boxes containing Murashige & Skoog (MS) basal salt 
mixture (Sigma-Aldrich) supplemented with 1% sucrose (W/V) and 0.8% agar, and 




.  Seedlings were 
grown under 16 h light and 8 h darkness for 21 days. Mutants were obtained from the 
Arabidopsis Biological Resource Center (ABRC). Tobacco plants (Nicotiana 
benthamiana) were grown at 26 °C with a 16-h photoperiod.  
5.2.2 Bacterial strains and growth conditions 
 B. cenocepacia K56-2 and its isogenic mutants (Table 5.1) were cultured at 37 °C in 
Luria Bertani broth overnight. B. cenocepacia K56-2 is a clinical isolate that belongs to 
the ET-12 epidemic strain lineage (57). Strain MSS25 carries a polar insertion in the fliC 
gene, which prevents the synthesis of the flagellin filament and also likely inactivates the 
downstream genes fliD1 and fliT, encoding a flagellar hook and an accessory protein, 
respectively (35). To analyse growth rate of mutants, overnight cultures were diluted into 
fresh medium at a starting optical density (OD) at 600 nm of 0.05. Samples were then 





Table 5.1: Bacterial strains used in this study 
Strain    Characteristics Source and/or reference 
K56-2           B. cenocepacia ET12 clone related to J2315, CF clinical isolate      BCRRC
a
 
K56-2 atsR    K56-2 carrying an unmarked deletion of the atsRgene             (37) 
MH55    K56-2, arnT-arnBC+lptGD31H (lptG
S
)              (27) 
BCAL0111    K56-2, unmarked deletion of flmQ (BCAL0111)                          (33) 
MSS25    K56-2, fliC::pSM62, insertional inactivation of fliC             (35)
 
a




















measuring the OD600 every hour under continuous shaking for 24 h in a Bioscreen C 
automated growth curve analyser (MTX Lab Systems, Vienna, VA, USA). All bacteria 
grew at similar rates in Luria Bertani medium (Fig. 5.9B). 
5.2.3 Plant inoculation methods 
 Five to 6 week-old A. thaliana or Nicotiana benthamiana plants were used for initial 
inoculation experiments. For soil drainage infection, plants were watered with bacterial 
suspensions in MES (4-morpholineethanesulfonic acid sodium salt) buffer. For surface 
spraying method bacteria from overnight cultures were suspended in 10 mM MES buffer 
at different CFU. For inoculation by the syringe-infiltration method, bacteria were 
infiltrated into the leaves using a needleless syringe. For wound inoculation seedlings 
were wounded at the leaf surface by scratching. Wounded seedlings were immediately 
inoculated with bacterial suspensions. MS-agar plates containing inoculated seedlings 
were sealed with parafilm and placed in growth chambers for 7 days. Plants were 
monitored for disease symptoms daily. At day 7, three leaves from each plantlet were 
excised, washed with 5% bleach for 1 min and rinsed with sterile water. The leaf was 
blotted dry on sterile filter paper and imprinted on LB agar plates to determine if there 
were any bacteria on the surface of the leaves. The imprinted plates were incubated at 37 
°C for 24 h. The leaves were then weighed and macerated in 500 µl PBS (phosphate-
buffered saline) with a micro-pestle, serially diluted and plated on LB agar plates in 
triplicates. Only leaf samples that did not show any bacterial growth on the imprinted 
plates were counted to avoid counting contaminating bacteria from leaf surfaces. Other 
mutants were similarly infiltrated into leaves and HR symptoms were visualized by 





enhanced visualization of HR development in leaves and facilitate comparison with the 
parental strain.   
5.2.4 RNA isolation, cDNA synthesis and RT-PCR 
 Total RNA was extracted from frozen leaves of A. thaliana using the SV Total RNA 
Isolation System (Promega, USA) and 1 µg of RNA was reverse transcribed using 
Quantitect Reverse Transcription kit (Qiagen, USA). The coding sequence of PR-1 and 
ACTIN-2 genes, available through GenBank, was used to design the following primers: 
Forward 5'-GATGTGCCAAAGTGAGGTG- 3' and reverse 5'-
CTGATACATATACACGTCC-3' to amplify PR-1 and forward 5 -
T CTCTTCCTCAT CTAT-3  and reverse 5 -ATCCTCC ATCCA ACACT -3 to 
amplify ACTIN. PCR was carried out with an initial denaturation step at 94 
o
C for 4 min, 
followed by 30 cycles of denaturation (30 sec at 94 
o
C) for PR-1 and 21 cycles for 
ACTIN, annealing (30 sec at 53 
o
C) and extension (1 min at 72 
o
C). After the last cycle, a 
final extension was carried out for 5 min at 72 
o
C. PCR products were visualized on 1% 
agarose gels using UV light in a Gel-Doc system (Alpha Innotech, USA). Relative 
mRNA levels of PR-1 were normalized relative to untreated control and internal control 
(ACTIN-2) by densitometry using ImagJ. 
5.2.5 LPS extraction, mass spectrometry, and flagellin purification 
 LPS was extracted from equal biomass using proteinase K method as previously 
described (58). Extracted LPS was dissolved at 1 mg/ml in water containing 2.5 mM 
MgCl2 plus 1 mM CaCl2 and shaken for 3 h on a rotary shaker. If not mentioned 





mM CaCl2 and 2.5 mM MgCl2 (pH 7.6), as a control. Flagellin purification was 
performed as described earlier (33). Lipid A of strains MH55 and K56-2 (Table 5.1) was 
examined by mass spectrometry (MS) using matrix-assisted laser desorption/ionization-
time of flight (MALDI-TOF). Cells were grown overnight in Luria-Bertani broth, 
centrifuged (10,000 ×g), washed twice with phosphate buffer (10 mM Na2HPO4, 1.7 mM 
KH2PO4), and freeze-dried. Lipid A was extracted and desalted, as previously described 
(59). For MS analysis, dihydroxybenzoic acid (DHB) (Sigma Chemical Col, St. Louis, 
MO) was used as a matrix and prepared to saturation in acetonitrile: 0.1% triflouroacetic 
acid (1:2 v/v). A 2-μl sample was loaded on the target, dried, covered by 1 μl of DHB, 
and inserted in a Bruker Autoflex MALDI-TOF spectrometer. Data were acquired and 
analyzed using the Flex Analysis software. 
5.2.6 In vivo NO and ROS analysis 
 NO was measured in guard cells of leaf epidermal peels prepared from leaves of 3-week-
old plants (grown as described above) using diaminofluorescein diacetate (DAF-2DA) 
fluorescence as described (60) with the following modifications. Leaves were submerged 
in buffer (pH 5.7) containing 5 mM MES-KOH, 0.25 mM KCl, and 1 mM CaCl2, with 5 
µM DAF-2DA and transferred either to reaction buffer containing 100 µg/mL LPS or 
pre-incubated for 10 min in reaction buffer containing 50 µM sodium nitroprusside (SNP) 
or 200 µM N
G
-nitro-L-Arg-methyl ester (L-NAME) and then for 20 min with LPS. The 
epidermal peels were placed underneath a cover slip on a microscope slide with several 
drops of reaction mix. In a similar way ROS was detected by 2 µM 2, 7-
dichlorofluorescein diacetate (DCF) and flagellin treatment following the incubation of 






 Fluorescence and phase-contrast images were acquired using a QImaging Retiga-SRV 
camera on an Axioscope 2 (Carl Zeiss).  
5.2.8 Fluorometric Quantification of NO and ROS 
 To monitor NO accumulation in Arabidopsis leaf peels, the DAF-2DA fluorescence was 
measured at excitation of 480 nm and emission of 521 nm, using a Cary Eclipse 
fluorescence spectrophotometer (Varian, Inc., Mississauga, Ontario, Canada). The plate 
was rocked for 20 sec before measuring. Similarly, for determining accumulation of ROS, 
DCF was added to a final concentration of 2 µM. Fluorescence was measured at 
excitation of 480 nm and emission of 521 nm in 96-well white plates. Background 
fluorescence of each probe in buffer control was subtracted. Autofluorescence of the 
buffer, without adding the probes, was measured and corrected by subtraction from the 
fluorescence signals. The suspensions were protected from light throughout the assays to 
avoid photo-oxidation. 
5.2.9 Bacterial Swarming and Swimming Motility Assays 
 Swarming motility assays were performed as described previously (37). Assays were 
done in triplicate and repeated independently three times.  Bacterial swimming motility 
was analyzed on soft agar plates (1% Bacto tryptone in 0.3% agar). The OD600 of 
overnight cultures was adjusted to 1 and 2 μl of culture were inoculated in the centre of 
agar plate. Diameter of growth zone was measured after 24 h of incubation at 37 °C. 





 G. mellonella larvae were obtained from Recorp and stored in the dark at 4 °C. Injections 
of 10 µl containing 1 × 10
4
 CFU diluted in 10 mM MgSO4  7H2O supplemented with 100 
µg ampicillin µl
−1
 were given to the larvae into the haemocoel through the hindmost right 
proleg. Infected larvae were incubated at 30 °C and larval survival was monitored up to 
75 h as judged based on lack of movement in response to stimuli. Control larvae were 
injected with 10 µl of the same buffer without bacteria. Ten larvae were used for each 
condition and the experiment was repeated on three independent occasions. 
5.3 Results and discussion 
5.3.1 Pathogenicity of B. cenocepacia in A. thaliana and tobacco seedlings 
 We investigated the ability of B. cenocepacia K56-2, a CF clinical isolate, to induce HR 





bacteria and examined for symptoms over one week. A simple 
infection model was developed in which leaves were wounded, and then inoculated with 
dilute suspensions of B. cenocepacia. Disease was scored for every seedling on an index 
of 1 to 6 based on the extent of HR symptoms and tissue necrosis using a standard HR 
scoring system (34). Depending on the bacterial dose, infection of seedlings via wound 
inoculation or syringe infiltration led to necrosis (brown areas on leaves at higher doses) 
or chlorosis (yellowing of the leaf tissue), which were clearly visible after day 4 post 
infection. In contrast, infections by soil drainage or surface spray gave few symptoms 
even at day 7-post infection (Fig. 5.1A). There was a direct correlation between inoculum 
size and HR symptoms (Fig. 5.1B). Similar results were observed in tobacco plants, 
where infection via roots or leaves spraying did not cause distinguishable symptoms in 






Figure 5.1: HR in plant leaves using various inoculation methods. A) Quantitative 
scoring of HR in leaves of wild-type Arabidopsis inoculated with K56-2 by different 
inoculation methods. Symptom scores assigned using an index from 1-6 based on the 
extent of tissue collapse and color change where: 0 is no symptom; 1, random yellow or 
dark spots; 2, chlorosis over the inoculation site; 3, chlorosis and mild tissue collapse at 
and around the inoculation site; 4, more than 50 % collapse at and around the inoculation 
site; 5, 100% collapse at the inoculation site; 6, 100% collapse beyond the inoculation 
site. The average score was calculated based on a minimum of 45 leaves per treatment 
cumulative from 3 individual repeats. B) Effect of inoculum size on the incidence of 
infection. Values indicate percent ± SE of seedlings showing disease symptoms at 7 days 




 CFU; 15 plants per infection 
dose were tested. Data represent the average of three experiments. C) Representative 
images of 5-week-old tobacco plants inoculated with a dose of 10
8
 CFU of B. 
cenocepacia by different inoculation methods. Arrows indicate mild symptoms that are 





receptors are available for A. thaliana ecotype Colombia Col-0, we used only seedlings 
from this species for the remainder of this study, which were inoculated with 10
8
 CFU via 
wound inoculation or syringe infiltration. 
5.3.2 L-Ara4N modification of LPS and flagellin glycosylation are required to cause 
pathology in A. thaliana 
 B. cenocepacia requires L-Ara4N modification of LPS for viability and resistance to 
antimicrobial peptides (27). However, a suppressor mutation in the lptG gene, which 
encodes an essential protein for the export of LPS to the outer membrane, restores 
viability in the absence of L-Ara4N LPS modification (27). We therefore investigated if 
lack of L-Ara4N in the LPS of this mutant (MH55, ∆arnT lptGD31H) could affect B. 
cenocepacia survival in A. thaliana. Infection of A. thaliana seedlings with ∆arnT 
lptGD31H caused mild symptoms of chlorosis in 27% of inoculated plants (Fig. 5.2A&C); 
very few bacteria were recovered from leaves, as compared to plants infected with the 
K56-2 parental strain (Fig. 5.2B). These data demonstrate that L-Ara4N modification of 
LPS is critical for B. cenocepacia pathogenicity. The poor infectivity of the suppressor 
mutant is most likely due to the lack of L-Ara4N in the LPS of ∆arnT lptGD31H, as 
revealed by mass spectrometry of purified lipid A (Fig. 5.4), which makes it extremely 
sensitive to naturally produced antimicrobial peptides in plants, as we previously 









Figure 5.2: Infection and replication of B. cenocepacia strains in Arabidopsis seedlings. 
A) Values show the percentages ± SE of the seedlings showing disease symptoms visible 
on day 7 post infection after wound inoculation with 10
8
 CFU of B. cenocepacia strains; 
15 plants per infection dose were tested. Data are the average of three repeats. B) Graph 
represents bacterial counts on day 7 post infection from Arabidopsis leaves infected with 
B. cenocepacia by wound inoculation. C) Photographs of representative leaves (from 
three replicate treatments) from Arabidopsis plants inoculated with B. cenocepacia strains 
by infiltration (Upper row). Leaves were removed from plants and bleached in ethanol 
(Lower row). An arrow indicates the inoculated region, which is more transparent and 
flattened undergoing tissue collapse compared with the rest of the leaf and wild-type 





Next, we evaluated the significance of flagellin in A. thaliana pathogenicity. For these 
experiments we used a fliC mutant that is nonmotile and unable to make flagellin (35), 
and the hypermotile, flagellated ∆atsR mutant (Table 5.1). The atsR gene encodes a 
global regulatory repressor protein that controls motility and the expression of various 
virulence factors (36-38). There were no statistically significant differences in disease 
symptoms between plants infected with ∆atsR and K56-2 at day 7 postinfection (Fig. 5.2). 
However, symptoms appeared two days earlier in ∆atsR-infected plants, and these results 
were reproducible in each experimental replica. These observations agree with the current 
model for the regulatory role of AtsR (37, 38) indicating that removal of inhibitory 
regulation on motility as well as other AtsR-controlled factors increases bacterial 
pathogenicity. Therefore, it is not surprising that ∆atsR provoked similar lesions to those 
found with the parental strain K56-2 (Fig. 5.2C). In contrast, loss of flagellin in the fliC 
mutant resulted in a strain that induced only mild HR symptoms in less than 30% of 
plants infected by wound inoculation (Fig. 5.2A), revealing the critical role of flagella in 
virulence and also suggesting that flagellar driven motility is important for infection. The 
wound inoculation method mimics entry of microbes into host plants through natural 
wounds, which results in bacterial spreading to intercellular spaces. In contrast, 
infiltration of bacteria with a syringe into the apoplast could bypass the first steps of the 
natural infection process and therefore, the requirement for bacterial motility. To probe 
this notion, we infected Arabidopsis seedlings by syringe infiltration into leaf abaxial 
surfaces. Under these conditions, the fliC mutant elicited similar HR symptoms as those 
induced by parental K56-2 (Fig. 5.2C). HR also correlated with higher numbers of 
bacteria recovered from leaves, a difference that was particularly pronounced when 








Figure 5.3: Infection of Arabidopsis seedlings by the wound inoculation method. A) 
Representative images of leaves inoculated with a dose of 10
8
 CFU of the various strains 
are shown. B) Bacterial counts on day 7 postinfection recovered from Arabidopsis leaves 









Figure 5.4: MALDI-TOF spectra of purified lipid A produced by the parental B. 
cenocepacia strain K56-2 and the ∆arnT lptGs mutant strain MH55 (Table 1). Lipid A 
samples were prepared and processed as indicated in materials and methods. The profiles 
represented were obtained using the negative-ion mode. Ion peaks are color coded to 















Since post-translational modification of flagellin by glycosylation affects the virulence of 
Pseudomonas syringae in tobacco plants (39, 40), we compared the ability of parental and 
∆flmQ (∆bcal0111) B. cenocepacia strains (Fig. 5.2A) to cause disease in A. thaliana. 
The flmQ gene encodes a flagellin glycosyltransferase in B. cenocepacia (33). In 
comparison to the parental strain, ∆flmQ was less pathogenic for A. thaliana (Fig. 5.2A & 
5.3A) and exhibited reduced bacterial survival (Fig. 5.2B). Further, ∆flmQ caused 
significantly less pathology on the leaves with less than 30% of plants having disease 
symptoms, although slight chlorosis was observable (Fig. 5.2C), suggesting that non-
glycosylated flagellin retains its elicitor activity. The reduced virulence of ∆flmQ on A. 
thaliana leaves also correlated with bacterial defects in swarming and swimming (Fig. 
5.5B&C), consistent with our previous report indicating that glycosylation affects 
bacterial motility (33). Together, these experiments demonstrate that L-Ara4N 




















Figure 5.5: Characterization of flagellin mutants. A) SDS-PAGE analysis of purified 
flagellin from WT and K56-2 ∆flmQ mutant strain of B. cenocepacia. B) Swarming 
(Upper row) and swimming (Lower row) motility on soft agar plates of B. cenocepacia 
strains. Data represent three independent experiments. C) Quantification of motility zone. 
Statistical analysis was performed by paired t-test using two-tailed P-values. Significant 
differences in comparison with B. cenocepacia parental strain (WT) as control are 









5.3.4 LPS induces robust and rapid nitric oxide burst in A. thaliana  
The reduced pathogenicity of ∆arnT lptGD31H could be due to reduced bacterial survival 
during the initial stages of infection or alternatively, poor recognition of LPS devoid of L-
Ara4N by the plant innate immune system. We therefore investigated the levels of NO 
production in A. thaliana guard cells upon exposure to B. cenocepacia LPS from mutant 
and parental sources. Guard cells are specialized epidermal cells in the leaf epidermis 
surrounding stomatal pores that come into close contact with bacterial pathogens. LPS 
typically induces NO generation in A. thaliana (20, 34). NO burst was detected in vivo 
using the NO-specific fluorescent dye DAF-2DA. Treatment of guard cells with ultrapure 
E. coli LPS control resulted in a rapid burst of green fluorescence, indicative of NO 
production (Fig. 5.6A). Robust LPS induction of NO in intact guard cells could be 
reproduced using phenol-extracted LPS from both WT K56-2 and mutant strain lacking 
L-Ara4N (Fig. 5.6B). Quantification of NO burst using a spectrofluorometric assay that 
detects NO accumulation indicated that LPS devoid of L-Ara4N has similar levels of 
elicitor activity suggesting that LPS modification does not affect the innate immune 
response in A. thaliana in vivo.  
Further, we compared LPS-induced NO production in guard cells isolated from parental 
A. thaliana and the Atnoa1 and dnd1 mutants. Atnoa1 is a loss-of-function mutant in 
Nitric Oxide Associated protein 1 (NOA1), which is required for arginine-dependent NO 
generation and involved in signal cascades responding to PAMPs (20, 41). The defense 
no death1 (dnd1-1) mutant has a null mutation in the CNGC2/DND1 gene and displays 
reduced NO generation (34, 42). Minimal responses were detected in Atnoa1 and dnd1 






Figure 5.6:  Role of L-Ara4N in NO generation in Arabidopsis guard cells. A) Leaf 
epidermal peels prepared from parental (WT) leaves were loaded with buffer control (top 
panel) or the NO-sensitive dye DAF-2DA (middle panel) prior to incubation with 100 
µg/mL ultrapure LPS from E. coli (bottom panel). B) Leaf epidermal peels prepared from 
WT leaves were treated with LPS isolated from K56-2 or K56-2 ∆arnT strains. This 
experiment was repeated twice and a minimum of three epidermal peels was used as 
treatment replicates. C) Fluorometric quantification of NO generated in WT Arabidopsis 
leaves. D) Induction of PR-1 gene expression in Arabidopsis leaves by LPS. Leaves were 





(lane 3) for 24 h followed by RNA preparation. ACTIN was used as an internal control for 


























was reduced dramatically in cells treated with the NOS inhibitor N
G
-nitro-L-Arg-methyl 
ester (L-NAME) (Fig. 5.7A, right panel). Similarly, LPS-dependent NO generation was 
not observed in dnd1-1 or Atnoa1 mutants after treatment with L-NAME, while 
incubation with the NO donor sodium nitroprusside (SNP) resulted in green fluorescence 
in parental A. thaliana and both mutants. Therefore, reduced NO burst in Atnoa1 and 
dnd1-1 cells was due to a defect in NO production (Fig. 5.7A, middle panel). NO was 
quantified in LPS-treated leaves of parental and mutant plants using a fluorometric assay. 
LPS treatment yielded 180 relative fluorescence units (RFUs) in parental leaves, 
compared with 78% and 66% reduction in RFUs observed for Atnoa1 and dnd1-1 
mutants, respectively (Fig. 5.7B). LPS-induced NO production in parental leaves was 
repressed by 6-fold upon treatment with the NO synthase inhibitor L-NAME (Fig. 5.7B). 
In contrast, parental and mutant leaves showed similar RFUs in the presence of SNP. 
Together, these results demonstrate that B. cenocepacia LPS triggers a robust NO burst in 
Arabidopsis leaves and both intact LPS and LPS lacking L-Ara4N can be equally 
recognized by the plant innate immune system. 
5.3.5 Flagellin perception in A. thaliana occurs irrespective of the flagellin 
glycosylation status 
 We also investigated if the glycosylation status of the B. cenocepacia flagellin alters the 
immunity response of A. thaliana, which involves a rapid and transient burst of ROS that 
is subsequently associated with programmed cell death (43). Treatment of plants with B. 
cenocepacia flagellin triggered ROS generation in parental A. thaliana leaves, but not in 
leaves from the fls2 mutant, which lacks the flagellin receptor (Fig. 5.8A). This result 






Figure 5.7: LPS activates NO production in WT, Atnoa1 and dnd1-1 guard cells. A) Leaf 
epidermal peels prepared from WT (top panels), Atnoa1 (middle panels) or dnd1-1 plants 
(bottom panels) were loaded with 5 µM DAF-2DA prior to incubation in reaction buffer 
alone (buffer control), 100 µg/mL LPS (left panel), 50 µM SNP (middle panel) or 200 
µM L-NAME (right panel). In each case, corresponding fluorescence and bright-field 
images are shown; the area of the peel subjected to analysis was greater than that shown 
in each case. This experiment was repeated three times using at least three epidermal 
peels per experiment. B) Fluorometric quantification of NO generated in leaves of WT, 
Atnoa1 and dnd1-1 Arabidopsis seedlings. C) Induction of PR-1 gene expression in 
Arabidopsis leaves by LPS. Arabidopsis leaves were treated with buffer (lanes 1, 3 & 5) 
or LPS (lanes 2, 4 & 6) for 24 h followed by RNA preparation. RT-PCR was performed 
with cDNAs for PR-1 and ACTIN. Numbers represent relative levels of PR-1 being 





importance of flagellin perception for ROS production and disease resistance (13, 15).  
Fluorometric quantification of ROS in parental and fls2 mutant leaves showed a 3-fold 
reduction indicating that flagellin recognition was necessary for eliciting ROS production 
(Fig. 5.8B). However, no significant differences were detected in ROS production by 
leaves treated with non-glycosylated flagellin, despite that infection with bacteria lacking 
glycosylated flagellin produce less symptoms of infection (Fig. 5.8C). This result 
suggests that reduced pathogenicity of A. thaliana exposed with the B. cenocepacia 
∆flmQ is due to reduced bacterial motility rather than differential perception of 
glycosylated vs. non-glycosylated flagellin by the FLS2 receptor.   
5.3.6. Induction of Pathogenesis Related gene-1 (PR-1) by LPS and flagellin 
 Host defense responses in A. thaliana depend on ROS and NO production and induction 
of host defense or stress-associated genes, such as genes encoding Pathogenesis Related 
proteins (20). We investigated PR-1 gene expression by RT-PCR, since the expression of 
this gene is considered a hallmark of defense response in plants (20, 21). PR-1 expression 
was significantly increased in parental A. thaliana leaves 24 h after treatment with either 
intact or L-Ara4N devoid LPS (Fig. 5.6D). In contrast, PR-1 mRNA accumulation was 
reduced in Atnoa1 mutant plants (Fig. 5.7C, lanes 3&4) suggesting a functional link 
between LPS-induced NO production and PR-1 expression. Similarly, PR-1 expression is 
activated by flagellin irrespective of its glycosylation status in parental A. thaliana but not 
in the flagellin-insensitive fls2 mutant (Fig. 5.8C). As expected, dnd1-1 mutant plants 
expressed high levels of PR-1 mRNA, which is due to the constitutively active salicylic 
acid signalling pathway in this mutant (44, 45). Together, our findings indicate that 






Figure 5.8: Flagellin activates ROS generation in guard cells of WT and fls2 leaves. A) 
Leaf epidermal peels prepared from WT (top panels) or fls2 plants (bottom panels) were 
loaded with the ROS-sensitive dye DCF prior to incubation with glycosylated (left panel) 
or unglycosylated flagellin (right panel) from K56-2. In each case, corresponding 
fluorescence and bright-field images are shown; Images are the representative of three 
individual experiments. In each experiment, at least three epidermal peels were used as 
treatment replicates. B) Fluorometric quantification of ROS generated in leaves of WT 
and fls2 Arabidopsis seedlings. C) Induction of PR-1 gene expression in Arabidopsis 
leaves by flagellin. Arabidopsis leaves were treated with buffer (lanes 1 & 4), WT (lanes 
2 & 5) or unglycosylated flagellin (lanes 3 & 6) for 24 h followed by RNA preparation. 
RT-PCR was performed with cDNAs for PR-1 and ACTIN-2. Numbers represent relative 





 and flagellin. This agrees with our results regarding induction of oxidative burst 
indicating that L-Ara4N modification of LPS and flagellin glycosylation are critical for 
infectivity in A. thaliana but do not alter the perception of these molecules by the plant 
innate immune receptors. 
5.3.7 Comparison of Arabidopsis and Galleria infection models 
 The previous results indicate that flagellin and LPS modifications alter the infectivity of 
B. cenocepacia in A. thaliana, but the plant can perceive these molecules irrespectively. 
Therefore, we tested the ability of B. cenocepacia strains utilized in the plant infection 
model for survival and pathogenicity in G. mellonella. G. mellonella moth larvae have 
been increasingly used as an infection model for many bacterial pathogens including 
several Burkholderia species (8, 46, 47). B. cenocepacia parental and mutant strains were 
injected into G. mellonella and survival was monitored for over 72 h. As with A. thaliana, 
K56-2 ∆atsR exhibited high virulence denoted by no larvae surviving at 48 h post 
injection with 10
4
 CFU (Fig. 5.9A), compared to 5 ± 3% survival of larvae infected with 
parental K56-2. In contrast, ∆arnT lptGD31H was greatly attenuated, as shown by larvae 
survival rates of more than 80% at 48 h post infection (Fig. 5.9A). At infection doses of 
10
4
 CFU, similar attenuation levels were observed in the fliC mutant, while ∆flmQ 
showed an intermediate phenotype (50 ± 13.5% survival). At 72 h post infection the 
larvae survival rates with ∆arnT lptGD31H, fliC, and ∆flmQ were 77 ± 14, 43 ± 12, and 28 
± 7%, respectively. Control larvae injected with buffer remained viable until the end of 
the experiment. These results are comparable to the data obtained from the A. thaliana 
infections, confirming the significance of flagellin glycosylation and L-Ara4N 







Figure 5.9: Virulence of B. cenocepacia strains in G. mellonella. A) Larvae were 
infected with 1 × 10
4
 CFU of the indicated Burkholderia strains. Larval survival was 
monitored during 75 h post infection. Data are means ± SEM. B) Growth rate of parental 
B. cenocepaica strain K56-2 and its isogenic mutants in LB medium. Data points 











Virulence and pathogenicity requires considering both the host and the microbe; the use 
of these terms to define a microbe in isolation of its host has recently been debated (48, 
49). We show here that modifications in the LPS molecule and flagellin glycosylation do 
not affect recognition by plant innate immune receptors, but are still required for bacteria 
to establish an infection. Our experiments using the B. cenocepacia K56-2-A. thaliana 
infection model reveal that plant seedlings sense LPS and flagellin as PAMPs and induce 
a burst of NO and ROS that contributes to basal resistance and eventually leads to a 
hypersensitive response against B. cenocepacia. Redox signalling has emerged as a main 
regulator of cellular function in plant pathophysiology (50). Pathogen recognition turns 
on a signalling cascade where free radicals, such as NO and ROS, act as infochemicals 
for activation of various defense genes that mediate disease resistance in plants (14). NO 
and ROS production upon K56-2 LPS or flagellin treatment potentiated the expression of 
PR-1, which is a disease resistance marker. In contrast, PR-1 gene expression was 
reduced when Atnoa1 and fls2 mutant plants were treated with LPS or flagellin, indicating 
that LPS-responsive genes are NO inducible (20). In our work, we did not observe a 
distinguishable difference in the expression of the PR-1 gene after treatment of leaves 
with intact or modified versions of LPS and flagellin.  
Although we did not use purified lipid A in our study, these observations contrast with a 
previous report indicating that isolated lipid A of a non pathogenic mutant of 
Xanthomonas campestris, consisting mainly of penta-acylated lipid A with 
phosphoethanolamine substitutions of its phosphate groups, was unable to elicit PR-1 





groups with phosphoethanolamine would neutralize the net negative charge of the lipid A, 
which could affect binding to putative plant receptors (23). In contrast, the B. 
cenocepacia lipid A phosphate groups are substituted by L-Ara4N molecules and 
disappearance of these residues in the ∆arnT lptGD31H would expose negative charges, 
thus maintaining the ability of lipid A to activate PR-1 expression. Importantly, the lipid 
A of B. cenocepacia is tetra- and penta-acylated, but the acyl chains are longer than those 
of the X. campestris lipid A (51). Therefore, the fact that parental and L-Ara4N devoid 
LPS from B. cenocepacia induce similar levels of PR-1 gene expression suggests that the 
acyl chain composition may also play a role in LPS detection by plant innate immune 
receptors. 
Irrespective of K56-2 LPS elicitor activity, B. cenocepacia mutants unable to produce L-
Ara4N-modified LPS have extremely high sensitivity to Polymyxin B (27), suggesting 
that they would also be highly sensitive to plant antimicrobial peptides. Further, we show 
that post-translational modification of flagellin by glycosylation affects bacterial motility 
and virulence in Arabidopsis, but does not significantly alter the elicitor activity of the 
protein. A correlation between defects in flagellin glycosylation in Pseudomonas syringae 
and reduced ability to induce HR in plants has been reported (39, 40), but the molecular 
mechanism is unknown. Our experiments indicate that reduced virulence but increased 
activation of plant defenses by the ∆flmQ mutant producing non glycosylated flagellin is 
due to bacterial motility defects that prevent bacteria to establish infection. This could be 
clearly demonstrated by showing that the attenuation of the K56-2 fliC mutant strain is 
bypassed if bacteria are directly infiltrated into the plant deeper tissues. A role for 





carotovora (52), Ralstonia solanacearum (53), and several pathovars of P. syringae and 
Xanthomonas campestris (54-56).  
In conclusion, we demonstrate that flagellin glycosylation and LPS modification with L-
Ara4N play a significant role on bacterial survival during the early stages upon infection, 
but do not alter the perception of these molecules by the plant innate immune receptors, 
indicating these modifications are only critical to establish infection. Our experiments 
therefore illustrate the notion that microbe's perception by the host and establishment of 
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The opportunistic nature of Burkholderia cenocepacia is manifested by its amazing 
ability to adapt to and survive in a wide range of environmental and anatomical niches, 
which explains its pathogenesis in human (1), plants (2), nematodes (3) and animals (4). 
This requires an ability to sense and respond to the surrounding environment, which 
depends on regulatory networks that wire signal perception to coordinated gene 
expression and adaptive responses. Our data indicate that the AtsR protein has a major 
role in this process due to its nature as a sensor kinase and its high conservation in 
Burkholderia.  
6.2 AtsR mechanism of action 
It has been established that quorum sensing and T6SS are required for in vivo infection 
and therefore AtsR is involved in regulating virulence factors. However, the predicted 
structural features of AtsR suggested this protein could not directly control gene 
expression because it lacks an effector domain. In chapter two, we identified AtsR’s 
cognate response regulator and demonstrated key properties of the AtsR to AtsT 
phosphotransfer mechanism. First, upon autophosphorylation AtsR transfers the 
phosphate directly to the response regulator AtsT without involving other intermediate 
protein. Second, the His-245 residue of AtsR is absolutely required for function both in 
vitro and in vivo. Third, the C-terminal receiver domain of AtsR plays a role in 
modulating the stability of phosphorylated AtsR. It is very common in hybrid sensor 
kinases that the aspartate residue on the receiver domain modulates phosphotransfer and 





long half-life of phosphorylated AtsR and AtsT maintains the response memory for 
longer periods allowing the regulation of gene expression. Finally, the rapid 
phosphotransfer from AtsR to AtsT within 2 minutes represents the specificity of signal 
transduction based on molecular recognition indicating that they are true cognate pairs. 
Non-specific phosphotransfer between non-cognate pairs occur with prolonged incubation 
times at a much slower rate in vitro (9). For more in depth analysis to determine the 
critical residues for molecular recognition a combination of traditional single amino acid 
mutagenesis and more computational and systematic approaches as well as structural 
studies is required. 
6.3 AtsR topology 
To begin understanding the signal(s) or conditions that lead to activation or deactivation 
of the AtsR/AtsT phosphorelay we wanted to determine the critical amino acids residing 
in the sensory domain of AtsR. We first experimentally validated the predicted topology 
of the protein and then studied its sensory domain. We further identified 4 residues in the 
periplasmic region that are absolutely required for the function of the protein. Based on 
PSIPRED modeling system the periplasmic region of AtsR has four major α-helices. A 
well known example of periplasmic domain with antiparallel four-helix bundle is NarX. 
NarX responds to nitrate and nitrite and regulates anaerobic respiration. A high-resolution 
X-ray crystal structure of the NarX periplasmic sensor domain from E. coli revealed that 
nitrate-binding induces conformation changes that result in a piston-type displacement 
between the N- and C-terminal helices of the periplasmic domain (10). This might 
represent a conserved mechanism of ligand binding in histidine kinases with antiparallel 





identified 4 residues within the periplasmic loop facilitating an interaction with a 
signalling molecule or maintaining the binding pocket.  
The middle gene of the atsR operon is Bcam0380, which encodes a protein with a 
molybdopterin domain that is found in a variety of oxidoreductases. We tested if any of 
the cysteine residues in the AtsR protein is required for its function to link it functionally 
to the neighboring gene Bcam0380. A cys-less version of AtsR localized to the membrane 
and remained functional indicated that the native cysteines are dispensable for AtsR 
function. Currently, experiments are undergoing to identify potential signalling 
molecules. 
6.4 Cellular functions under the regulation of AtsR/AtsT  
Our data strongly support the notion that AtsR phosphorylation has a significant 
biological relevance as a virulence regulator modulating the expression of genes through 
AtsT. This notion was further confirmed by our comparative genetic and biochemical 
analysis in chapter 3. 
We compared the expression profiling of atsR mutant with a high throughput sequencing 
procedure. This combination defines the direct and indirect AtsR/AtsT regulon in the B. 
cenocepacia genome. Some of the identified genes encode proteins with unknown 
function and the rest have known or predicted functions in a wide range of cellular 
processes including T6SS, metallopeptidases, lipoproteins, quorum sensing related genes 
and a few genes encoding regulatory proteins that might function as intermediates in 
regulatory cascades (Table 3.3 and Table 3.4). Our results also have an interesting feature 





of atsR operon. Such negative autoregulation is in line with the prolonged nature of 
phosphorylated AtsR observed in our work. Assuming that the optimum goal of a two 
component circuit is to reach a steady-state protein concentration to detect environmental 
signals and to avoid overloading of the receptors, a negative regulatory circuit with a 
relatively stable phosphorylation status such as that of AtsR works far better to maintain 
steady-state levels by do-novo synthesis rather than protein turn-over. This way, 
unoccupied receptors are always available to perceive new signals and adjust responses 
accordingly. 
Another interesting observation is the variable affinity of AtsT DNA-binding to different 
promoters regardless of its phosphorylation status in vitro. This indicates that different 
binding affinities to the three promoters we tested here may represent a “fine-tuning” 
mode of action. In other words, this highly flexible mode of occupancy at promoters 
would likely render the expression of these genes relative to changes in AtsT-P levels; 
thus, it does not resemble an on-off switch. However, it should be noted that AtsT 
behaviour under in vivo conditions might be different than in vitro. For the majority of 
response regulators the phosphorylated form typically has a higher affinity for their target 
promoters (11). Also, certain response regulators bind DNA in vivo only when they are 
phosphorylated and produced at physiological levels (12, 13). This might be due to the 
accessibility of promoters or the presence of accessory proteins that promote or prevent 
phosphorylation. 
Although we aimed to identify genes directly regulated by AtsT, comparison of gene 
profiles from atsR mutant with ChIP-Seq data showed that there are a few genes present 





systems and that AtsT might be involved in other signalling pathways and act as a 
regulatory arm for several receptor proteins besides AtsR. Overall, AtsT directly regulates 
the expression of nearly 100 genes and is predominantly a repressor of genes encoding 
proteins associated with T6SS as well as lipoproteins, transposases, transport system 
binding proteins, glycosyltransferases, to name a few for which differences in expression 
have been observed in ∆atsT mutant and wild-type strains. By in silico analysis of ChiP-
seq data the AtsT-regulated genes can be grouped into different functional categories such 
as DNA repair and recombination, glycan biosynthesis and metabolism, mitochondrial 
biogenesis, environmental information processing and membrane transport.  The genes 
that are required for biofilm maturation and quorum sensing as a hallmark of AtsR/AtsT 
function are three main classes that are involved in encoding surface proteins, the 
biogenesis and maintenance of membrane integrity, and those that encode regulatory 
factors that affect N-acyl homoserine lactone production or perception. Examples of these 
classes have been identified in our combined approaches (Tables 3.3 and 3.4). 
Furthermore, our bioinformatic and DNase I foot printing analyses reveal the AtsT 
binding site architecture that likely has important implications for gene regulation in B. 
cenocepacia in many ways whether in the CF lung environment or its interaction with 
other environments. 
6.5 Burkholderia cenocepacia as an opportunistic model bacterium  
B. cenocepacia cause opportunistic infections in plants, insects, animals and humans, 
suggesting that "virulence" depends on the host and its innate susceptibility to infection. 
In chapter 5, I used B. cenocepacia as an opportunistic model bacterium and the host 





lipopolysaccharide and flagellin, in contributing to infection and also in eliciting a host 
response. I hypothesized that modifications in key bacterial molecules recognized by the 
innate immune system modulate host responses to B. cenocepacia. Indeed, modification 
of lipopolysaccharide (LPS) with 4-amino-4-deoxy-L-arabinose and flagellin 
glycosylation attenuates B. cenocepacia infection in Arabidopsis thaliana and Galleria 
mellonella insect larvae. However, B. cenocepacia LPS and flagellin triggers rapid bursts 
of nitric oxide and reactive oxygen species in A. thaliana leading to activation of the PR-1 
gene. These responses were drastically reduced in plants with fls2 (flagellin FLS2 host 
receptor kinase), Atnoa1 (Nitric Oxide Associated protein 1), and dnd1-1 (reduced 
production of nitric oxide) null mutations. Together, our results indicate that LPS 
modification and flagellin glycosylation do not affect recognition by plant receptors, but 
are required for bacteria to establish overt infection.  
6.6 Final remarks 
The results from this work provide insight into the diversity of AtsR/AtsT regulon and 
facilitate the potential of gene manipulation for redirecting information flow within 
bacteria to eliminate virulence in B. cenocepacia. We provided a comprehensive 
description of AtsR/AtsT phosphorelay mechanism that would be helpful for future 
studies investigating the nature of the AtsR activating signals and whether AtsR function 
can be manipulated pharmacologically to control B. cenocepacia infection. We further 
showed that the progression of B. cenocepacia virulence is both host- and strain-
dependent. In fact, virulence and pathogenicity are properties ascribed to microbes, which 
require careful consideration of the host since the microbe's capacity to establish a niche 





example of microbes whose ability to cause disease is intimately related to the host’s 
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After several attempts to purify DNA segments co-purified with AtsT, very low amounts 
of DNA were obtained (ranging from 1- 2 ng/µl). The minimum DNA concentration for a 
successful ChIP-Seq is 5 ng/µl. Here in this section I show the results of in vivo 
chromatin immunoprecipitation experiments and troubleshooting steps. 
B. cenocepacia culture expressing AtsT-Flag 
Crosslinking with formaldehyde 

















To create C-terminal Flag-tagged AtsT, atsT gene was amplified using 5108-2794 
primers and cloned into pDA17. The resulting plasmid was introduced into K56-2 ∆atsT 
and tested on DBH-I milk plates to check if the flag-tagged AtsT is functional (Fig. A.2). 
Exponentially growing culture in LB was incubated with formaldehyde to a final 
concentration of 1%. Crosslinking was quenched by adding glycine to 0.5 M final 
concentration. Cell pellets were washed in PBS and resuspended in lysis buffer [50 mM 
Tris-HCl (pH8.0), 10 mM EDTA, 1% SDS] plus protease inhibitor mixture (Sigma). The 
cells were sonicated for 25 cycles of 30 sec on/ 30 sec off at max power with a Bioruptor, 
and debris was pelleted by centrifugation. A 1 ml of sample was taken as input control. 
Following centrifugation,1/10 volume of 10% TritonX-100 in lysis buffer was added to 
each sample followed by 100 μL of Dynal-Protein G beads coated with anti-flag antibody 
(Sigma), and samples were incubated overnight with rotation. The beads were washed 1 × 
with low salt buffer [20 mM Tris (pH7.5), 150 mM NaCl, 2mM EDTA, 1% Triton, 0.1% 
SDS], 1× in high salt buffer [20 mM Tris (pH7.5), 500 mM NaCl, 2mM EDTA, 1% 
Triton, 0.1% SDS] and then with LiCl buffer (0.25 M LiCl, 1% Nonidet P-40, 1% Na-
deoxycholate, 1 mM EDTA, 10 mM Tris-HCl), and 1× in Tris-EDTA pH 8.0. 
Immunocomplexes were eluted with elution buffer (1% SDS, 0.1 M NaHCO3). Samples 
were incubated at 65° C for 4 h to reverse crosslinks, followed by incubation with DNAse 
free RNase A for 1 h at 37°C and then with proteinase K at 55°C for 2h and were purified 
with Qiagen PCR Reaction Cleanup Kit and quantitated with Sybr-green kit (Invitrogen). 
There was no difference between input and output DNA Q-PCR result which suggests 
that chromatin was not pulled down. All attempts for optimizing ChIP conditions failed 
and did not result in any improvement of flag-beads binding affinity which indicates that 









Figure A.2: B. cenocepacia expressing AtsT-Flag is functional. Complementation assay 
using AtsT-Flag on DBH-I milk agar plates to check the functionality of the tagged 















Aim 1: To determine if AtsT-Flag is detected by Western blot 






Figure A.3: Western blot result of B. cenocepacia expressing AtsT-flag. Numbers refer 













No significant difference between 
OD600 of 1 or OD 600 of 0.5. 
Which OD is the best for AtsT 
to be crosslinked?  











Figure A.4: Western blot results using Anti-flag to compare the efficiency of lysis 
methods. A) Lyzozyme was used in the lysis buffer along with Tris, NaCl, EDTA, 
sucrose, PMSF and protease inhibitor cocktail. Cells were incubated on ice for 40 min. B) 
Cells were incubated with lysis buffer without lysozyme and instead were disrupted by 





1: Before crosslinking 
2: After crosslinking 
3: After quenching 
4: After lysis 
5: After One shot 
6: After sonication 
7: After overnight incubation 
with Dynabeads protein A 
8: After wash 1 
9: After wash 2 
 
Optimization of Lysis 
method: Lyzozyme 
versus One shot 
Lyzozyme degrades AtsT despite 
having PMSF and protease inhibitor 


































Beads: Protein A versus G Magnetic 
beads  
Fth: Flow through 
W 1: After wash 1 
W 2: After wash 2 
W 3: After wash 3 
W4: After wash 4 
E: Eluate 
 
Figure A.5: Optimization of Chromatin immunoprecipitation by 
comparing binding affinity of protein A versus G. Western blot result using 
anti-flag for B. cenocepacia expressing AtsT-flag. Using protein A 





Aim 5: To improve binding affinity  



















1: Flow through 
2: After wash 1 
3: After wash 2 
4: After wash 3 
5: After wash 4 
6: Eluate 
 
Figure A.6: Optimization of Chromatin immunoprecipitation by blocking 
beads with BSA before loading the sample. Western blot analysis of 
immunoprecipitated AtsT-Flag troubleshooting. Blocking beads with BSA 






2- Increase incubation time of anti-flag with beads from 30 min to 2 h. 
 
3- Incubate anti-flag with sample before adding to the beads instead of adding 






























Fth: Flow through 
W1: After wash 1 
W2: After wash 2 
W3: After wash 3 
W4: After wash 4 
E: Eluate 
M:marker 
 Figure A.7: Optimization of Chromatin immunoprecipitation by applying 
antibody to the sample versus to the beads. Incubating antibody with sample 
before adding to the beads has no advantage over incubating antibody with 



























Figure A.8: Optimization of Chromatin immunoprecipitation by changing 
the incubation time. Western blot representing Co-Immunoprecipitation steps 
of AtsT-Flag using Protein G Magnetic Dynabeads. No difference observed 
with different incubation time in lysis buffer. 
Fth: Flow through 
W 1: After wash 1 
W 2: After wash 2 
W 3: After wash 3 







5- Boil beads with 1× SDS loading dye for 10 min to test if there is any protein 
(AtsT) bound to the beads. 
 





Figure A.9: Optimization of Chromatin immunoprecipitation by changing the beads. 
Western blot representing a control for crosslinking step of AtsT-flag using Protein G 







Fth: Flow through 
W 1: After wash 1 
W 2: After wash 2 
W 3: After wash 3 













Figure A.10: Optimization of Chromatin immunoprecipitation by changing the 
stringency of elution condition. Western blot representing ChIP steps of AtsT-flag using 











1: Flow through 
2: wash 1 
3: wash 2 
4: wash 3 
5: wash 4 
6: Eluted with 2% SDS 
7: Eluted with low pH 
8: Beads were boiled in 
SDS loading buffer after 
elution in 2% SDS 
9: Beads were boiled in 
SDS loading buffer after 














Figure A.11: Optimization of Chromatin immunoprecipitation of AtsT with different 
position of Flag tag. A) Western blot representing Co-Immunoprecipitation steps of AtsT 
fused to Flag tag (N-terminally) or (C-terminally) using Protein G Magnetic Dynabeads. 
Similar to previous results, AtsT is mostly in the flow through and barely in the elution 
fraction (E2). E1 represents elution fraction eluted with 1% SDS+ 0.1 M NaHCO3 and E2 
represents eluate boiled with 1× SDS loading dye. B) Same samples as in A were run for 








Figure A.12: Relative quantitative expression of Bcas0627 using input and output DNA. 
Based on the graphs, output DNA amplified 4.8 times more Bcas0627 than input DNA. 
Comparing this with Microarray, amplification is minor (Bcas0627 was upregulated 
almost 100 times in atsR mutant). Besides, this low amount of DNA (1.2 ng) is not 








Any of the above mentioned conditions did not improve elution of the AtsT from the 
beads. I believe it is very likely due to the crosslinking that the binding site of Flag tag is 
altered and therefore tag is not accessible. I have also used straptavidin column and 
biotinylated antibody but neither were helpful. Attempts to create AtsT tagged with HA 
and His was not successful as none of the plasmids in a complementation assay failed to 
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